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Tripartite motif family proteins (TRIMs) are a wide family of E3 ligases involved in the control of 
several cellular processes such as intracellular signaling, innate immunity, transcription, cell cycle 
regulation and carcinogenesis. In recent years, some members of this family have been found to have a 
role in autophagy.  
The central theme of this thesis is the role of two TRIM proteins in selective autophagy. I joined 
this project born from a screen of 22 different TRIM proteins using the double-tag assay, which 
represented the 11 TRIM family subgroups. The goal of this screen was to identify candidates with a 
potential role in autophagy, alleging that their presence in the lysosome linked them somehow with the 
autophagy process. From our screen, TRIM27 and TRIM32 were identified as new potential autophagic 
substrates, and we decided to further investigate their role in autophagy.  
We found that TRIM27 has an effect in starvation-induced autophagy and associates with core 
autophagy proteins and the autophagy receptors p62/SQSTM1 and NBR1. Furthermore, TRIM27 
interacts directly with and ubiquitylates p62/SQSTM1. We established TRIM27 KO cells, which 
showed high expression levels of the lysosomal protein LAMP2 and formation of big LAMP2 rings in 
the cytosol.. TRIM27 is proposed to act as an oncogene. In line with this, we identify TRIM27 mRNA 
levels to be strongly upregulated in cancer tissue from breast cancer patients. Intriguingly, we found the 
protein level of TRIM27 in various breast cancer cell lines to be inversely correlated with LAMP2 and 
LC3B expression. This suggests a potential role of TRIM27 in autophagy in certain types of breast 
cancer.  
We also examined the autophagic role of TRIM32, including two mutant variants of TRIM32 
that are associated with Limb-Girdle-Muscular-Dystrophy 2H (LGMD2H) or Bardet-Biedl-Syndrome 
11 (BBS11), respectively. First, we found that TRIM32 is directed to autophagic degradation by 
p62/SQSTM1, but also act as a regulator of p62/SQSTM1 autophagic activity. This formed a feedback 
loop that was controlled by the direct interaction and ubiquitylation of p62/SQSTM1 by TRIM32. 
Interestingly, the TRIM32 mutant implicated in the muscular dystrophy disease LGMD2H failed to 
ubiquitylate p62/SQSTM1. Next, we further studied the role of TRIM32 towards the other proteins in 
the SLRfamily of autophagy receptors. We found that TRIM32 interacts and ubiquitylates the autophagy 
receptor NDP52, stabilizes the phosphorylated form of the autophagy regulator TBK1 and facilitates 
mitophagy. Lastly, we studied how TRIM32 auto-ubiquitylation regulates its activity and stability. We 
found that TRIM32 contains a PEST sequence, which exposure seems to be regulated by ubiquitylation 
and acetylation. This was a novel finding since to date, no PEST sequence has been identified in TRIM 
proteins. Taken together, these findings highlight the pivotal role of TRIM27 and TRIM32 as regulators 









“En resumen: toda obra grande es el fruto de la paciencia y de la perseverancia, combinadas 
con una atención orientada tenazmente durante meses y aun años hacia un objeto particular.” 
“In summary, all great work is the fruit of patience and perseverance, combined with tenacious 
concentration on a subject over a period of months or years.”  
 
 
Reglas y consejos sobre investigación científica,1899 
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Introduction 
Planet earth can be a hostile place, where organisms of all sorts are in a constant fight for 
survival. Evolution has provided cells the ability to improve the quality of those survival 
mechanisms, arriving to very high complex networks that work coordinately to try to ensure 
the continuity of the species. At a cellular level, eukaryote cells have developed a high degree 
of complexity in order to maintain homeostasis.  
 
Introduction to the Ubiquitin/Proteasome (UPS) system 
Synthesis and clearance of functional proteins regulate their availability within the cell, 
adapting the protein pool to the cellular needs. Thus, protein degradation is a crucial element in 
the maintenance of cellular homeostasis. In addition to the level, also the functionality of 
cellular proteins are continuously checked. For this purpose, the cell has several mechanism 
that work together to ensure the quality and functionality of the synthetized proteins. The 
protein quality control system of the cell monitors the complete life cycle of a protein at the 
different steps of its synthesis, acting as a surveillance mechanism (Pohl and Dikic 2019). From 
the very first stages of protein translation, there are cellular components in charge of controlling 
the quality of mRNA and their nascent protein products, so in case of mistakes they do not 
continue further of the synthesis chain (Dikic 2017). Furthermore, chaperons help on the protein 
folding process, as well as detecting misfolded proteins and send them for degradations if the 
efforts for correct folding fails (Saibil 2013). The cell is in constant battle in order to maintain 
its homeostasis, which leads to a constant control of protein concentration, as well as 
remodeling, repair or elimination of those proteins that became damaged. If the cell is not able 
to degrade those proteins at a certain moment, they can also be sequestered in special 
compartments until the cell is able to proceed to their degradation (Sontag, Samant, and 
Frydman 2017) . Such a crucial process for the cell’s well-being is tightly regulated in a spatially 
and timely manner through two main systems: the ubiquitin-proteasome system (UPS) and the 
lysosomal-mediated proteolysis (hereafter autophagy) (Figure 1). Around 80-90% of proteins 
are degraded through the UPS system whereas the remaining 10-20% are degraded by the 
lysosomal-mediated proteolysis. In general, small short-lived proteins are the main substrates 
for the proteasome, while long-lived proteins and bigger structures such as protein aggregates 
or whole organelles are mainly degraded by autophagy (Kleiger and Mayor 2014; Ding et al. 
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2014). However, these two systems are highly interconnected, thus, different degradation 












The ubiquitin-proteasome system consists in a well-defined network of components 
which act together to tag proteins for degradation. The main tag is a 76 amino acid globular 
protein called ubiquitin (Yu and Matouschek 2017). Targeted proteins are conjugated to 
ubiquitin by the mediation of three sequential reactions (Figure 2). The first reaction is the 
activation of ubiquitin by E1 enzymes, which is the only step of the process that requires ATP. 
The second members of the cascade are E2 enzymes, which conjugate ubiquitin for its delivery 
to the next step. The third and last reaction is mediated by E3 ligases that make possible the 
binding of the activated ubiquitin to the target molecule (Oh, Akopian, and Rape 2018). 
According to current knowledge, in the human genome there are two E1 enzymes genes, 40 E2 
genes and around 600 E3 ligase genes (Celebi et al. 2020) . Thus, while E1 and E2 enzymes are 
highly conserved and in most cases do not present much specificity, whereas E3 ligases are in 
charge of recognizing the substrate, which makes them the main regulator of ubiquitylation.  
 
Figure 1. Protein quality control of eukaryotic cells.  Chaperones facilitate the folding of nascent polypeptides and refolding 
of misfolded proteins. The UPS degrades both misfolded/damaged proteins and excess native proteins in the cell. The 
autophagy-lysosomal pathway removes protein aggregates formed by the misfolded proteins that have escaped from the 
surveillance of chaperones and the UPS. (X. Wang and Su 2010) 
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Figure 2. Enzymatic reaction of ubiquitylation. For activation of the ubiquitylation process, E1 enzyme makes a thioester 
bond with the ubiquitin molecule, and the required energy is supplied by the hydrolysis of ATP. In the conjugation step, the 
ubiquitin on the E1 enzyme is transferred to the E2 enzyme. Finally, the substrate–E3 enzyme bond is involved, and the C-
terminal of the ubiquitin molecule makes a covalent bond with the substrate. (Celebi et al. 2020) 
 
Ubiquitylation consists in the covalent binding of an ubiquitin molecule to a protein. 
The most common type of ubiquitylation is called canonical ubiquitylation and is defined by 
the formation of an isopetide bond between a lysine residue of the target protein and the C-
terminal glycine 76 of an ubiquitin molecule (mono- ubiquitylation) (Kleiger and Mayor 2014). 
Other molecules of ubiquitin can then be attached to that mono-ubiquitin in eight potential sites: 
M1, K6, K11, K27, K29, K33, K48 and K63, which originate different linkages of polyubiquitin 
chains (poly- ubiquitylation). In addition, there may exist branched linkage types (Dikic 2017), 
and other ubiquitin-like proteins may also be conjugated to ubiquitin, such is the case of SUMO 
or NEDD8 molecules (Swatek and Komander 2016). Overall, this provides a wide range of 
combinations referred as “ubiquitin code” that is essential in directing the cellular fate of the 
ubiquitylated protein. Ubiquitin as a post-translational modification (PTM) that plays a role in 
many cellular processes such as DNA repair response, cell cycle regulation, autophagy, cellular 
differentiation and cell-mediated immunity (Yu and Matouschek 2017; Kwon and Ciechanover 
2017). 
The established ubiquitin modification shown to label proteins for degradation by the 
UPS is the addition of K48-linked chains. Ubiquitylated proteins tagged for degradation by the 
UPS are transported to the 26S proteasome, more commonly called “the proteasome” (Figure 
3). The 26S proteasome is a barrel-shaped proteolytic organelle formed by the 20S central 
catalytic complex and two 19S complexes that function as a lid (Bard et al. 2018). The 
degradation and recycling of proteins occurs in the 20S central subunit, whereas the 19S 
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complexes regulate the binding to cargo-loaded shuttling proteins, deubiquitylate the substrates 










Ubiquitylation: A full world beyond protein degradation 
In the beginning, ubiquitin was identified merely as a tag for degradation, however in the last 
decades evidences have shown that ubiquitin has other important roles beyond tagging a protein 
for degradation in the proteasome. Ubiquitylation is a reversible modification that shows a high 
level of specificity, this makes the ubiquitin-dependent signaling very rapid and dynamic (Jia 
Liu et al. 2015). Therefore, it is not surprising that ubiquitylation as a signaling mechanism is 
involved in numerous cellular processes that require a quick switch. Among those processes 
can be found chromatin architecture, gene-specific transcription, DNA repair, protein quality 
control at the translational level, protein transport, control of signal transduction and cellular 
defense against pathogens (Oh, Akopian, and Rape 2018). 
Histones can be modified by the addition of one or more molecules of ubiquitin. 
Depending on the type of linkage, the outcome can lead to different consequences in controlling 
gene expression, DNA methylation or DNA repair (Meas and Mao 2015). Interestingly, de-
ubiquitinases (DUBs) work doing the opposite roles of E3 ligases, removing ubiquitin from 
previously ubiquitylated proteins (Wilkinson 2009). At first, it was thought that the only role 
of the dynamic between E3 ligases and DUBs was merely counteract each other’s actions. 
However, it has been shown that these two enzymes acting in direct opposition can generate a 
more complex signaling output. An example of this mechanism has been shown during the 
Figure 3. Structure of proteasome and degradation of ubiquitylated substrates. The 26S proteasome has a multicomplex 
structure that is composed of a 19S regulatory units and a 20S catalytic core unit. In the 19S regulatory complex, the 
ubiquitinated proteins are unfolded, and ubiquitin tags are separated from the protein by deubiquitinase enzymes. 
Consequently, the unfolded polypeptide chain is delivered to the 20S catalytic core complex where they are degraded into 
small peptides. (Celebi et al. 2020) 
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process of mitophagy (autophagy of mitochondria), when an activation of the E3 ligase 
PARKIN and an inhibition of the counteracting USP30 take place simultaneously. This leads 
to a rapid tagging of defective mitochondria with a dense ubiquitin signal that will lead to its 
prompt degradation. (Cunningham et al. 2015) Therefore, it is not uncommon to find E3 ligases 
and DUBs forming part of the same complexes, which highlights the importance of reversibility 
in ubiquitin signaling (Harrigan et al. 2018).  
Ubiquitin signaling is also able to act as a quality control at the translational level. E3 
ligases are present next to the ribosomes to ensure the quality of the proteins being synthesized 
(Grumati and Dikic 2018). There are proteins that are attached to ribosomes such as E3 listerin, 
which binds stalled ribosomes (Shao, Von der Malsburg, and Hegde 2013). In addition, there 
are E3 ligases that cooperate with chaperones that detect misfolded or mislocalized proteins, or 
by the binding of an E3 ligase to a degron (degenerated motif of a misfolded polypeptide) 
(Davey and Morgan 2016). All these mechanism will lead the low quality proteins to 
degradation before they accumulate and disturb the homeostasis of the cell. Once the proteins 
are correctly synthesized, ubiquitin-signaling also contributes to control their transport and 
delivery to their programmed destination. Ubiquitylation is a modification that can show high 
spatial precision, which can impose directionality onto signaling cascades. A good example of 
the effect of ubiquitylation in protein trafficking is the internalization of EGFR for its 
inactivation (Levkowitz et al. 1998). Ubiquitin has also a crucial role in the defense of the cell 
against pathogens. Both bacteria and viruses have developed mechanism to highjack the 
ubiquitylation system in order to not be detected and proceed to infection (Zong et al. 2021). 
 
Autophagy: The phagophore’s turn 
The term and idea of autophagy came to life by a Belgium scientist called Christian de Duve, 
who firstly described lysosomes as a new cellular organelle, and later on the degradation of 
cytoplasmic material in these lytic compartments. He defined this process as autophagy, which 
means self-eating in Greek (Ohsumi 2014). However, the lack of methodology to continue the 
research in the role of autophagy and its mechanistic lead to a delay in the field. In the late 
1990, many new methods in molecular biology made possible to decipher the insights of this 
degradation pathway. In the last 20 years, there has been an outbreak of discoveries and 
knowledge surrounding autophagy. Starting with the discovery of the autophagy related 
proteins by Yoshinori Ohsimi, which lead him to a Nobel Prize in Medicine in 2016, to the 
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description of the LC3-interactiong region (LIR) motif and autophagy receptors (Kirkin 2020; 
Zimmermann et al. 2016; Johansen and Lamark 2020). All these achievements have allowed us 
to understand better, how the cell maintains its homeostasis through a very complex equilibrium 
between synthesis and degradation.  
Even though the concept of autophagy is simple, cytoplasmic material delivered to the 
lysosomes for its degradation, the way and reasons why that cytoplasmic material ends up in 
the lytic compartment is much more complex and still to date not fully understood. There are 
three described types of autophagy: microautophagy, chaperon-mediated autophagy (CMA), 
and macroautophagy (Figure 4).  
 
Figure 4. Types of autophagy. There are three types of autophagy: macroautophagy, microautophagy, and chaperone-
mediated autophagy. Macroautophagy is a type of autophagy that delivers cellular contents to the lysosome via the formation 
of double-membrane structures called autophagosomes, which then fuse with lysosomes. Microautophagy facilitates the direct 
uptake and breakdown of cytosolic cargo by lysosomes. Chaperone-mediated autophagy refers to the chaperone-dependent 
targeting of specific cytosolic proteins to lysosomes for proteolysis. (Ho et al. 2019) 
 
Microautophagy is defined by the sequestration of cytoplasmic material directly into the 
lysosome or endosomes through an invagination of the membrane that eventually pitches off 
into the lumen (Li, Li, and Bao 2012; Mejlvang et al. 2018). During CMA, which only happens 
in mammals, proteins that expose a pentapeptide signature motif (KFERQ) are recognized by 
heat shock 70 kDa protein 8 (HSPA8/HSC70), which in turn binds to the lysosomal-associated 
membrane protein LAMP 2A (LAMP2A) that translocates the protein directly into the 
lysosome (Kaushik and Cuervo 2018). By definition, CMA is a selective mechanism, and 
microautophagy can also be defined as selective until a certain extent, since it seems that the 
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cell selects which proteins are going to be delivered to the lysosome. The best-characterized 
autophagy pathway is macroautophagy, which is commonly called autophagy. The main feature 
of this form of autophagy is the engulfment of cellular material by a double-membrane structure 
called phagophore. The phagophore then is transported through microtubules and eventually 
fused with lysosomes, which will degrade the delivered substrates through the action of 
lysosomal hydrolases. This process can be non-selective, the so-called bulk-autophagy, or 
selective, which is called selective autophagy. At first, it was thought that macroautophagy was 
merely a response for nutrient depravation, which leaded to the degradation of any cellular 
material accessible in the cell in order to provide molecular building blocks while no nutrients 
were available. However, growing evidences show that not only this form of autophagy can be 
highly selective, but that there are many stimuli that can activate this cellular mechanism (L 
Galluzzi et al. 2017). 
The main steps of the autophagic pathways are initiation, nucleation of the phagophore, 
membrane expansion/elongation, maturation and fusion (Figure 5). The proteins involved in 
the regulation of autophagy are called ATG proteins (autophagy-related genes). Despite the fact 
that there are more than 40 of those ATG proteins, which all play a role in autophagy, there are 
17 conserved ATG proteins that are essential and sufficient to make the autophagic process 
possible. This subset of essential ATG is called the “core autophagy machinery”.  These ATG 
proteins are recruited to the site of autophagosome formation and act in a sequential manner in 
order to fully form a closed autophagosome that will eventually fuse with a lysosome for the 
degradation of its content (Melia, Lystad, and Simonsen 2020). The ATG proteins were firstly 
described in yeast. However, autophagy seems to be a conserved mechanism among eukaryotes, 
therefore, many ATG present in yeast have their counterparts in mammals (Reggiori and 
Klionsky 2013). As expected, a higher degree of complexity is added to higher eukaryotes, 
adding new regulators and mediators to this process.  
The autophagy process starts at the Endoplasmatic Reticumul (ER) by the unbedding of 
a cup shaped-membrane leading to the formation of a pre-autophagosome or omegasome 
(Hurley and Young 2017). Under normal conditions, autophagy is mainly controlled by nutrient 
availability and the metabolic needs of the cell. The status of threonine-serine kinase ULK1 is 
the main determinant of autophagy activation, due to its position as the most upstream kinase 
within the autophagy core machinery. The two main regulators of this kinase are AMP-activated 
protein kinase (AMPK) and mTORC1, which directly phosphorylate ULK1. On one side, 
AMPK activity positively regulates autophagy, whereas mTORC1 inhibits autophagy under 
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nutrient-rich conditions (Alers et al. 2012). Starvation and rapamycin treatment are sufficient 
to activate autophagy via mTORC1, which has been reported to have a regulatory role not only 
in initiation of autophagy but also in nucleation, elongation and fusion of autophagosome to 
lysosomes (Dossou and Basu 2019). Starvation induced autophagy is initiated by the activation 
of ULK1 via mTORC1 inhibition, which leads to the phosphorylation of ULK1. The ULK1 
complex formed by ULK1/2, ATG13, FIP200 and ATG101 is rapidly recruited to this 
developing membrane. Next, the class III lipid kinase complex I formed VPS34, VPS15, 
ATG14 and Beclin 1, is recruited. Beclin 1 is then phosphorylated by ULK1, which leads to 
Beclin 1 transforming phosphoatidylinositol-2-phosphate into phosphatidylinositol-3-
phosphatase (PtdIns3P) (Russell et al. 2013). The increasing of the levels of PtdIns3P in the 
pre-autophagosome leads to the recruitment of WD-repeat protein interacting with 
phosphoinositides (WIPI) proteins. There are four members of this family (from WIPI1 to 
WIPI4), which act as a bridge between PdIns3P production and ATG8 proteins lipidation 
(Proikas-Cezanne et al. 2015). The ATG8 family in mammals consists of at least 6 proteins 
(LC3A, B, and C, GABARAP, GABARAP-L1 and L2), all of which hereafter referred as ATG8 
proteins. Pro-LC3 is the LC3 fresh form coming from translation, which is cleaved by ATG4 
and deacetylated by SIRT proteins, forming LC3-I. Then WIPI2 recruits the ATG12-ATG5-
ATG16L complex, which catalyzes the conjugation of LC3-II into the expanding autophagy 
membrane. The lipidation of LC3 molecules and elongation of the membrane leads to the 
closure of the autophagosome, which then becomes a mature autophagosome. This 
autophagosome can either fuse with late endosomes to form amphisomes, which later fuse with 
lyososmes, or directly fuse with a lysosome. The fusion product of an autophahosome and a 
lysosome is called autolysosome. The supply of lipids to form this autophagosome is mediated 
by ATG9, through ATG9 vesicles, which come from membrane reservoirs like Golgi apparatus 
(Matoba et al. 2020; Gómez‑Sánchez et al. 2018). This autophagosome will be transported via 
microtube tracks towards the lysosomes, which are commonly found in the perinuclear region 
of the cell (Johnson et al. 2016). This transport is possible thank to small GTPase Rab7, which 
links autophagosome to microtubule motors through FYVE and coiled-coil domain containing 
1 (FYCO1) (Pankiv, Alemu, et al. 2010). There are other proteins involved in the transport of 
autophagosome along the microtubules, however, their mechanism is still poorly understood. 
Once in close proximity, the autophagosomes fuse with a lysosome via a Rab GTPases, which 
localize in specific membranes and recruit tethering complexes that act as bridges to bring the 
autophagosome and lysosomes together. On the other side, these tethering complexes help 
membrane-tethering complexes and soluble N-ethylmaleimide-sensitive factor attachment 
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protein receptors, commonly known as SNAREs proteins, to physically drive the fusion of 
opposing lipid bilayers (Nair and Klionsky 2011). Once the fusion has taken place, the cargo 
delivered to the lysosome will be degraded (Nakamura and Yoshimori 2017).  Despite the exact 
mechanism of which autophagosome formation and who contributes to this process is not fully 
understood, it is becoming clear that all intracellular compartment contribute in different 
degrees. 
 
Figure 5. Overview of selective autophagy in mammalian cells. The main steps of autophagy are initiation, nucleation, 
expansion cargo recruitment, closure, maturation and cargo degradation.  
 
In this context, autophagy is shown to be non-selective, trying to degrade any available 
cytosolic molecules to obtain nutrients. However, autophagy has also been shown to behave in 
a selective manner, regulating the degradation of big cellular structures such as organelles, 
nuclear components, the proteasome, protein aggregates or invading pathogens. In this context, 
autophagy has a much more complex role than being a response to scarcity, and depending on 
the stresses that the cell has to face, it works as a powerful cytoprotective mechanism 
(Zaffagnini and Martens 2016).  
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Selective autophagy: Entering the world of LIRs 
In contrast to bulk-autophagy, selective autophagy can have different substrates that are 
selected for degradation under certain conditions, which vary depending on the stress or stimuli 
that the cell receives (Lamark, Svenning, and Johansen 2017). In the last years, there has been 
an outbreak surrounding this type of autophagy (Kirkin 2020). Selective autophagy is classified 
into “-phagies”, describing the organelle or structure that is targeted for degradation: for 
example, pexophagy is the autophagic degradation of peroxisomes (Germain and Kim 2020), 
ER-phagy refers to the autophagic degradation of the ER (Nakatogawa and Ohsumi 2020), 
mitophagy involves autophagy of mitochondria (Swerdlow and Wilkins 2020), aggrephagy 
refers to the degradation of protein aggregates (Lamark and Johansen 2012), and so forth. The 
list of types of autophagy is growing and it is likely to expand even further in the years to come 
(Kirkin and Rogov 2019). The main interaction to control selective autophagy is by the 
interaction of ATG8s with LC3-interacting motifs, the so-called LIRs (Birgisdottir, Lamark, 
and Johansen 2013). The core consensus sequence of a LIR is [W/F/Y]xx[L/I/V], where 
negatively charged amino acids are commonly found in the middle of the sequence (x) (Birna 
Birgisdottir et al. 2019; Lamark, Svenning, and Johansen 2017). The LIR motif forms an 
extended B-sheet positioned in a crevice formed by the N-terminal arm and the ubiquitin-like 
domain of the ATG8.  The LIR is bound to hydrophobic pockets HP1 and HP2 in the ATG8s 
(Birgisdottir, Lamark, and Johansen 2013; Sora et al. 2020). The LIRs that follow this definite 
pattern are called canonical LIR motifs, which is the case for the majority of found functional 
LIRs. However, non-canonical LIRs have also been described, which interestingly show more 
restricted binding preference relative to ATG8 family members (Rogov et al. 2014). 
Intriguingly, it seems that LIRs-containing proteins can bind other elements of the autophagic 
core machinery through their LIR motifs than ATG8 proteins, as is the case of the binding of 
ATG19 to ATG5 via its LIR motif, forming an axis with the ATG12-ATG5-ATG16 complex. 
The binding of ATG19 to either ATG5 or ATG8 through its LIR motif seems to be mutually 
exclusive, suggesting a hierarchy of binding events that might ensure the directionality of 
reactions in the process of autophagosome formation (Fracchiolla, Sawa-Makarska, and 
Martenshttps 2017). This novel finding adds another function to LIRs, which seems to be 
beyond their binding of ATG8s. 
ATG8 proteins act as adaptors or scaffold for recruitment of LIR-containing proteins to 
both surfaces of the growing phagophore (Johansen and Lamark 2020). This way they serve 
four main functions in autophagy: First, they act as membrane scaffolding of LIR-containing 
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core autophagy components of the ULK1/2 complex, class III PI3K complex I, the ATG4B 
protease processing ATG8s (Rasmussen et al. 2017), and ATG12-ATG5 to the rim and outer 
surface of the phagophore. Secondly, there is a LIR-dependent attachment of Selective 
autophagy receptors (SARs) to the inner surface of the pagophore. Third, help in the fusion of 
autophagosome and fourth assisting transport of autophagosomes to the lysosomes. 
Interestingly, ATG8 are not necessary for autophagosome formation, but essential for 
autophagosome-lysosome fusion. Their removal causes smaller autophagosomes, as well as 
slower initiation of the formation of those, leading to a very inefficient autophagic flux (T. N. 
Nguyen et al. 2016). Among the human ATG8 proteins, LC3s seem to be highly involved in 
elongation of the phagophore membrane, whereas the GABARAP subfamily is essential for 
autophagosome maturation (Jacquet et al. 2020). It is still not clear what the exact role of the 
different ATG8s are. They seem to add redundancy to the system, since there are cargos that 
can be recognized by more than one receptor. However, there are receptors that show a 
preference for certain members of the ATG8 proteins. This is the case of NDP52, which show 
a much stronger binding towards LC3C (von Muhlinen et al. 2012). The preference of receptors 
to different forms of ATG8s proteins suggests that the diversity adds both redundancy and 
specificity to the autophagic process (Wirth et al. 2019).  
Intriguingly, it seems that LIRs-containing proteins can bind other elements of the 
autophagic core machinery through their LIR motifs than ATG8 proteins, adding additional 
functionality to LIRs. It has been suggested that this is a way to ensure the directionality of 
reactions. In addition, ATG8 can also bind other proteins through their non-LIR motif. A decade 
ago a study suggested a possible interaction between a large range of protein interacting with 
ATG8 independently of their LIR docking site (LDS) (Behrends et al. 2010), however, there 
are still only a few examples describing such an interaction. The recently described ubiquitin-
binding motif (UIM) shows a LIR-independent interaction of the ATG8 proteins through the 
UIM-docking side (UDS). These two biding surfaces are well separated, which enable 
simultaneous biding. This was observed in Arabidopsis, where ATG8 binds RPN10 through on 
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Autophagy receptors: The big guardians 
How the cell selects the cargo to be degraded and in which conditions that happens leads to a 
very complex network of pathways that work together to maintain the homoeostasis of the cell. 
The big guardians of this process are the so-called autophagy receptors (SARs) (Johansen and 
Lamark 2020). Not all act at the same time or in the same conditions. They show a certain 
degree of redundancy, helping resolving emergencies for the cell even in the absence of one or 
more SARs. The most known autophagy receptors are: p62/SQSTM1, NBR1, TAX1BP1, 
Optineurin and NDP52 (Calcoco2), which all together are called SLRs (SQSTM1-like 
receptors) (Fig X). However, in the past years there has been an increase in the number of 
proteins that can also act as autophagy receptors, such as TRIM family proteins (see sections 
bellow) or organelle-bound receptors (Jia et al. 2018) (Zaffagnini and Martens 2016). This 
suggest that the cell has many resources to ensure the proper clearance of damaged elements.  
 
Figure 6. Domain architecture of selective autophagy cargo receptors SLRs. The sequestosome-1-like receptors (SLRs) 
constitute of p62, NBR1, NDP52, TAX1BP1 and OPTN (optineurin) in mammals. (Birgisdottir et al., 2013) 
 
The SLRs are typically degraded in the lysosome, where they end up after binding the 
cargo and forming autophagosome, or by being imbedded directly to the lysosome by 
microautophagy (Mejlvang et al. 2018). Some of them such Optineurin can also be degraded 
by the proteasome (Wild et al. 2011). The description of the SLRs and their mechanistic have 
helped establishing the characteristics that are needed to qualify as an autophagy receptor. The 
essential characteristics of a bona fide autophagic receptor are: first, SARs have a LIR motif 
that binds to the ATG8s lipidated to the inner surface of the phagophore. Secondly, they are 
able to bind the cargo directly or through ha labelling protein such ubiquitin, and third they are 
degraded together with their cargo (Lamark, Svenning, and Johansen 2017). 
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P62: the pioneer 
The most well-known and firstly discovered autophagy receptor is called p62/SQSTM1 (Atg19 
in yeast) (Bjørkøy et al. 2005). The p62 domain architecture consists in an N-terminal headed 
by self-interacting PB1 domain, followed by ZZ-type zinc finger domain (ZZ), two nuclear 
localization signals (NLS), a nuclear export signal (NS), a LIR motif, and a KEAP1-interacting 
region (KIR) (Lamark, Svenning, and Johansen 2017) (Figure 7). In the C-terminal shows an 
ubiquitin associated UBA domain (Pankiv et al. 2007; Pankiv, Lamark, et al. 2010). The PB1 
domain mediates p62 polymerization and binds other PB1-domain containing proteins, while 
the UBA domain binds the ubiquitylated substrates, showing preference for K63-linked 
polyubiquitin chains (Lamark et al. 2003).  
 
Figure 7. Domains of p62. P62 is a 440 amino acid protein containing a PB1 domain (PB1), a ZZ-type zink finger domain 
(ZZ), two nuclear localization signals 1 and 2 (NLS1 and NLS2), a nuclear export signal (NES), an LC3- interacting region 
(LIR), a Keap interacting region (KIR), and an ubiquitin-associated domain (UBA). (Birgisdottir, Lamark, and Johansen 2013) 
 
Even though p62 commonly binds ubiquitylated substrates and leads them to 
degradation, this bona fide autophagy receptor can also bring to degradation non- ubiquitylated 
cargos (Lamark, Svenning, and Johansen 2017). The regulation of p62 occurs both in the 
transcriptional and translational level. NRF2 is an important regulator of p62 levels, and its 
translocation to the nucleus leads to a rapid increase in the levels of p62 transcription 
(Katsuragi, Ichimura, and Komatsu 2016). Post-transcriptional modifications (PTMs) are the 
main responsible of p62 regulation after its transcription, which form a complex network of 
modifications that control the functionality of this autophagy receptor. Among those PTMs are 
found phosphorylation and ubiquitylation (Lamark, Svenning, and Johansen 2017). A strong 
recruitment of p62 occurs when the cell faces high levels of oxidative stress or a high 
accumulation of protein aggregates (Cohen-Kaplan et al. 2016). The homopolydimerization of 
p62, via its PB1 domain, leads to long polymeric chains forming helical filaments (Jakobi et al. 
2020). These polymeric chains mixed with ubiquitin chains often undergoing phase separation, 
leading to the formation of droples. This condensates form a network surrounding the selected 
cargo (Sun et al. 2018).  
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Besides p62 pivotal role in autophagy, this autophagic receptor has several roles in 
several cellular signaling pathways involved in cellular survival and growth. The roles of p62 
have been found to be important in a variety of cancers (Ning and Wang 2018). The over 
expression of p62 has been described in many studies, and elevated levels of p62 expression is 
associated with poor prognosis (Ruan et al. 2018). Selective autophagy is one of the 
mechanisms through which p62 dysregulation leads to advantageous growth for cancer cells 
(D. Nguyen et al. 2019). P62 also activates pro-survival signaling and gene expression, as well 
as stabilization of a set of pro-metastatic mRNAs (Ségal-Bendirdjian et al. 2014).  
 
NDP52: The pathogens’ enemy 
Another well-known SLR is NDP52, which is also called Calcoco2 (calcium binding and 
coiled-coil domain 2) (Von Muhlinen et al. 2010). This autophagy receptor is a member of the 
nuclear dots (NDs) and it is formed by a  SKICH domain at the amino terminus, followed by a 
LIR motif, a coiled-coil domain in the central region, and a Ubiquitin binding zinc finger (UBZ) 
in the carboxyl terminus (T. Fu et al. 2018; Fan et al. 2020) (Figure 8). The finger motifs contain 
the binding domain for ubiquitin, mediating the important role of this receptor in ubiquitin-
mediated protein degradation (Xie et al. 2015).  
 
Figure 8. Structure of NDP52. NDP52 contains 446 amino acid, including the domains of SKICH, LC3-interaction region 
(LIR), COILED-COIL (CC), and UBZ. UBZ domain interacts with Ub, identifies and binds autophagy substrates. LIR domain 
interacts with LC3 and assists substrate anchoring to autophagosome membranes. From (Birna Birgisdottir et al. 2019)  
 
NDP52 is tightly linked to innate immunity and has a crucial role in the degradation of 
invading pathogens (xenophagy) (Von Muhlinen et al. 2010). On one side, NDP52 targets 
bacteria to the nascent autophagosome by binding ubiquitin coated bacteria and ATG8 through 
its LIR motif, leading to the delivery of the tagged bacteria to the forming autophagosome (von 
Muhlinen et al. 2012). On the other side, NDP52 promotes autophagosome maturation by 
interacting with ATG8 through a distinct LC3-interacting region and the motor protein 
MYOSIN VI (Verlhac, Viret, and Faure 2015). NDP52 recognizes and targets ubiquitin coated 
Salmonella for degradation by binding via its SKICH domain the adaptor proteins Nap1 and 
Sintbad, which recruit TBK1 (Thurston et al. 2009). At the same time, TBK1 regulates the 
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autophagic functions of NDP52 by phosphorylating its SKICH domain (Heo et al. 2015). 
Moreover, NDP52 forms a trimeric complex with FIP200 and NAP1, which promotes the 
progression of antibacterial autophagy (Ravenhill et al. 2019). Furthermore, NDP52 interacts 
with Galectin-8 (Gal8), a cytosolic lectin that acts as a danger receptor, binding host glycans 
exposed on damaged Salmonella-containg vacuoles. NDP52 contains a Galectin-8 interacting 
region between the coiled-coil and UBZ domains. Therefore Gal8 activates NDP52-mediated 
xenophagy by detecting complex glycans that are not commonly present in the cellular cytosol, 
acting as a monitor of endo-lysosomal integrity (Thurston et al. 2012).  
Another important role of NDP52 is the mediation of clearance of mitochondria 
(mitophagy) (Vainshtein and Grumati 2020). It has been shown that NDP52 is recruited to the 
mitochondria by the internal mitochondrial protein PTEN-induced kinas 1, commonly known 
as PINK1 (Lazarou et al. 2015). Once there, NDP52 associates with the ULK1 complex by its 
interaction with FIP200 (Ravenhill et al. 2019), interaction that is necessary for NDP52-induced 
mitophagy (Shi et al. 2020). The association of NDP52 with FIP200 is facilitated by TBK1, 
which is able to induce autophagy in the absence of LC3 (Vargas et al. 2019). In this context, 
the ULK1 complex activation mediated by NDP52 is independent of AMPK and mTOR 
activity. 
Moreover, NDP52 mediates the degradation of other proteins involved in miRNA 
regulation, genomic stability and immune signaling. NDP52 mediates the degradation of 
retrotransposon RNA, DICER and protein argonaute 2 (Ago2) in the miRNA level (Gibbings 
et al. 2012). NDP52 sends to degradation the retrotransposon RNA, acting as a physiological 
buffer against genetic variegation (Guo et al. 2014). Furthermore, NDP52 deals with the 
degradation of mitochondrial antiviral signaling protein (MAVS), involved in Type I Inteferon 
signaling. (S. Jin et al. 2017). Another contribution of NDP52 to the regulation of the immune 
response is by mediating the degradation of the signaling adaptor protein TUR domain 
containing adaptor molecule 1 (TRIF) and Myeloid differentiation primary response protein 
MyD88 (MyD88), which are both implicated in Toll-like receptor (TLR) signaling (Inomata et 
al. 2012). Mutations found in NDP52 have been linked to Crohn disease, characterized by a 
chronic inflammation of the gastrointestinal tract. In this disease, NDP52 has been suggested 
to have a role in controlling NFKB signaling downstream of the toll-like receptor pathway, 
which is crucial in inflammatory signaling (Till et al. 2013).  
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Mitophagy: recycling big energy factories 
Mitochondria are double-membrane organelles that constantly supply the cell with energy in 
form of ATP by the oxidation of fatty acids and pyruvate in the electron transport chain 
(Raimundo et al. 2017). Mitochondria have a bacterial origin, and even though the exact origin 
is unknown, it is clear that at some point in time an eukaryote cell integrated a bacterium as an 
organelle, stablishing a relationship of endosymbiosis (Zachar and Gergely Boza 2020). 
Through the years, mitochondria has not become only the powerhouse of the cell, but it has also 
developed an essential role in many other cellular functions such as production of reactive 
species (ROS), apoptosis, necrosis, autophagy, stress regulation, production of lipids and 
carbohydrates, Ca2+ storage and innate immunity (Murphy 2009; Nieminen 2003; Lorenzo 
Galluzzi et al. 2012).  
Mitochondria are exposed to constant threats to their integrity and functionality, 
especially from the oxidative stress coming from the electron transport chain and production of 
ROS (Lorenzo Galluzzi et al. 2012). The protection of the fitness of this organelle is formed by 
a sophisticated system that acts both at the mitochondrial and cellular level. The mitochondria’s 
first response to stress is through the action of antioxidants, DNA repair, protein folding and 
degradation (Scheibye-Knudsen et al. 2015). Moreover, fusion and fission of mitochondria also 
contribute to dilute and segregate damaged mitochondria respectively, acting as another layer 
of quality control (Eisner, Picard, and Hajnóczky 2018). On the other side, the autophagy 
machinery is able to target damaged mitochondria and lead them to degradation in the 
lysosomes. This process of engulfment and removal of mitochondria is called mitophagy, which 
acts as an important quality control of mitochondria at a cellular level (Wilkins et al. 2021). 
However, it is important to acknowledge that mitophagy is not limited to the removal of 
damaged mitochondria. This mechanism of selective autophagy is actually a natural mechanism 
that the cell has to control the amount of mitochondria that is present in the cytosol (Onishi et 
al. 2021). A good example of this mechanism under normal conditions is the removal of 
mitochondria on erythrocytes during their maturation (Mortensen et al. 2010). As the main 
responsible of transporting oxygen along the human body, erythrocytes have to get rid of the 
mitochondria they contain during their maturation process, so oxygen can be exclusively 
transported instead of partially consumed by the electron transport chain of mitochondria.  
Mitophagy in yeast occurs through a protein present in the mitochondrial outer 
membrane (OMM) called ATG32, which acts as a mitophagy-specific autophagy receptor 
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(Okamoto, Kondo-Okamoto, and Ohsumi 2009). Upon nitrogen starvation or stationary growth, 
the expression of ATG32 is induced at the transcriptional level, which leads to higher level of 
this ATG protein in the OMM. Then, ATG32 binds ATG11, which works as an adaptor protein 
for selective types of autophagy, recruiting other ATG proteins that will promote 
autophagosome formation (Kanki et al. 2009). ATG32’s activity seems to be regulated via 
different modifications and actions of regulators, diversifying the control of this mechanism.  
In mammals, mitophagy seems to be a more sophisticated process and the signals that 
activate it are different to the ones in yeast (Madruga, Maestro, and Martínez 2021). Among 
the stressors that lead to activation of mitophagy, disruption of mitochondrial membrane 
potential seems to be one of the most potent triggers (S. M. Jin and Youle 2013). A proton-
selective ionophore, called CCCP, causes mitochondrial depolarization and accumulation of 
mitophagy receptors on the OMM (Figure 9). Because of its powerful effect on mitochondria, 
CCCP is one of the most widely used activators of mitophagy in vitro (Yoo and Jung 2018). 
The recognition of target mitochondria to be degraded occurs through two main mechanism in 
mammals, by the direct interaction of LC3 with its receptors and by LC3 adapters, which can 
occur in an ubiquitylation-dependent and independent manner (Swerdlow and Wilkins 2020). 
There are several receptors 
suggested to mediate the 
elimination of mitochondrial 
under both physiological and 
pathological conditions. Among 
those receptors are BNIP3 and 
NIX, FUNDC1, BCL2L13 
(mammalian functional 
counterpart of yeast ATG32), 
and FKBP8 (Bhujabal et al. 
2017) (Figure 10). 
 
 
Figure 9. Mitophagy produced by depolarization of mitochondria. From (Jia Liu et al. 2019) Mitophagy can be divided 
into Parkin-dependent or independent pathways. Under normal conditions, PINK1 localizes to mitochondria and is 
translocated to the mitochondrial inner membrane (MIM), where it is cleaved and subsequently degraded. However, when 
mitochondria become depolarized, PINK1 accumulates at the outer mitochondrial membrane (OMM) and recruits Parkin. 
Activated Parkin leads to the ubiquitination of substrates and the recruitment of autophagy receptors to initiate mitophagy. In 
addition, Parkin-independent mitophagy includes receptor-mediated and ubiquitin ligase-mediated mitophagy.  
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PTEN-induced putative kinase 1 (PINK1) and Parkin form an essential axis for the 
control of induction and control of mitophagy. Under normal conditions, PINK1 is continuously 
being degraded by the proteasome. A damage in the mitochondria, such membrane 
depolarization, reduced the cleavage of PINK, which consequently accumulates in the 
mitochondrial outer membrane (OMM). The accumulated PINK1 become them 
autophosphorylated and activated, consequently phosphorylating ubiquitin and leading to 
recruitment of Parkin. As an E3 ligase, Parkin poly ubiquitylates its substrates and leads them 
to degradation. The degradation of such substrates eventually induces mitochondrial fission and 
mitophagy (Geisler et al. 2010). The SLRs, which in the case of mitochondria act as adapters, 
are recruited to the K63-linked polyubiquitylated substrates on the mitochondria. Then those 
SLRs recruit the necessary machinery for autophagosome formation surrounding those 
mitochondria and bring them to degradation. The two most important SLRs implicated in 
ubiquitin dependent mitophagy are OPTN and NDP52 (Lazarou et al. 2015). The kinase Tank-
binding kinase 1 (TBK1) becomes activated by OPTN and promotes mitophagy through the 
phosphorylation of OPTN and NDP52. Interestingly, PINK1 is also able to recruit OPTN and 
NDP52 independently of the action of Parkin (Lazarou et al. 2015). Damaged mitochondria can 
also be recognized by autophagy receptors in an ubiquitin-independent manner. This is the case 
of the recruitment of p62 by mitochondrial protein CHDH (choline dehydrogenase), leading to 
the formation of the CHDH-p62-LC3 complex, which promotes mitophagy (Park et al. 2014). 
Moreover, there are also mitochondrial proteins such as BNIP3, NIX and FUNDC1, that can 
act as receptors (Onishi et al. 2021) (Figure 10). FK506-bidning protein 8 (FKBP8) is located 
in the OMM and leads to mitophagy by its interaction with LC3A. An additional point of 
regulation of mitophagy by FKBP8 is its localization. This mitochondrial protein migrates to 
the ER under stress conditions, and the inability to do so leads to an activation of mitophagy 
(Bhujabal et al. 2017). 
 
Figure 10. Most studied Mitophagy receptors. FUNDC1, BNIP3, NIX mammalian autophagy receptors and ATG32, 
receptor in charge of mitophagy in yeast.  
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The regulation of the amount and fitness of such an important organelle as the 
mitochondria is crucial for the well-being of the cell, therefore it is not surprising that a 
dysfunction in mitophagy is linked to many pathological conditions. Mitophagy seems to be 
implicated in several diseases, including Parkinson’s disease, Alzheimer’s disease, 
Huntington’s disease, Amyotrophic lateral sclerosis (ALS), cancer, cardiovascular diseases and 
atherosclerosis. (Rottenberg and Hoek 2021)  
 
The lysosomes and LAMPs: at the acidic edge 
The lysosomes are cellular organelles that constitute the main degradative compartment of the 
cell (Davidson and Vander Heiden 2017). However, it has been reported that lysosomes are 
involved in several cellular processes besides degradation of the delivered cellular material such 
as cholesterol homeostasis, plasma membrane repair, bone and tissue remodeling, defense 
against pathogens, cell death and cell signaling (Saftig and Klumperman 2009). The substrates 
are delivered to the lysosome via endocytosis, phagocytosis or autophagy (Tancini et al. 2020). 
There are two essential groups of proteins in lysosomes: soluble lysosomal hydrolases and 
integral lysosomal membrane proteins (LMPs). Lysosomal hydrolases are delivered to the 
lysosomes from the Golgi and require a pH between 4.5-5.5 to become active, which allows the 
cell to be protected from the action of those hydrolases in unwanted locations (Parenti, Medina, 
and Ballabio 2021). The acidic pH of the lumen of lysosomes is achieved and maintained by an 
H+-ATPase (Johnson et al. 2016). LMPs are mainly found in the lysosomal limiting membrane, 
where they perform diverse functions, including acidification of the lysosomal lumen, protein 
import from the cytosol, membrane fusion and transport of degradation products to the 
cytoplasm (Saftig and Klumperman 2009). Some of the most abundant LMPs are the lysosome 
associated membrane proteins (LAMPs), which are glycosylated proteins commonly found in 
the membrane of the lysosomes. There are 5 different types of LAMPs, which are unequally 
expressed along tissues, suggesting a diversification of functions. The most abundant and best 
studied are LAMP-1 and LAMP-2 (Alessandrini, Pezzè, and Ciribilli 2017). These two LAMPs 
present a similar length and 37% amino acid sequence homology. Their structure consists in a 
highly glycosylated luminal region, a transmembrane region and a short C-terminal cytosolic 
domain. LAMP-1 or LAMP-2 deficient mice are viable and fertile, which suggest that they 
might have similar functions or those functions partially overlap (E.-L. Eskelinen 2006). 
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Whereas LAMP-1 presents only one transcript, LAMP-2 has three different splicing isoforms: 
LAMP-2A, LAMP-2B, and LAMP-2C. Mutations in LAMP-2 lead to Danon disease, a 
multisystem disorder that presents skeletal myopathy, cognitive defects and visual problems 
(Rowland et al. 2016). However, recent findings point towards LAMP-2B as the main 
responsible of this disease (Myerowitz, Puertollano, and Raben 2021). LAMP-2A is one of the 
essential components of CMA, taking the selected proteins into the lysosome for degradation 
(Kaushik and Cuervo 2018). LAMP-2B is involved in macroautophagy, mediating the 
autophagosome-lysosome fusion, through its binding to ATG14 and VAMP8 (Chi et al. 2018). 
LAMP-2C acts as an inhibitor of CMA and mediates the autophagy of nucleic acids by binding 
RNA and DNA (Fujiwara et al. 2015). Due to the difference in expression among different cell 
types and not a high degree of homology among them, it seems clear that LAMPs have 
diversified their functions to fulfill different needs in different tissues (Alessandrini, Pezzè, and 
Ciribilli 2017).  
Lysosomes have a crucial role in cellular homeostasis, and the dysfunction of this 
organelle is involved in several diseases. Defects in genes encoding lysosomal proteins lead to 
lysosomal storage diseases (Platt 2018). Moreover, the impairment of lysosomal function has 
also been reported in other more common pathologies, including inflammatory and 
autoimmune disorders, cancer, neurodegenerative diseases and metabolic diseases (Reddy 
Bonam, Wang, and Muller 2019). 
Even though they LAMP2 is a widely used lyosomal marker, its mechanism of action 
and its implication in cancer is still poorly understood. LAMP2 plays a role in the support of 
early cancer progression, helping cancer cells surviving in acidic enviroments (Mogami et al. 
2013). Moreover, LAMP2 is highly expressed in poorly expressed in several cancer, where 
reduced expression of LAMP2 has been associated with a loss of migration and invasion 
capabilities (Koukourakis et al. 2015). LAMP2A isoform has shown increased expression in 
breast tumor tissue, and its inhibition results in sensitibilization of tumor cells to radioation and 
doxorubicin therapy (Saha 2012). 
 
Crosstalk of UPS and autophagy 
For many years and due to the lack of research in autophagy, the degradation pathways of UPS 
and autophagy were perceived as two separate cellular mechanisms that acted in parallel of 
each other without interacting. UPS was in charged of small short-lived proteins mainly for 
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mediating cellular responses through protein pool control, whereas autophagy was responsible 
for the degradation of large and long-lived proteins or organelles (Ji and Kwon 2017). 
Proteasomal degradation took place in the cytosol, whereas degradation via autophagy took 
place in the lysosomes. Furthermore, proteasomal degradation associated with degradation of 
proteins, providing temporal control of proteins such as cell cycle regulators (Kravtsova-
Ivantsiv and Ciechanover 2012). On the contrary, autophagy was perceived merely as a cellular 
response to starvation. However, it is becoming more clear that these two pathways are not only 
linked by several common players, but also stablish a network of crosstalk and cooperation 
(Nam et al. 2017).  
The most relevant common denominator shared by UPS and autophagy is the molecule 
of ubiquitin. The current model defends that the nature of poly-ubiquitin chains determines the 
mode of degradation. UPS has a preference for K48-linked chains, while autophagy has a 
predilection for K63-linked chains, organelles and mono-ubiquitylated substrates (Grice and 
Nathan 2016). Sharing such an essential player in both pathways and due to their pivotal role 
in maintaining cellular homeostasis, it is imperative that these two degradation mechanism 
crosstalk and regulate each other. Autophagy is activated when the proteasome is already 
working at full capacity. However, the proteasome seems not to be able to take over when 
autophagy is inhibited, due to the proteasomes limitations in the size of the proteins is able to 
degrade (Wurzer et al. 2015). One of the suggested regulators of this phenomenon is the master 
tumor repressor p53, which upon UPS inhibition, accumulates, leading to an activation of 
AMPK and inhibition of mTOR1 (Horn and Vousden 2007). UPS and autophagy have another 
point of interplay in the degradation of the proteasome, a type of autophagy called proteaphagy 
(Enenkel et al. 2020). Interestingly, certain conditions, such as muscle atrophy in fasting 
requires both mechanisms (J. Zhao et al. 2007), indicating the complementary relationship 
between the two degradation pathways. Hence, these two mechanism of degradation have a 
compensatory and complementary relationship, ensuring in most cases a win in the battle for 
homeostasis.  
TRIM proteins, as E3 ligases, are linked to the UPS. Growing evidences show their 
crucial role in autophagy (Michael A Mandell, Saha, and Thompson 2020). Thus, they also 
become common denominators of both pathways. TRIM proteins have a great contribution in 
misfolded proteins clearance, facilitating their degradation through both the UPS and autophagy 
(Boise et al. 2020), which I will go in further detail in the section dedicated to TRIM proteins 
in autophagy. Moreover, TRIM proteins not only act as E3, ligases. TRIM27 or TRIM19, which 
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both have SUMOylation ligase activity, which may also regulate the degradation of proteins 
(Chu and Yang 2011).  
 
Phase separation: a new layer of complexity and regulation 
The primer idea of an organelle is a structure surrounded by a double-membrane. However, this 
idea has been left behind by the discovery of biomolecular condensates in a cellular context 
(Dignon, Best, and Mittal 2020). The formation of these membraneless organelles by liquid-
liquid phase separation (LLPS) adds another layer of complexity and dynamism to many 
cellular processes. Phase separation involves demixing of a homogenous liquid solution of 
macromolecules into two phases that coexist, a dense phase that is enriched and a dilute phase 
that is depleted for specific macromolecules (Boeynaems et al. 2018). This phase allows rapid 
and dynamic exchange of components of the condensate with the surrounding environment. 
The viability of these phase separates is possible due to multivalent interactions that often 
include folded globular domains, intrinsically disordered proteins (IDPs) or intrinsically 
disordered regions (IDR) and/or RNA or DNA scaffolds (Yoshizawa et al. 2020). Among all 
those elements, they can be categorized into two groups depending on their role in the formation 
of phase separates: stickers and spacers. Stickers are those macromolecules that engage in 
reversible non-covalent intra or intermolecular interactions, leading to physical crosslinks, thus, 
they “stick” to another macromolecule. On the contrary, spacers are found between stickers, 
and even though they are not directly involved in the crosslink, they can influence the assembly 
of linked molecules (Choi, Holehouse, and Pappu 2020). Even though the better known is the 
liquid-liquid phase separation, membraneless organelles can be in the form of different phase 
separations such hydro-gel or liquid-solid separation. This seem to be the case of p62 bodies in 
the liver cell line huh-1, where p62 forms gel-like droplets, which work as platform for 
autophagosome formation (Kageyama et al. 2020). 
The membraneless compartments can be found both in the cytosol and the nucleus. The 
presence of the so-called bodies have been known for years, but a lack of methodology to 
analyze them made it difficult to fully describe their nature. Arising evidences suggest that 
nuclear structures such as promyelocytic leukemia (PML) bodies, Cajal bodies, SUMO bodies, 
NEAT bodies, histone locus bodies, or the mitotic spindle are indeed biomolecular condensates 
that participate in nuclear organization and regulation (Zimber, Nguyen, and Gespach 2004). 
Promyelocytic leukemia (PML) bodies are present in the nucleus, where they have an important 
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role in the regulation of chromatin dynamics (Corpet et al. 2020), and in the cytoplasm, 
commonly linked to the ER and mitochondria (Carracedo, Ito, and Pandolfi 2011). PML bodies 
undergo phase separation, stablishing a dynamic network between their components 
(Yoshizawa et al. 2020). Interestingly, the major mediator of the structure of these bodies is 
TRIM19, which also known as PML. TRIM19 has ubiquitin and SUMO E3 ligase activity that 
contribute to the formation and maintenance of their structures by the interaction with 
scaffolding proteins (Corpet et al. 2020).  
Since this is a spontaneous reaction, the question of how the cell is able to control phase 
separation of cellular components rapidly arises. It has been reported that PTMs such as 
phosphorylation, ubiquitylation, arginine methylation and sumoylation can act as cellular 
switches controlling phase separation (Hofweber and Dormann 2019; Owen and Shewmaker 
2019). Interestingly, many proteins commonly involved in phase separation show in their 
sequence many residues targeted by PTMs. Another control point of phase separations seems 
to be controlling the concentration and distribution of the elements participating in the process. 
Thus, the cell is able to shuttle phase separation prone elements in and out of the nucleus or 
other cellular compartments to control the formation of the biomolecular condesate 
(Boeynaems et al. 2018). 
 
The role of ubiquitin in phase-separation: The infrastructure of the cross-
talkers 
Liquid-liquid phase separation (LLPS) has emerges as an additional player in the 
spatiotemporal regulation of quality control in the cell. This control mechanism seems to be for 
several structures ubiquitin dependent (Lei, Wu, and Winklhofer 2020). LLPS provides a 
transient and dynamic compartmentalization of several cellular processes, such as autophagy 
(Banani et al. 2017). The autophagic receptor p62 plays a key role in protein quality control. 
Growing evidences show that p62 is able to perform this function undergoing phase separation. 
Polymerization of p62 increases its affinity to polyubiquitin-linked cargo and LC3B, while 
dimeric p62 shuttles ubiquitylated proteins to the proteasome (Wurzer et al. 2015). 
Additionally, mono-ubiquitin of p62 has been observed to inhibit phase separation, likely due 
to its interference in the binding of the UBA domain with the cargo. Inhibition or impairment 
of the proteasome leads to a lower abundance of mono-ubiquitin, and in consequence a higher 
number of ubiquitylated substrates (Berkamp, Mostafavi, and Sachse 2020). In this context, 
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p62 is called by those ubiquitylated substrates, which promotes p62 condensation and 
subsequent autophagosomal degradation (Figure 11). In the past years, it has been suggested 
that p62 also undergos a further step of phase separation, forming a gel-like structure 










This ability to quickly form these condensates provides an efficient way of sequestering and 
processing cellular material destined to be degraded.  Hence, ubiquitin seems to be not only the 
major common denominator between UPS and autophagy, but it also controls the compensatory 
mechanisms between these two pathways.  
 
TRIMs: a family of E3 ligases 
Tripartite motif family proteins (TRIMs) are a wide family of proteins involved in the control 
of several cellular processes such as intracellular signaling, innate immunity, transcription, cell 
cycle regulation, autophagy and carcinogenesis (Boise et al. 2020; M A Mandell et al. 2014; 
Watanabe and Hatakeyama 2017). To date, there are more than 80 distinct protein members in 
the TRIM family. The vast majority of those TRIMs present E3 ligase activity since they 
contain a RING finger-domain, with a few exceptions such as TRIM16 or TRIM20, which lack 
this domain but still has the ubiquitin binding activity (Michael A Mandell, Saha, and 
Thompson 2020). Individual TRIM proteins have also showed functions of SUMOlyation and 
NEDDylation of themselves or their interacting partners (Chu and Yang 2011; Noguchi et al. 
Figure 11. Poly-ubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Polyubiquitin chain-
induced p62 phase separation drives autophagic cargo segregation. p62 proteins form oligomers through the PB1 domain 
(green part) and bind ubiquitin through the UBA domain (yellow part). Both domains facilitate multivalent interactions. When 
protein concentrations reach a threshold, liquid–liquid phase separation occurs to form p62 bodies. Other client proteins, such 
as LC3 and Keap1, are also recruited to p62 bodies. p62 bodies are then degraded by autophagy. cation–piFrom (Sun et al. 
2020) 
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2011). Those TRIMs defined as E3 ligases are characterized by the presence of tripartite motif 
RBCC domain. The RBCC domain contains in the N-terminal one RING-finger domain, one 
or two B-boxes (B1/B2) and a coiled-coil (CC) domain (Reymond et al. 2001). The B-box 
together with the coiled-coil domain mediate protein-protein interactions. The coiled-coil 
domain is the responsible of TRIM hetero- and homodimerization, crucial for many TRIM 
proteins that require dimerization to be catalytically active (Koliopoulos et al. 2016). In 
addition, most TRIMs also present domains at the C-terminus, which gives them specificity for 
their target proteins (Ikeda and Inoue 2012). Based on the composition of the C-terminus 
domain and domain organization, TRIMs can be classified in 12 subfamilies (I-XI). (Figure 12) 
The C-terminus domains present in TRIM proteins are: COS domain, fibronectin type III repeat 
(FNIII), SPRY domain, PRY domain, PHD domain, bromodomain (BROMO), filamin-type IG 
domain (FIL), NHL domain, Meprin and TRAF-homology domain (MATH), ADP-ribosylation 
factor family domain (ARF), transmembrane region (TM) and acid-rich (Watanabe and 
Hatakeyama 2017; Michael A Mandell, Saha, and Thompson 2020). 
 
Figure 12. Generic structure of Tripartite motif (TRIM) proteins and subfamilies. (Michael A Mandell, Saha, and 
Thompson 2020)  
 
TRIMs expression is found down or upregulated in numerous cancers (Shigetsugu 
Hatakeyama 2011). In general, a significant decrease of TRIM expression suggests a tumor 
suppressive role, whereas a significant overexpression suggest an oncogenic role. To date, the 
TRIMs that have been associated to cancer are TRIMs 11, 14, 24, 25 ,27, 28, 29, 33, 37, 44, 
and 59 (Michael A Mandell, Saha, and Thompson 2020). This list is likely to grow in the 
following years, and the general rule of thumb of the effect by decreased/increased expression 
might change overtime if more versatile roles of TRIM in cancer are discovered.  
Over the years, there has been found an association of TRIM genes with chromosomal 
translocations, leading many times to the contribution to oncogenesis. One of the most known 
is the translocation between TRIM19 gene (PML) on chromosome 15 and the retinoic acid 
receptor alpha (RARα) gene located on chromosome 17 (Cambiaghi et al. 2012). This 
ACID 
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translocation is associated with acute promylocytic leukemia, and acts by repressing genes 
associated with retinoic acid signaling (Corpet et al. 2020). Moreover, the RET genes on 
chromosome 10 has been found in translocations with several TRIM genes, including TRIM24, 
TRIM27 and TRIM33 (Crawford, Johnston, and Irvine 2018). TRIM24 has been found 
translocated with RET gene in papillary thyroid cancer (Santoro and Carlomagno 2013), with 
BRAF gene in melanoma (Hutchinson et al. 2013) and lung cancer (Nakaoku et al. 2014), and 
with FGFR1 gene in myeloproliferative syndrome (Belloni et al. 2005). All these fusion 
proteins lead to the upregulation of activity of the RET, BRAF or FGFR1 kinases, resulting in 
the activation of multiple pro-survival signaling. The fusion of these genes with TRIM proteins 
lead to a gain-of-function that has profound effects in oncogenesis.  
Some TRIMs are involved in the regulation of pathways seminal to cancer stemness, 
including STAT signaling, AKT signaling, NANG-Sox2-Oct3/4 networks, and pathways 
related to epithelial mesenchymal transition (EMT). (reviewed by (Jaworska et al. 2020)), 
suggesting a TRIM-dependent contribution to cancer stemness. TRIM28 is reported to maintain 
Oct-3/4-Sox-NANOG expression in breast cancer cells (Czerwińska, Mazurek, and 
Wiznerowicz 2017), whereas TRIM24 enhances STATS3-mediate transcriptional activation, 
leading to cancer stemness in glioblastoma (Lv et al. 2017). In addition, TRIM14, TRIM24 and 
TRIM27 have been reported to mediate AKT signaling, enhancing EMT (Eberhardt et al. 2020).  
In contrast, TRIM16 has been found to be a negative regulator of stemness in breast (Yao, J. 
Xu, T. Tian, T. Fu, X. Wang, W. 2016) and ovarian cancer cells (H. Tan et al. 2017). A deeper 
description, as well as more TRIMs involved in stem cells cell-renewal abilities is likely to arise 
in the following years. Autophagy plays a pivotal role in cancer stemness through its 
contribution in cellular homeostasis and longevity (Chang 2020). Autophagic regulation is a 
very prominent feature of TRIMs, so it would be unsurprising that the effect of this family of 
proteins on autophagy lead to effects in cancer stemness.  
The tumor suppressor protein p53 has a central role in the regulation of genomic stability 
by inducing cell cycle arrest and apoptosis if extensive cellular DNA damage occurs (Horn and 
Vousden 2007). The interaction between TRIM proteins and p53 has been extensively 
described (reviewed in). TRIMs 11, 21, 24, 25, 28, 29, 31, 32, 39, and 59 are found to negatively 
regulate p53 by directly ubiquitinating p53, leading to its proteasomal degradation in the 
cytoplasm.  
Breast cancer is the most common malignancy in women worldwide, and it is curable 
in the 70-80% of the cases if it is diagnosed in its early stages (Harbeck et al. 2019). To date, 
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there are 15 TRIM proteins associated to breast cancer. The expression of TRIMs 13, 21 and 
62 was found decreased, whereas the expression of TRIMs 11, 24, 37, 44 and 59 was found 
increased (Michael A Mandell, Saha, and Thompson 2020). Decreased levels of TRIM13 
expression was associated with worse distance metastasis free survival, diseases specific 
survival, metastatic relapse free survival ad relapse free survival (W. X. Chen et al. 2019). The 
decreased expression of TRIM21 correlates with poor overall survival in breast cancer patients 
(Vicenzi et al. 2019). Up-regulation of TRIM11 has been suggested to act through 
AKT/GLUT1 signaling pathway in breast cancer (Song et al. 2019), while up-regulation of 
TRIM24 and TRIM37 have been linked to histone modifications in breast cancer (Tsai et al. 
2010; Bhatnagar et al. 2014). Elevated levels of TRIM32 and TRIM44 were associated with 
effects in the NFKB pathway in breast cancer (Kawabata et al. 2017; T. T. Zhao et al. 2018). 
Moreover, TRIM59 is found up-regulated in metastatic breast cancer, where it is observed to 
mediate the p62-selective degradation of tumor suppressor PDCD10 (P. Tan et al. 2018), 
highlighting the role of a TRIM protein acting on autophagy in breast cancer.  
 
TRIMS in autophagy: the newcomers 
TRIM proteins play several roles in autophagy, acting at different levels of regulation both as 
regulators and effectors (Michael A Mandell, Saha, and Thompson 2020) (Figure 13). Some 
TRIMs regulate autophagy at the mRNA levels by affecting the transcription of autophagy 
genes. Good examples of this phenomenon is TRIM59, which negatively regulate the 
expression of Becn1 mRNA or TRIM37, which acts as a suppressor of autophagy by inhibiting 
the activation and nuclear translocation of the pro-autophagy transcription factor TFEB (W. 
Wang et al. 2018; Han et al. 2018). In addition, TRIM16 promotes the expression of p62 by 
driving Nrf2 activation under conditions of oxidative stress (Kumar Jena et al. 2018). Other 
TRIMs can act as transcriptional regulators, as is the case of TRIM28. This TRIM is also known 
as KAP1 and represses the expression of miRNAs that target autophagy factors such as ULK1, 
Becn1 and Atg12 (Czerwińska, Mazurek, and Wiznerowicz 2017). Interestingly, TRIM65 
promotes autophagy by preventing miRNA-based down-regulation of ATG7 (X. Pan et al. 
2019).  
Certain TRIM proteins seem to be involved in the regulation of autophagy through the 
regulation of upstream signals such as mTOR and AMPK pathways, as well as STING/TAK1 
pathway. TRIM37 interacts directly with mTOR complex components and promotes assembly 
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of active mTOR complexes to the lyososome. Interestingly, TRIM37 deficient cells show high 
rates of autophagy flux, becoming “autophagy addicted”, leading to cell death if autophagy is 
inhibited (W. Wang et al. 2018). TRIM proteins also regulate AMPK and its ability to induce 
autophagy. TRIM28 ubiquitylates the AMPKα1 subunit, leading it to degradation, thus 
repressing autophagy. Pro-cancer kinase TAK1 is involved in the regulation of AMPK activity. 
Interestingly, TRIMs 5 and 8 activate this kinase, whereas TRIM38 inhibits it (Pertel et al. 
2011; Hu et al. 2014). On the other hand, another essential pathway for the control of autophagy 
is STING-TBK1 signaling axis. Several TRIMs are involved in the regulation of these pathways 
through interaction of different players of this pathway. STING is found in the ER membrane 
in an inactive state, and it becomes activated in response to cytosolic DNA detection, that leads 
to the recruitment of TBK1. The activation of the STING-TBK1 complex re-localizes to the 
ER-intermediate compartment and activates transcription factor IRF3 (Kimura et al. 2015). 
TRIM56 and TRIM32 catalyze the formation of K63-linked polyubiquin chain of STING 
(Tsuchida et al. 2010; Wu et al. 2020). TRIM27 promotes the proteasomal degradation of TBK1 
(Zheng et al. 2015). TRIM23 is a unique TRIM that contains an ARF domain, which interacts 
with TBK1 and is implicated in TRIM23-mediated autophagy (Sparrer et al. 2017).  It is likely 
that more TRIMs are able to regulate autophagy by acting on TBK1. In addition, TRIM16 has 
an important role in lysophagy through its binding to Galectin-3. Upon invasion of 
mycobacterium, the vacuoles that contain them (endosomes and eventually lysosomes) can 
experience membrane damage, which can eventually release the invading bacteria into the 
cytosol. Galectin-3 detects the glycans exposed by the damaged membrane, which presence is 
unusual in the cytosol. Then Galectin-3 recruits TRIM16, which in turn serves as a platform for 
autophagic initiation factors (Chauhan et al. 2016).  
Some TRIMs are able to directly interact with the conserved core autophagy machinery, 
thus modulating autophagy. Some TRIMs, such as TRIM5α, 6, 16, 17, 20, 22, 49 and 55, act 
as a platform through the assembling of ULK1 and Beclin 1. This regulatory complex has been 
name TRIMosome, which regulates selective autophagy (Nicely reviewed in (Kimura et al. 
2015)). TRIM 5α, 6, 17, 22 and 49 interact with ULK1 and Beclin 1. TRIM5α also interacts 
with ATG14L1 and AMBRA1, which are both interactors of the Beclin 1 complex . Other 
TRIMs that interact with ULK1 and/ or Beclin 1 complexes are TRIM 13, 16, 20, 21, 28, 32, 
and 50. In general, the action of these TRIMs lead to an induction of autophagy. However, there 
are TRIMs such TRIM17 that interacts with ULK1 and Beclin 1 and inhibits autophagosome 
formation (Michael A. Mandell et al. 2016). TRIM 6, 16, and 20 also form protein complexes 
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with ATG16L1, and TRIM5α co-immunoprecipitates with ATG5, however, their effect of 
ATG8 lipidation and autophagosome membrane elongation has not been elucidated yet. 
Interestingly, there are some TRIMs that are able to modulate autophagy through its non-E3 
ligase activity. A good example is TRIM20, which lacks a RING domain but can still assemble 
active autophagy initiation complexes. TRIM28 is able to SUMOylate Hvps34, enhancing the 
PI3 kinase activity of Beclin 1 complex (Czerwińska, Mazurek, and Wiznerowicz 2017). In 
addition, TRIM32 promotes the activity of ULK1 complex through the generation of unattached 
K63-linked poly-ubiquitin chains (Di Rienzo, Piacentini, and Fimia 2019). It would not be 
surprising that other TRIMs can modulate autophagy through their SUMO or NEEDylation 
activities, as well as interaction with the autophagy machinery that does not require their E3 
ligase action.  
 
Figure 13. Roles of TRIM proteins in autophagy to date. Schematic of different steps/stages of the autophagy pathway by 
TRIM proteins (top). Summary of TRIM actions in autophagy (bottom). ♠ Symbol indicates proteins with reported cancer 
relevance. (Rottenberg and Hoek 2021) 
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The vast majority of TRIMs contain a RING domain that acts as an E3 ligase, therefore, 
the idea that TRIMs tag substrates for being recognized by autophagy receptors is one of the 
first one that comes to mind. However, such TRIM-mediated autophagy has not been well-
described yet. A study suggested that TRIM21 ubiquitylates kinase IKKβ, facilitating its 
degradation by autophagy (Niida, Tanaka, and Kamitani 2010). Some TRIMs actually seem to 
act as autophagy receptors themselves, binding the substrate while recruiting the autophagic 
machinery (Kimura, Mandell, and Deretic 2016). TRIM5 acts as an autophagy receptor during 
viral infection. TRIM5α contains two LIR motifs that directly binds ATG8 proteins, while it 
has a SPRY domain in its C-terminal that can bind the autophagic substrates (Michael A 
Mandell et al. 2015). There are other TRIMs that are able to bind ATG8s (Rienzo et al. 2020). 
It is likely that more TRIMs can act as autophagy receptors themselves upon certain stress or 
stimuli that the cells face. Typically, autophagy receptors end being degraded in the lysosomes 
together with their targeted proteins (Johansen and Lamark 2020). To date, several TRIMs has 
been reported to be degraded by autophagy (found in lyosomes): TRIM 5α, 13, 16, 20, 21, 23, 
27, 31, 32, 45, 50, and 56 (Nicely reviewed in (S Hatakeyama 2017) and (Michael A Mandell, 
Saha, and Thompson 2020)).  
Due to its multifunctional nature, the mechanisms that the cells have to control p62 
action is tightly regulated and are not completely elucidated. In the last years, TRIM proteins 
have emerged as key regulators of p62. Many TRIMs have been shown to interact with p62 or 
to colocalize with p62 in cellular structures (Reviewed in Michael A Mandell et al., 2020). One 
of the main functions of p62 is the organization and sequestration of ubiquitylated proteins into 
cytoplasmic punctate structures called p62 bodies, which have liquid droplet-like properties. It 
is suggested that these structures may act as a platform for p62-mediated signaling, 
concentrating and leading cellular waste to degradation (Zaffagnini et al. 2018). To date, 14 
TRIMs have been linked to the regulation of the formation and clearance of these structures. A 
subgroup formed by TRIM 5, 16, 17, 32, 50, 52, and 58 seem to increase the abundance of p62 
bodies, whereas TRIM 14, 19, 21, 22, 25, 65, and 76 have the opposite effect (Kimura, Mandell, 
and Deretic 2016; J. A. Pan et al. 2016; Kumar Jena et al. 2018; Kehl et al. 2019; Overå et al. 
2019). In contrast, TRIM16 is required for the formation of p62 bodies in the same 
circumstances (Kumar Jena et al. 2018). TRIMs have also been suggested to modulate p62 
activity via the control of its phosphorylation status (Michael A Mandell, Saha, and Thompson 
2020). Another mechanism TRIM proteins have to control p62 dynamics is by their action on 
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Nrf2.  TRIM21 negative regulates Nrf2-directed cytoprotective antioxidant response of p62 
(Bartolini et al. 2018). 
All these examples of the regulation of autophagy by TRIM proteins show the high 
specificity of this family of E3 ligases. Interestingly, no TRIM homologs have been identified 
in yeast, which is well-studied autophagy model organism. Thus, TRIM proteins might add 
complexity to the mammalian autophagy system, being able to regulate more specific 
degradation processes (Michael A Mandell, Saha, and Thompson 2020). 
 
TRIM27 and its known roles 
TRIM27 is an E3 ligase also known as Ret finger protein (RFP protein), which was firstly 
described as a fusion protein with the tyrosine kinase domain of the c-RET proto-oncogene 
originated by DNA rearrangement (Hasegawa et al. 1996). This 58-kDa protein is part of the 
largest subclass on the TRIM protein family of proteins, class-IV. TRIM27 can be found both 
in the cytoplasm and the nucleus of the cells, depending on the cell type (G. Tezel et al. 1999). 
TRIM27 expression is found in all human tissues, however, it is significantly higher in male 
germ cells (Zhuang et al. 2016). TRIM27 structure consists in a N-terminal formed by a RING 
domain, that confers the E3 ligase activity as well as SUMOylation (Chu and Yang 2011), 
followed by a B-box and a coiled-coil domain, which are in charge of oligomerization. In the 
C-terminal TRIM27 contains a PRY followed by an SPRY domain (Figure 14). TRIM27 
contains in the coiled-coil region a nuclear export (NES) sequence that allows shuttling between 
the nucleus and the cytoplasm (Harbers et al. 2001).  
 
Figure 14. TRIM27 structure. A RING-finger domain, a B-box, two coiled-coil domains, a LIR motif in between the coiled 
coil domains, followed by a PRY and SPRY domains in its C-terminal form TRIM27. 
 
TRIM27 is involved in the regulation of several cellular processes such as immunity, 
apoptosis, cell growth, proliferation, transcriptional regulation, tumorigenesis and endosomal 
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recycling (Nie et al. 2016; Zoumpoulidou et al. 2012; Y. Liu et al. 2014; Zhuang et al. 2016). 
TRIM27 is reported to have several roles in host defense against pathogens. TRIM27 acts as a 
host restriction factor during mycobacterial infection, enhancing immune-inflammatory 
response and cell apoptosis (J Wang et al. 2016). Interestingly, TRIM27 is found downregulated 
in mycobacterium tuberculosis (Mtb) patients compared to latent and healthy subjects, 
suggesting that TRIM27 might play a role in response to Mtb infection (Y. Chen et al. 2017). 
In addition, TRIM27 has been identified as a degradation target of Herpes Simple Virus 1 ICP0 
(Conwell et al. 2015), and together with USP7 negatively modulates antiviral type I Interferon 
(INF) signaling (Cai et al. 2018). Additionally, TRIM27 is linked to the regulation of NfKB 
pathway by mediating the degradation of nucleotide-binding oligomerization domain-
containing protein 2 (NOD2) (Zurek et al. 2012).  TRIM27 plays a role in endosomal recycling 
when it is in complex with USP7 and MAGE-L2. This complex regulates the activity of the 
WASH/retromer-mediated endosomal recycling through its ubiquitylation status (Hao et al. 
2015).  
TRIM27 has been identified as an oncogene, highly expressed in various cancer types 
such as breast cancer (Xing et al. 2020). TRIM27 promotes proliferation mainly through its 
nuclear function, participating in transcriptional regulation complexes (Horio et al. 2012; 
Iwakoshi et al. 2012; Tsukamoto et al. 2009; G. G. Tezel et al. 2009; Nie et al. 2016; H. X. 
Zhang et al. 2018; Y. Zhang et al. 2018). It has also been proposed to be involved in cell 
migration and invasion (Y. Zhang et al. 2018). TRIM27 acts as a transcription repressor through 
interactions with myocardin related transcription factor B (MRTFB) (Kato et al. 2014), 
retinoblastoma susceptibility gene (RB1) (Zoumpoulidou et al. 2012), and enhanced of 
polycomb (EPC) (Shimono et al. 2000). TRIM27 also mediates the IL-6-induced activation of 
STAT3 via a retromer-dependent pathway, leading to inflammation associated cancer 
development (H. X. Zhang et al. 2018). Moreover, a recent study suggests that TRIM27 plays 
a role in the Hippo-BIRC5 axis in gastric cancer, a crucial pathway in regulating tissue 
homeostasis and organ growth (Y. Yao et al. 2020).  
TRIM27 is involved in the regulation of apoptosis via ubiquitylation of PTEN, which 
inhibits its phosphorylation activity and does not allow the PTEN-dependent activation of 
TRAIL expression (Lee et al. 2013). PI3K/AKT pathway plays an important role in cancer 
progression through its involvement in cellular metabolism. (Q. Wang, Chen, and Hay 2017) 
Growing evidences show that TRIM27 regulates the action of this pathway through different 
mechanisms. On one side, TRIM27 has been shown to activate p-AKT in colorectal cancer (Y. 
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Zhang et al. 2018). In addition, TRIM27 controls PTEN activity, which suppresses the 
activation of AKT via PTEN on esophageal squamous cell carcinoma (ESCC) (L. Ma et al. 
2019). Furthermore, PTEN/AKT axis has been shown as a target in suppressing glycolysis 
activity in cancer cells under hypoxic conditions (F. Chen et al. 2015), which represents a link 
between TRIM27 and glycolysis metabolism.  
TRIM27 has been associated with several human diseases such as Parkinson’s disease 
(Y. Liu et al. 2014), immune disorders and cancer (Watanabe and Hatakeyama 2017). TRIM27 
expression levels have been found upregulated in a variety of human cancers, including breast, 
endometrial, lung and colon cancer (Xing et al. 2020; Tsukamoto et al. 2009; S. Liu et al. 2020; 
Zoumpoulidou et al. 2012). Altogether, the important role of TRIM27 in cancer development 
and metastasis seems evident, however, the mechanistic through which TRIM27 acts is not 
fully elucidated yet.  
 
TRIM32 and TRIM32-related diseases 
TRIM32 is a part of the TRIM family proteins subgroup C-VII. This group is characterized by 
the presence of NHL (NCL-1, HT2A and LIN-41) motifs in its C-terminal (Figure 15). TRIM32 
contains six NHL repeats, which mediate protein-protein interaction (Slack and Ruvkun 1998).  
Of note, NHL domains have a positively charged top surface, which is able to bind RNA 
(Loedige et al. 2013). This suggests that TRIM-NHL family play a role as miRNA regulators 
(Tocchini and Ciosk 2015). The B-box and the RING domain cooperate to specify TRIM32 
subcellular localization (Lazzari and Meroni 2016). Additionally, the B-box of TRIM32 is 
responsible for its oligomerization, which is necessary for its catalytic activity (Koliopoulos et 
al. 2016). TRIM32 undergoes auto-ubiquitylation in presence of E2 enzymes belonging to the 
D and E subfamilies (Napolitano et al. 2011). Due to the ability of TRIM32 to work with several 
UBE2 enzymes, its catalytic activity leads to several possibilities of ubiquitin chains on the 
substrates. TRIM32 is able to tag both K48, mainly implicated in proteasomal degradation 
(Grice and Nathan 2016), and K63, which is strongly implicated in immune signaling and 
autophagy (Erpapazoglou, Walker, and Haguenauer-Tsapis 2014). Hence, TRIM32 leads the 
ubiquitylated proteins to different fates. 
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Figure 15. TRIM32 structure and diseases-related mutations. TRIM32 is formed by the RBCC motif characteristic of the 
TRIM protein family, followed by 6 NHL domains. A point mutation in the B-box (P130S) causes BBS11, and the six marked 
mutations of the NHL cause LGMD2H. From (Lazzari and Meroni 2016) 
 
TRIM32 expression is detectable in all cells of the body, with high expression levels in 
the brain and heart (Frosk et al. 2002). Among the identified substrates of TRIM32, there are 
many muscular-relevant proteins such as actin, α-actinin, desmin, tropomyosin, suggesting that 
TRIM32 has an important role in muscle homestosasis (Cohen et al., 2009; Kudryashova et al., 
2005). Other TRIM32 substrates are cell cycle regulators such as c-Myc, MYCN and p53 
(Lazzari and Meroni 2016). In addition other proteins that become substrates of TRIM32 are 
the cytoplasmic enzyme NDRG2 (Mokhonova et al. 2015), the RARα nuclear receptor (Sato et 
al. 2011), the PB1 viral RNA polymerase and the innate immunity adaptor STING (J. Zhang et 
al. 2012).  
As mentioned, TRIM32 has a large number of substrates that are tagged for protein 
degradation, therefore it comes as no surprise that the impairment of the degradation of some 
of those substrates leads to several human pathologies. E3 ligases play an essential role in 
muscular physiology, especially in muscular atrophy (Sandri 2013). Genetic mutations in the 
NHL domains of TRIM32 cause the muscle disorder Limb Girdle Muscular 4 Dystrophy 2H 
(LGMD2H), which is associated with impaired auto-oligomerization and self-ubiquitylation, 
and reduced TRIM32 expression level (Zhao et al., 2019, Locke et al., 2009). TRIM32 is 
associated with this muscular disease through seven mutations in the NHL domain: D487N, 
R394H, V591M, D588del, T520TfsX13, L535SfsX21 and I590LfsX38 (Figure 15). LGMD2H 
caused by TRIM32 mutations is a form of autosomal recessive muscular dystrophy. LGMD2H 
patients present a wide range of symptoms, ranging from no apparent muscular impairment to 
severe muscle weakness (Lazzari et al. 2019). Conversely, a missense-mutation (P130S) in the 
B-Box domain results in the disease Bardet-Biedl syndrome 11 (BBS11), which has a 
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pleiotropic phenotype (Chiang et al., 2006). BBS11 is characterized by obesity, retinal 
degradation, genito-urinary tract malformations, and cognitive impairment (Chiang et al. 2006). 
Interestingly, BBS11 patients do not show any muscle alterations, highlighting the functionality 
differences between the B-box and NHL domains of TRIM32. A mouse TRIM32 model created 
by (Kudryashova et al. 2009) found that muscular dystrophy caused by TRIM32 mutations 
involves both neurogenic and myogenic characteristics. This same group produced a Knock-In 
(KI) mouse model with the LGMD2H mutation D487N. Interestingly, this mutation destabilizes 
the protein, which leads to its degradation, resulting in the same phenotype as TRIM32 mice 
(Kudryashova et al. 2011). Further studies by this group with the TRIM32 null mice showed 
that even though TRIM32 plays a key role in muscle regrowth after atrophy, it is not necessary 
to trigger muscle atrophy (Kudryashova, Kramerova, and Spencer 2012). Even though the 
pathological mechanism of TRIM32 that leads to LGMD2H is still unclear, several studies 
suggest that the loss of E3 ligase activity and/or interaction properties of TRIM32 are involved 
in the pathogenesis of this disease.  
Several proteins involved in tumorgenesis are found among TRIM32 substrates (Lazzari 
and Meroni 2016). Depending on the context and the targeted protein, TRIM32 acts as an 
oncogene or a tumor suppressor. TRIM32 expression has been found increased in colorectal 
cancer, lung cancer, hepatocellular carcinoma and head and neck squamous cell carcinoma 
(Lazzari and Meroni 2016; T. T. Zhao et al. 2018; Ju Liu et al. 2014). On one side, TRIM32 
regulates p-53-mediated cellular stress responses. In response to stress, the tumor suppressor 
p53 induces the expression of TRIM32. Consequently, TRIM32 interacts and sends p53 to 
degradation, creating a feedback loop that regulates the activity of p53 (Ju Liu et al. 2014). 
Moreover, TRIM32 is responsible for the degradation of tumor suppressor Abl interactor 2 
(Abi2), promoting cell proliferation, transformation and metastasis (Kano et al. 2008). 
Additionally, TRIM32 has been shown to positively mediate TNF-induced apoptosis via 
proteasomal degradation of the anti-apoptotic factor XIAP (Ryu et al. 2011). TRIM32 also 
regulates UVB-induced keratinocyte apoptosis through induction of NFkB by the degradation 
of its inhibitor Piasy (Albor et al. 2006). Furthermore, TRIM32 supports MYCN degradation, 
promoting asymmetric cell division in neuroblastoma cells (Izumi and Kaneko 2014). A recent 
study found that TRIM32 interacts and degrades the transcription factor Gli1, which is involved 
in sonic hedgejog (SHH) signaling (M. Wang et al. 2020). This pathway is involved in 
neurogenesis during development and its dysregulation often leads to tumorgenesis. In this 
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context, TRIM32 acts as a tumor suppressor. All these roles of TRIM32 in different cellular 
pathways show its prominent implication in cancer development. 
Moreover, it has also been shown that TRIM32 activates ULK1 via the autophagy 
cofactor AMBRA 1, facilitating autophagy in muscle cells upon atrophy induction (Di Rienzo, 
Piacentini, and Fimia 2019). Importantly, the LGMD2H disease mutant of TRIM32 was unable 
to associate with ULK1 and induce autophagy (Di Rienzo, Piacentini, and Fimia 2019). These 
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Aim of the study 
This project was born from a screen of 22 different TRIM proteins using the double-tag assay, 
which represented the 11 TRIM family subgroups. The goal of this screen was to identify 
candidates with a potential role in autophagy, alleging that their presence in the lysosome liked 
them somehow with the autophagy process. Previous studies have already recognized some 
TRIM proteins as regulators and receptors in selective autophagy. Our hypothesis was that 
within the 80 members of the TRIM family, there are additional TRIM proteins that are 
degraded by autophagy and might potentially function as autophagy receptors or regulators. 
From the screen, TRIM27, TRIM32 and TRIM45 were identified as new potential autophagic 
substrates. We decided to further investigate the roles of TRIM27 and TRIM32 in autophagy, 
to try to test our hypothesis. 
The following aims were defined to test this hypothesis: 
1. Identify if these TRIM proteins are autophagy substrates 
2. Identify which part of the core autophagy machinery is mediating their autophagic 
degradation 
3. Identify if these TRIM proteins have characteristics as autophagy receptors 
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Summary of papers  
 
Paper I 
TRIM27 is an autophagy substrate implicated in autophagy induction and regulation of 
LAMP2 
Garcia, J.G., Overå, K.S., Bhujabal, Z., Knutsen, E., Evjen, G., Lamark, T., Johansen, T., 
Sjøttem, E. 
Manuscript 
In this study, we investigated the role of TRIM27 in autophagy. Firstly, we identified TRIM27 
as an autophagic substrate, which degradation was depended on ATG7 and the SLRs family of 
autophagy receptors. We mapped a LIR domain in its coiled coil region with specificity towards 
LC3C and GABARAP. Establishment of HEK293 FlpIn TRIM27 KO cells showed that 
TRIM27 has an effect in starvation-induced autophagy. Reconstitution of the TRIM27 KO cells 
with EGFP-TRIM27 showed that TRIM27 associates with core autophagy proteins and the 
SLRs p62 and NBR1. Furthermore, TRIM27 interacts directly with and ubiquitylates p62. 
Interestingly, the TRIM27 KO cells displayed high levels of LAMP2 expression, forming big 
LAMP rings in the cytosol of the cells. TRIM27 is described as an oncogene, and we found 
TRIM27 mRNA levels to be strongly upregulated in cancer tissue from breast cancer patients, 
as well and in various breast cancer cell lines. Intriguingly, TRIM27 expression seems to be 
inversely correlated with LAMP2 and LC3B expression in the analyzed cell lines, linking 
TRIM27 to the regulation of autophagy in breast cancer cell lines Thus, these cell lines are 
potentially a model system to identify the roles of TRIM27 in autophagy in breast cancer and 
its implication in the pathology of this cancer. 
 
Paper II 
TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is 
targeted to autophagic degradation by p62/SQSTM1. 
Overå, K.S., Garcia, J.G., Bhujabal, Z., Jain, A., Øvervatn, A., Larsen, K.B., Deretic, V., 
Johansen, T., Lamark, T., and Sjøttem, E. (2019). 
J. Cell Science. PMID 31828304. 
In this first study on TRIM32, we identified TRIM32 as an autophagic substrate. TRIM32 
degradation was mediated the Sequestrome-like receptor p62 in an ATG7 dependent pathway. 
We showthat TRIM32 directly interacts and ubiquitylates p62on lysine residues involved in the 
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regulation of p62 activity. This forms a feedback loop between TRIM32 and p62. Interestingly, 
the TRIM32 mutant implicated in the muscular dystrophy disease LGMD2H was not able to 
undergo autophagic degradation and failed to ubiquitylate p62. In contrast, the BBS11 disease 
mutant strongly facilitated p62 ubiquitylation, sequestration and degradation. These findings 
pointed to a dual role of TRIM32 in autophagy, as a cargo and a regulator of p62. Notably, the 
LGMD2H mutation phenotype suggests thatdysfunctional TRIM32-mediated regulation of p62 
may represent one of the pathological mechanisms of this disease.  
 
Paper III 
TRIM32 – a putative regulator of NDP52 mediated selective autophagy 
Garcia, J.G., Bhujabal, Z., Overå, K.S., Sjøttem, E. 
Manuscript  
In paper III, we further studied the role of TRIM32 towards the other SLRs, which we identified 
in paper II as putative mediatorss of TRIM32 degradation by autophagy. In this study, we show 
that TRIM32 downregulates the protein levels of all SLR proteins. Focusing on NDP52, we 
show that TRIM32 interacts directly with and ubiquitylates NDP52. On the other side, NDP52 
was able to direct autophagic degradation of TRIM32. NDP52 is important for recruiting ULK1 
and the autophagic machinery to damaged mitochondria. We show that reintroduction of 
TRIM32 in TRIM32 KO cells leads to ULK1 stabilisation, and increased phosphorylation of 
the autophagic regulator TBK1. Conversely, the LGMD2H mutated version of TRIM32 does 
not affect NDP52 and ULK1 expression, or facilitate TBK1 autophosphorylation.  Finally, we 
show that mitophagy is impaired in TRIM32 KO cells compared to normal cells and TRIM32 
KO cells reconstituted with TRIM32. Thus, TRIM32 seems to be a regulator of NDP52, ULK1 
and TBK1, which together may facilitate selective degradation of mitochondria.   
 
Paper IV 
Generation of the short TRIM32 isoform is regulated by Lys 247 acetylation and a PEST 
sequence 
Garcia-Garcia J., Overå, K.S., Khan, W., Sjøttem, E.  
PLOS One. In revision. 
In paper IV, derived from our findings in paper II, we studied how TRIM32 auto-ubiquitylation 
regulates its activity and stability. TRIM32 has two variants, a full-length protein and a 
truncated protein. However, the mechanism regulating these two isoforms is poorly understood.  
In this third study, we found that TRIM32 contains a PEST sequence located in the unstructured 
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region between the coiled coil domain and the NHL repeats. This PEST sequence directs the 
cleavage of TRIM32, resulting in a cleaved protein similar to the short isoform. Furthermore, 
we found that the exposure of this PEST sequence seems to be regulated by ubiquitylation and 
acetylation of the lysines K50, K247 and K401. The produced short isoform is catalytic 
inactive, suggesting a dominant negative role. This was a novel finding since to date, no PEST 
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Discussion 
The central theme of this thesis is the role of two TRIM proteins in selective autophagy. I joined 
this project born from a screen of 22 different TRIM proteins using the double-tag assay, which 
represented the 11 TRIM family subgroups. The goal of this screen was to identify candidates 
with a potential role in autophagy, alleging that their presence in the lysosome linked them 
somehow with the autophagy process. The knowledge surrounding the role of TRIM proteins 
in autophagy has increased in the recent years. TRIM proteins show several links to autophagy, 
and one of them is the function as autophagy receptors. Previous studies have already 
recognized TRIM5α, TRIM13, TRIM16, TRIM20, TRIM21 and TRIM63 as regulators and 
receptors in selective autophagy (Kimura, Mandell, and Deretic 2016). From our screen, 
TRIM27, TRIM32 and TRIM45 were identified as new potential autophagic substrates. We 
decided to further investigate the roles of TRIM27 and TRIM32 in autophagy, and our findings 
are presented in the following papers. In paper I, we investigated the role of TRIM27 in 
autophagy, finding that TRIM27 has an effect in starvation-induced autophagy and associates 
with core autophagy proteins and the SLRs p62 and NBR1. Furthermore, TRIM27 interacts and 
ubiquitylates p62/SQSTM1 (hereafter p62). TRIM27 KO cells show high levels of LAMP2 
expression, forming big LAMP rings in the cytosol of the cells. Furthermore, we found TRIM27 
mRNA levels to be strongly upregulated in cancer tissue from breast cancer patients, as well 
and in various breast cancer cell lines. Intriguingly, TRIM27 expression seems to be inversely 
correlated with LAMP2 expression in the analyzed cell lines. In paper II, we examined the 
autophagic role of TRIM32 including two TRIM32 mutations associated with two different 
diseases. In this first study on TRIM32, we found that TRIM32 is directed to autophagic 
degradation by p62, but also a regulator of p62 autophagic activity. This formed feedback loop 
was controlled by the direct interaction and ubiquitylation of p62 by TRIM32. Interestingly, the 
TRIM32 mutant implicated in the muscular dystrophy disease LGMD2H failed to ubiquitylate 
p62. In paper III, we further studied the role of TRIM32 towards the other SLRs. In this study, 
we found that TRIM32 interacts and ubiquitylates the autophagy receptor NDP52, stabilizes 
the phosphorylated form of TBK1 and facilitates mitophagy. In paper IV, derivate from our 
findings in paper II, we studied how TRIM32 auto-ubiquitylation regulates its activity and 
stability. In this third study, we found that TRIM32 contains a PEST sequence, which exposure 
seems to be regulated by ubiquitylation and acetylation of the lysines K50, K247 and K401. 
This was a novel finding since to date, no PEST sequence had been identified in TRIM proteins. 
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Taken together, these findings highlight the pivotal role of TRIM proteins as regulators of 
autophagy. 
 
Exploring the role of TRIM27 in autophagy 
We hypothesized that the presence of TRIM27 in the lysosomes using the double-tag assay 
could be an indicative of this TRIM protein playing a role in regulation of autophagy. TRIM27 
is part of the same subclass as TRIM5α, a well-recognized TRIM that acts as an autophagy 
receptor upon viral infection (Keown et al. 2018). We could not help but wonder if TRIM27 
might act in a similar manner. In an attempt to answer this question, we tried to further 
investigate how TRIM27 ended up in the lysosomes. Flow cytometry assays using HEK293 
FlpIn cells with inducible expression of EGFP-TRIM27 (Larsen et al. 2010) showed that 
TRIM27 could be degraded by both the proteasomal and the autophagic pathway, having the 
proteasome as the main degradation pathway both under normal and starved conditions (data 
not shown). Many TRIM proteins have a role and interact with the autophagy machinery under 
very specific circumstances, such as oxidative stress or invasion of pathogens (Kumar Jena et 
al. 2018; Sparrer et al. 2017). Therefore, TRIM27 might not have an active role in basal 
conditions, but it is plausible that another type of stimuli leads to the activation of TRIM27 
autophagic function, thus ending up in the lysosomes. In this study, we show that TRIM27 
autophagic degradation is mediated by the SLRs family of autophagy receptors in an ATG7 
dependent pathway, pointing to selective autophagy being responsible for TRIM27 
degradation.  
It is recently shown that the only transmembrane autophagy protein ATG9 plays an important 
role in the nucleation of the autophagosome (Sawa-Makarska et al. 2020). ATG9 vesicles 
traffics from Golgi to endosomes in a ULK1-dependent manner under stress conditions (Young 
et al. 2006), and ULK1 phosphorylation regulates trafficking of ATG9 under autophagy-
inducing conditions (Zhou et al. 2017). In this work, we show that depletion of ATG9 leads to 
increased levels of TRIM27. Further, TRIM27 seems to be modified in the ATG9 KO cells, 
resulting in a slower migrating band visualized by Western blotting. Moreover, certain EGFP-
TRIM27 bodies co-localized with ATG9 in the reconstituted HEK293 FlpIn EGFP-TRIM27 
cell line. Interestingly, the autophagy receptors p62 and NBR1 also displayed increased protein 
levels in the ATG9 KO cells, and occurred as slower migration bands on the Western blot gels. 
This clearly points to TRIM27 as an autophagy substrate similarly as NBR1 and p62. In 
contrast, the autophagy receptor NDP52 did not display aberrant mobility in the ATG9 KO cell 
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extract, even if its protein level were slightly increased. Protein levels of lipidated LC3B were 
decreased in the ATG9 KO cells. This is in line with recent reports describing that ATG9 
vesicles recruit the autophagy machinery and establish membrane contact sites with membrane 
donor compartments. ATG2 mediates transfer of lipids from donor membrane to the 
autophagosome formation sites, leading to PIP3 formation and ATG8 lipidation. Hence, 
lipidation of LC3 is dependent on ATG9 vesicles (Sawa-Makarska et al. 2020). Interestingly, 
we observed decreased levels of LC3B dots in the HEK293 FlpIn TRIM27 KO cell lines, 
indicative of reduced LC3B lipidation in these cells. Seeing that some autophagy related 
proteins such as the autophagy receptors p62 and NBR1 are modified upon ATG9 depletion, 
raise the question if ATG9 vesicles contain more than lipids. There is the possibility that ATG9 
vesicles contain protein modifiers such as phosphatases or de-ubiquitinases (DUBs), which are 
able to modify TRIM27, p62 or NBR1. The impairment in the delivery of those modifiers could 
explain the slower migrating bands we have observed. Another plausible scenario is that ATG9 
depletion inhibits the degradation of certain autophagy-related proteins and consequently they 
accumulate. This accumulation of non-degraded proteins may recruit E3 ligases and kinases 
that modify them. The role that ATG9 plays in promoting these changes in TRIM27, p62 and 
NBR1 is a question that would be interesting to address in future experiments. 
In this study, we found that TRIM7 interacts with p62 in vitro and co-precipitates and co-
localizes with p62 in cells. However, interaction of TRIM27 with NDP52 was only seen by 
GST-pull down assays, which does not represent the real environment of the cell. However, we 
also observed that NDP52 mediated TRIM27 degradation in Penta KO cells reconstituted with 
NDP52. These results suggest that NDP52 may have a connection with TRIM27. NDP52 is a 
big player in xenophagy, detecting invading pathogens and bringing them do degradation 
(Verlhac, Viret, and Faure 2015). NDP52 interacts specifically with LC3C via a so-called CLIR 
motif, and this interaction was proposed to be crucial for innate immunity since cells lacking 
either protein was not able to protect their cytoplasm against Salmonella (von Muhlinen et al. 
2012). We found that TRIM27 contains a LIR motif in between its coiled-coil domain. 
Intriguingly, our results show that the TRIM27 LIR motif also has a preference for LC3C. This 
may suggest, even though very preliminary, a potential collaboration of TRIM27 and NDP52, 
linked to LC3C by their LIR motifs. Previous studies on TRIM27 highlight its strong ties to 
immune signaling regulation (Conwell et al. 2015; Zurek et al. 2012; J Wang et al. 2016). 
Therefore, these findings may suggest that TRIM27 represents a link between innate immunity 
and selective autophagy.  
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In pursuance of getting a better understanding on the role of TRIM27 in selective autophagy, 
we produced a TRIM27 knock-out cell line in HEK293 FlpIn T-Rex cells with CRISPR-Cas9 
technology (Ran et al. 2013), and re-constituted it with EGFP-TRIM27 and EGFP only. EGFP-
TRIM27 was very efficiently expressed in the reconstituted cells, hence we used only 100 ng 
of Tetracycline or Doxycycline to obtain an expression level close to the endogenous expression 
level of TRIM27. EGFP-TRIM27 seems to be very prone to aggregation, a characteristic we 
did not observe for f.ex.TRIM32 which expression was re-constituted in HEK293 FlpIn 
TRIM32 KO cells. . This fact suggested that TRIM27 overexpression produces high levels of 
ubiquitin, leading to high aggregation. This matter has been a big concern for us over the 
development of this project, since autophagy is responsible for clearing ubiquitylated protein 
aggregates in the cell (Lamark and Johansen 2012). The HEK293 FlpIn cell line, TRIM27 KO 
and reconstituted cell lines stained with different antibodies detecting autophagy related 
proteins shed some light on this concern. On one side, TRIM27 co-localized with members of 
the autophagy initiation complex, such as ATG9, ATG13 and ULK1. Moreover, we also found 
co-localization with the autophagy receptors p62 and NBR1. This raised the question if this co-
localization happened to be unspecific and due to the TRIM27 aggregation tendency. For that, 
we also stained with antibodies against various marker proteins such as LC3B 
(autophagosome), GM130 (Golgi),Calreticulin (ER), FK2 (Ubiquitin) and UPS7 (recognized 
TRIM27 interactor). Interestingly, TRIM27 did not co-localize with LC3B more than in a few 
dots, suggesting that not all autophagy-related proteins were present in the TRIM27 aggregates. 
Furthermore, TRIM27 was not found in proximity to the Golgi marker GM130 and the ER 
marker Calreticulin, which was in line with the literature on the cytoplasmic and nuclear 
localization of TRIM27 (Harbers et al. 2001). In addition, TRIM27 did co-localize with UPS7, 
which is a well-known interaction partner, as well as ubiquitin (Zaman et al. 2013). These two 
positive controls indicated that the localization of reconstituted EGFP-TRIM27 is close to the 
localization of endogenous TRIM27. Unfortunately, this could not be verified by 
immunostaining of endogenous TRIM27, since we could not find any TRIM27 antibody that 
worked in immunostaining. 
Importantly, our MS analysis of immunoprecipitated EGFP-TRIM27 identified co-precipitation 
of several autophagy related proteins, among them ATG7, TBK1, LAMP2, p62, NBR1, NDP52 
and TAX1BP1. The association of TRIM27 structures with all SLRs further supported our 
hypothesis that the SLRs mediate TRIM27 degradation. Likewise, the co-precipitation of 
TRIM27 with ATG7 and LAMP2 also highlighted a link between TRIM27 and autophagy. 
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Previously, TRIM27 in shown to induce TBK1 degradation via K48-linked ubiquitylation at 
Lys251 and Lys372 promoted by Siglec1 in interferon type I mediated antiviral innate immune 
response (Zheng et al. 2015). This supports our finding of TBK1 as one of the potential TRIM27 
interactors in the MS analysis. However, we were not able to detect any effect of TRIM27 on 
TBK1 levels, in neither basal nor starved conditions. This can be explained by the fact that 
TRIM27 mediated degradation of TBK1 only happens upon stimulation of the antiviral immune 
system. However, we observed that TRIM27 protein levels in HeLa TBK1 KO cells were 
stabilized compared to normal HeLa cells (data not shown). This may suggest that TBK1 
regulates the protein levels of TRIM27. Due to the pivotal role of TBK1 in autophagy, this is a 
novel finding that would be worth exploring further. 
Surprisingly, we identified LAMP2 as a TRIM27 interaction partner. LAMP2 is a highly 
glycosylated protein decorating the luminal surface of lysosomal membranes (E. L. Eskelinen, 
Tanaka, and Saftig 2003). It is an important regulator of maturation of autophagosomes, and 
LAMP2 deficiencies leads to accumulation of autophagosomes (Saftig, Beertsen, and Eskelinen 
2008). Depletion of TRIM27 either by genetic KO, or by TRIM27 siRNA treatments, resulted 
in accumulation of LAMP2 protein levels, and the formation of large LAMP2 rings in HEK293 
FlpIn cells. The large LAMP2 rings were often localized in the perinuclear region, in close 
proximity with TRIM27 bodies and mitochondria. Whether LAMP2 accumulation as such leads 
to formation of large lysosomes, or whether these large LAMP2 rings indicate that TRIM27 is 
implicated in the regulation of lysosome biogenesis, is an interesting question to address in 
further studies. However, we clearly show that TRIM27 deficiency results in accumulation of 
LAMP2. This accumulation can be due to impaired degradation of LAMP2 in TRIM27 KO 
cells, since TRIM27 is an E3 ligase that directs proteins to degradation by ubiquitylation. 
Alternatively, it can be due to increased expression of LAMP2 at the transcriptional level.  
TRIM27 has been proposed as a oncogene promoting cell proliferation (Zurek et al. 2012), as 
well as cell migration by activating EMT (Y. Zhang et al. 2018). In this study, HEK293 FlpIn 
TRIM27 KO cells showed an enhanced proliferation rate compared to normal HEK293 FlpIn 
cells. This is partially in contradiction with the general literature, proposing that TRIM27 
facilitates cell proliferation (Y. Yao et al. 2020; Zoumpoulidou et al. 2012; Y. Ma et al. 2016). 
This may suggest that the effect of TRIM27 on cell proliferation is dependent on the specific 
cancer cell type. On the contrary, the migration capacity of HEK293 FlpIn TRIM27 KO cells 
was decreased compared to normal HEK293 FlpIn cells or the TRIM27 KO cells reconstituted 
with EGFP-TRIM27. This is in line with other studies studies suggesting a role of TRIM27 in 
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EMT (Y. Zhang et al. 2018). Therefore, the reconstituted HEK293 FlpIn TRIM27 KO EGFP-
TRIM27 cells seem to be a realiable source that mimic the function of endogenous TRIM27.  
Interestingly, we found LAMP2 expression to be upregulated in the breast cancer cell lines 
displaying  no or very low expression levels of TRIM27. This correlates well with our analyses 
in HEK293 cells, suggesting that loss of TRIM27 leads to enhanced LAMP2 expression. 
LAMP2 plays a role in the support of early cancer progression, helping cancer cells surviving 
in acidic enviroments (Mogami et al. 2013). LAMP2 is highly expressed in several cancers, 
where reduced expression of LAMP2 has been associated with a loss of migration and invasion 
capabilities (Koukourakis et al. 2015). LAMP2A isoform has shown increased expression in 
breast tumor tissue, and its inhibition results in sensitation of tumor cells to radioation and 
doxorubicin therapy (Saha 2012). Autophagy helps cancer cells to survive under nutrient and 
oxygen stress (Filomeni, De Zio, and Cecconi 2015). TRIM27 seems to facilitate starvation 
induced autophagy. Hence, this can be one mechanism that TRIM27 uses to facilitate growth 
of cancer cells. Collectively, these results point to TRIM27 as a putative regulator of autophagy, 
and that one of its oncogenic features is to facilitate the autophagy process in cancer cells. 
Moveover, breast cancer cell lines with various expression levels of TRIM27 represent 
promising model systems for further revealing the molecular mechanisms of TRIM27 in 
autophagy and cancer. 
 
TRIM32 as an autophagic substrate and its role in autophagy 
After identifying the presence of TRIM32 in the lysosome both under normal and starvation 
conditions, the first question that raised was how it ended up in the lytic compartment. In order 
to answer this broad question, we firstly investigated who was in charge of the degradation of 
TRIM32. BafA1 and MG-132 are widely used lysosomal and proteasomal inhibitors 
respectively. The effect of these two inhibitors on the levels of TRIM32 showed that both 
pathways mediate the degradation of TRIM32. Proteasomal degradation of TRIM32 showed to 
be the main degradative pathway under normal conditions, whereas autophagy was equally 
implicated in the degradation of TRIM32 under starving conditions. These results suggest a 
potential link of TRIM32 in autophagy. Later we found that the degradation of TRIM32 was 
dependent on ATG7 and the SLRs. The main SLRs responsible for bringing TRIM32 to the 
lysosomes were the autophagy receptors, p62 and NDP52. Moreover, we found a direct 
interaction and ubiquitylation of those SLRs by TRIM32. Moreover, we show that NBR1 seems 
also to mediate TRIM32 autophagy degradation, however, we have not proven any interaction. 
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It has been reported that TRIM32 interacts with the autophagy receptor TAX1BP1 (Yang et al. 
2017). However, our results did not show a TAX1BP1-dependent degradation of TRIM32 (data 
not shown), meaning that TAX1BP1 is associated with TRIM32 but does not mediate its 
degradation by autophagy. This difference might be due to this interaction being cell-type 
specific, in our study we used Hela cells, while Yang et al. 2017 used HEK293 cells. 
Nonetheless, we cannot exclude OPTN and TAXBP1 as potential mediators of TRIM32 
autophagic degradation just yet, since we used an over-expression system and more 
experiments are needed to rule them out. 
The lipidation of LC3-I to LC3-II is a widely used autophagy marker, using the number of LC3-
II in the cell as the number of autophagosomes formed (Yoshii and Mizushima 2017). Another 
commonly used marker to evaluate autophagy is p62, which binds LC3 and is degraded in the 
lysosome (Pankiv et al. 2007). Our results showed co-localization of TRIM32 with LC3B and 
p62. TRIM32 ablation showed a reduction of the formation of p62 dots compared to TRIM32 
WT. Of note, the inhibition of autophagosome degradation also increases the amount of LC3-
II and p62 (Bjørkøy et al. 2005; Tanida et al. 2005). Thus, the amount of LC3-II and p62 in the 
cell might not accurately represent the degradation of autophagosomes, since it does not allow 
us to distinguish if the observed effect is due to the induction of autophagy or its inhibition. 
Moreover, it has been shown that LC3B-II is also localized in non-autophagic structures not 
associated with the lysosome, commonly due to overexpression of the protein by transient 
transfection or the formation of aggregates (Kuma, Matsui, and Mizushima 2007). To try to 
answer this question, we analyzed the protein levels of both the SLRs and LCB in TRIM32 KO 
cells. The cells lacking TRIM32 display higher expression of all SLRs (p62, NBR1, NDP52, 
Optineurin and TAX1BP1), and this effect is recovered when reconstituting with myc-
TRIM32WT. We analyzed the mRNA levels of these SLRs in the TRIM32 KO, which shows no 
change on the transcriptional level of the SLRs, meaning that the changes in the expression of 
the SLRs are due to TRIM32 effects on their degradation rather than their synthesis. Moreover, 
the analysis of the expression of the SLRs and LC3 on TRIM32 KO cells in starvation 
conditions followed by a treatment with BafA1 and MG132 did not show a difference between 
TRIM32 KO and WT, suggesting that TRIM32 ablation does not have an effect on global 
autophagy. Of note, in paper II we show that reintroducing NDP52 or NBR1 in Penta KO cells 
facilitates TRIM32 degradation. This suggest that at least to date, three SLRs mediate 
autophagic degradation of TRIM32, and that their action seems to be independent of each other. 
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Taken together, these results suggests that TRIM32 autophagic degradation is mediated by 
selective autophagy. 
We observed co-localization of LC3 and TRIM32, thus we wondered if TRIM32 could work 
as an autophagy receptor itself. In order to try to answer this question, we evaluated the 
interaction between TRIM32 and the six human ATG8s. Our results showed affinity of TRIM32 
towards LC3A, LC3C, GABARAP and GABARAP-L1, while displaying a weak affinity 
towards LC3B and GABARAP-L2. Our inability finding a LIR motif within TRIM32 by the 
use of different strategies lead us to think that the interaction of TRIM32 and the mentioned 
ATG8s was mediated in a non-LIR dependent manner. The autophagy protein RPN10 of 
Arabidopsis contains a UIM-docking site (UDS) that is able to bind ATG8s proteins (Marshall 
et al. 2019). In the case of TRIM32, where we did not find a UIM motif either, the interaction 
with ATG8s does not seem to be mediated by one linear motif. Instead, it is likely that this 
interaction is carried out through several regions of TRIM32. Nevertheless, this interaction 
could be interesting to investigate further to see whether it has a role in autophagy. Importantly, 
ATG8s have roles outside autophagy (Lorenzo Galluzzi and Green 2019), therefore, it is 
plausible that TRIM32 and ATG8s might cooperate together in a non-LIR fashion to perform 
a function that is not related to autophagy. 
 
TRIM32 and TRIM32-related diseases on p62  
To continue to investigate the association between TRIM32 and p62, we analyzed the 
interaction between these two proteins. Our results showed that TRIM32 interacts with p62 
both in vitro and in cells. However, the absence of p62 still leaded to TRIM32 RedOnly dots, 
meaning that p62 is not the only SLR in charge of TRIM32 degradation. Importantly, TRIM32 
KO showed lower levels and an impaired turnover of p62, which were recovered by re-
introduction of myc-TRIM32. In paper II, we show how TRIM32 ubiquitylates p62, and that 
ubiquitylation is lost upon TRIM32 ablation or by the use of the deubiquitinase USP2. 
Catalytically inactive TRIM32C44S also showed the inability to ubiquitylate p62, indicating that 
TRIM32 E3 ligase activity is in charge of mediating this ubiquitylation reaction.  
Genetic mutations in the NHL domains of TRIM32 cause the muscle disorder Limb Girdle 
Muscular Dystrophy 2H (LGMD2H), whereas a missense-mutation (P130S) in the B-Box 
domain results in the disease Bardet-Biedl syndrome 11 (BBS11) (Chiang et al., 2006). These 
two diseases, despite being affected by mutations on the same gene, lead to two completely 
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different phenotypes. LGMD2H is associated with different degrees of muscle atrophy (Zhao 
et al., 2019, Locke et al., 2009), whereas BBS11 has a pleiotropic phenotype that shows no 
effects in muscular homeostasis (Chiang et al., 2006). TRIM32 is associated with this muscular 
disease through seven mutations in the NHL domain (Saccone et al. 2008; Cossée et al. 2009), 
however in this study we have focused on the most common, D487N mutation. In order to 
investigate if these mutations had an effect on the degradation of TRIM32 by autophagy, we 
reconstituted TRIM32 KO cells with both mutants TRIM32D487N and TRIMP130S. The 
LGMD2H mutant show a very similar phenotype to the one observed in TRIM32 KO cells, 
characterized by the inability to ubiquitintate p62. Interestingly, TRIM32 D487N is able to bind 
to p62, but does not shows any catalytically activity. As expected, TRIM32 D487N is not able to 
auto-ubiquitylate itself either, due to its catalytically inactive form. These findings are in line 
with previous studies, where a Knock In mouse model with the LGMD2H mutation D487N 
shows the same phenotype as the TRIM32 null mice due to the destabilization of the protein 
and subsequent degradation (Kudryashova et al. 2011). On the contrary, the BBS11 mutant 
shows the opposite effect. TRIM32P130S is not only able to successfully ubiquitylate p62, but it 
shows a higher association with the autophagy receptor. Moreover, TRIM32P130S also displays 
a higher TRIM32 RedOnly dot formation upon starvation in comparison to TRIM32WT, 
suggesting that this mutation in the B-Box may lead to higher autophagic degradation of 
TRIM32.  
TRIM32 requieres oligomerization to be catalytically active, which is provided by its RING 
domain. The B-Box helps in the oligomerization but it has been shown dispensable (Lazzari et 
al. 2019). Other TRIM proteins have been reported that their B-Box can confer E3 ligase 
activity, such is the case of TRIM16 (Bell et al. 2012). However, a recent study showed that 
this does not seem to be the case of TRIM32 (Lazzari et al. 2019). In the case of TRIM16, this 
E3 ligase lacks a RING domain but contain two B-Boxes, one of them being structurally similar 
to a RING domain, and the dimerization of both may resemble to an actual RING domain, thus 
conferring E3 ligase catalytic activity (Bell et al. 2012). This does not apply to TRIM32 due to 
their differences in structure, where TRIM32 only contains one B-Box, which does not 
resemble to a RING domain. The RING domain of TRIM32 is necessary for association with 
E2 enzymes, whereas the B-Box is not (Napolitano et al. 2011). However, we cannot rule out 
that the B-Box might determine the topology of the ubiquitin chain together with E2. It has 
been shown that deletion of the B-Box in TRIM32 and point mutations C100/C103A leads to a 
slightly higher efficiency in the building of polyubiquitin chains activity due to the closer 
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proximity of the RING and NHL domains. This suggests that the B-Box might acts as a spacer 
for modulating TRIM32 processivity (Lazzari et al. 2019). Both the RING domain and B-Box 
mediate TRIM32 localization. The absence of the RING domain leads to larger aggregates 
dispersed throughout the cytoplasm, while ablation of the B-Box, leads to less 
aggregates/cytoplasmic bodies. Interestingly, these RINGless or B-Boxless mutants retain the 
ability to self-associate (Lazzari et al. 2019). This suggest that these two domains might mediate 
TRIM32 subcellular localization by the interaction with other proteins, ultimately controlling 
TRIM32 enzymatic activity since it is a way to regulate the availability of active TRIM32 in 
cells. 
The phenotype of BBS11 has little similarity to the one from LGMD2H. The B-Box of TRIM32 
mediates TRIM32 localization, eventually regulating its availability within the cell and 
therefore its function. Moreover, TRIM32 B-Box might be a regulator of the RING domain 
catalytic activity by bringing the enzymatic pocket closer to its substrate, which could explain 
why in our results, P130S shows a higher localization of TRIM32 with p62 (its substrate) and 
thus, it shows a higher turnover of p62 and a stronger tendency to form TRIM32 RedOnly dots. 
The symptoms observed in BBS11 patients might be a consequence of the higher efficiency on 
E3 ligase activity by this point mutation, and its modulation of its localization, eventually 
impeding or dysregulating the binding of TRIM32 to some of its substrates, which are involved 
in many cellular processes, leading to a multisystem phenotype. 
P62 is commonly organized in flexible polymers where its PB1 domain constitute a helical 
scaffold. These scaffolds form filaments that are able to bind LC3 and the addition of long 
ubiquitin chains induces disassembly and shortening of these filaments (Ciuffa et al. 2015). 
Therefore, it is suggested that p62 forms a highly structured but flexible assembly that provides 
a large molecular scaffold for the nascent autophagosome, while being able to accommodate 
the selected cargo (Jakobi et al. 2020). Interestingly, dimerization and ubiquitylation of p62 are 
incompatible with each other due to the occlusion of the ubiquitin binding sites when dimerized 
(Isogai et al. 2011). E2 enzymes are in charge of transporting the activated ubiquitin to the E3 
ligases, which bind the ubiquitin to the substrate. Nevertheless, E2 enzymes are also able to 
directly ubiquitylate, which might be a way for the cell to have even more diversity in the 
control of the pattern of ubiquitylation (Stewart et al. 2016). To date, the two E2 enzymes 
UBE2D2 and UBE2D3 have been reported to be able to interact and mediate p62 ubiquitylation. 
The interaction between the E2 enzymes and p62 occurs via the EIR region of p62, which results 
in ubiquitylation at nine lysine residues, which among those we can find K157 and K295 (Peng 
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et al. 2017). This poly-ubiquitylation of p62 relieves the inhibition of the UBA domain in the 
p62 dimer, allowing binding and tethering of ubiquitylated cargo to the ATG8s conjugated to 
the phagophore (Peng et al. 2017). In an attempt to identify the exacts sides where TRIM32 
ubiquitylates p62, we performed an MS analysis with both the TRIM32WT and the TRIM32 
disease mutants TRIM32D487N and TRIM32P130S. The TRIMD478N mutant was used as a negative 
control, since it is not able to ubiquitylate p62. Our results showed that p62 was potentially 
ubiquitylated on two lysines, K157 and K295. Unfortunately, we were unable to map the exact 
lysines that TRIM32 was able to ubiquitylate in cells, indicating that TRIM32 might ubiquinate 
p62 in several sites. It would be worth continuing the mapping to find the sites of TRIM32-
mediated ubiquitylation of p62. Nonetheless, we did get some interesting observations. Our 
results showed TRIM32 mono-ubiquitylate p62, potentially on several residues. This mono-
ubiquitylation seems to enhance p62 body formation and p62-mediated autophagy. 
Interestingly, TRIM32D478N was not able to carry out the mono-ubiquitylation of p62, however 
still shows interaction with p62. This is in line with other studies were this mutant of TRIM32 
failed to promote mono-ubiquitylation but still bond dysbindin and its respective E2 enzyme 
(Locke et al. 2009). TRIM32 has been shown to interact with ULK1 and Piasy, however, this 
interaction is inhibited by TRIM32D478N (Albor et al. 2006; Di Rienzo, Piacentini, and Fimia 
2019). Therefore, the binding site of TRIM32 and p62 is in a different localization than the one 
between TRIM32 and either ULK1 or Piasy. Among TRIM32 targets, there are many proteins 
involved in muscle function regulation. The fact that TRIM32D478N, which causes LGMD2H, 
is able to interact with the substrate but not attach an ubiquitin molecule to it might partially 
lead to the pathology of this disease. The clear phenotype difference between these two diseases 
suggests the pivotal role of NHL domains in muscle tissue. NHL domains are in charge of 
protein-protein interaction, thus mutations on those may lead to an effect on the ability to 
ubiquitylate its substrates and/or auto-ubiquitylation. Interestingly, mutations in NHL domains 
(D478N) lead to an impairment of TRIM32 catalytic activity, suggesting that NHL domain may 
also partially regulate this function.  
 
TRIM32, NDP52 and mitophagy 
In paper II we show that the degradation of TRIM32 is mediated by p62, but the reconstitution 
of Penta KO cells with p62 does not completely recover TRIM32WT levels of RedOnly dots. 
This leads us to think that other SLRs are involved in TRIM32 autophagic degradation. In paper 
III we show that NDP52 also mediates the autophagic degradation of TRIM32. We also show 
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the interaction between NDP52 and TRIM32 both in vitro and in cells. Moreover, NDP52 levels 
considerable decrease in TRIM32 KO cells, while its trascription levels are unaffected, 
suggesting that TRIM32 contributes to autophagic degradation of this receptor. As the case of 
p62, TRIM32 is also able to ubiquitylate NDP52. Interestingly, both TRIM32WT and the disease 
mutants TRIM32PS130S and TRIM32D487N equally bind NDP52 in vitro and all co-localized with 
NDP52 in certain dots under normal conditions. Conversely, inhibition of lysosomes by BafA1 
produced the accumulation of NDP52 dots. In this context, the co-localizaiton of NDP52 with 
TRIM32D487N is much lower compared to TRIM32WT and TRIM32PS130S. These results suggest 
that the NDP52 interaction with TRIM32 is independent of TRIM32 catalytic activity. 
NDP52 has an important role in the clearance of mitochondria (Vainshtein and Grumati 2020), 
where it is recruited by PINK1 (Lazarou et al. 2015). Then, NDP52 associates with the ULK1 
complex by its interaction with FIP200 (Ravenhill et al. 2019). NDP52-induced mitophagy 
requires the interaction of NDP52 and FIP200, since this interaction promotes FIP200 
membrane binding capacity (Shi et al. 2020). Interestingly, TBK1 is able to induce autophagy 
in the absence of LC3 (Vargas et al. 2019). We then wondered if TRIM32 might affect the 
ability of NDP52 to induce mitophagy. For this purpose, we used the double-tag assay on the  
transmembrane region of the mitochondria protein OMP25 (OMP25TM) (mCherry-EGFP-
OMP25TM) as a way to monitor mitophagy, while overexpressing the mitophagy receptor 
FKBP8 together with its corresponding ATG8 protein and LC3A (Bhujabal et al. 2017). Our 
results show that TRIM32 ablation reduces the levels of mitophagy compared to HEK293 FlpIn 
cells, and reintroduction of myc-TRIM32 completely restores the mitophagy activity. 
Intriguingly, we found ULK1 expression to be upregulated in HEK293 FlpIn TRIM32 KO cells 
reconstituted with myc-TRIM32WT compared to TRIM32 KO cells. The BBS11 disease mutant 
TRIM32PS130S displays a similar ULK1 expression level as TRIM32WT, whereas TRIM32D487 
resembles to the TRIM32 KO cells. At this point we wonder if TRIM32 ubiquitylates ULK1, 
however, our results do not show a difference on the ubiquitylation status of ULK1 either in the 
TRIM32 KO cells, or reconstituted with TRIM32 both wildtype and mutants. These results 
suggest that TRIM32 promotes higher levels of ULK1 and this effect depends on TRIM32 E3 
ligase activity, but TRIM32 does not mediate the ubiquitylation of ULK1. These results are in 
line with another study that found that ULK1 is not a direct substrate of TRIM32 (Di Rienzo, 
Piacentini, and Fimia 2019).  
TBK1 kinase plays a dual role in the initiation of mitophagy. This kinase facilitates the 
interaction of NDP52 and FIP200, a member of the ULK1 complex. Meanwhile, TBK1 
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associates with the autophagy receptors OPTN, NDP52 and p62, which will recruit the core 
autophagy machinery and proceed to the formation of the autophagosome. TBK1 becomes 
activated by the ubiquitin chain binding of OPTN, and in response TBK1 phosphorilates OPTN 
in the position S177, which promotes OPTN ATG8 recruitment, and in position S473 and S513, 
which promotes ubiquitin chain binding, TBK1 activation and OPTN retention and efficient 
mitophagy in vivo (Heo et al. 2015). This creates a self-reinforcing positive feedback 
mechanism to ensure efficient mitophagy. TBK1 enrichment of the mitochondrial membrane 
induces the autophosphorylation of TBK1 in position S172. HEK293 FlpIn TRIM32 KO cells 
show low levels of S172 phosphorylated TBK1, and reconstitution of the KO cells with 
TRIM32WT, TRIM32PS130S or TRIM32D487N lead to increased levels of phosphorylation. This 
suggest that TRIM32 effect on TBK1 phosphotylation in position S172 is not mediated by its 
catalytic activity.  
To sum up, TRIM32 seems to induce NDP52-mediated autophagy. In this context, the ULK1 
complex activation mediated by NDP52 is independent of AMPK and mTOR activity. A 
previous study shows TRIM32 localized to the mitochondria, further supporting the possibility 
of TRIM32 playing a role in mediating or regulation mitophagy (J. Zhang et al. 2012). 
Moreover, TRIM32 interacts with AMBRA1, a mitophagic receptor and a positive regulator of 
ULK1 activity. It has been reported that AMBRA1 promotes mitophagy by the action of the E3 
ligase HUWE1 that acts as an inducing factor (Strappazzon et al. 2020). Moreover, AMBRA1 
is able to promote mitophagy in a PINK1/PARKIN- dependent and independent manner (Van 
Humbeeck, Cornelissen, and Vandenberghe 2011). It would be interesting to further investigate 
the regulation of both ULK1 and TBK1 by TRIM32 in relation to autophagy. AMBRA1 could 
be one possible mediator of this regulation. It would also be worth exploring if TRIM32 
interacts and has a similar effect in other autophagic receptors. We have described the direct 
effect that TRIM32 has on p62. Interestingly, this autophagic receptor is also able to mediate 
mitophagy (Geisler et al. 2010), therefore, we cannot rule out the possibility that TRIM32 has 
also a regulatory effect on p62-mediated mitophagy. Of note, NDP52 shows a preference for 
LC3C (von Muhlinen et al. 2012). In paper I we show the high affinity that TRIM32 presents 
for LC3C, an interaction that seem to be non-LIR dependent. The fact that these two proteins 
show a preference for LC3C could be a hint of a possible regulation of the autophagosome 
formation by the action of TRIM32 and NDP52 towards LC3C during mitophagy. 
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TRIM32 short isoform and its regulation 
There are two variants of TRIM32 protein in humans. The main variant, and the one that we 
have described in paper I and II, is a 653 amino acid protein. Meanwhile, the second variant is 
formed by only 172 animo acid and lacks the NHL-repeats and the unstructured region between 
RCC and the NHL-domain (ensemble.org and Uniprot.org Q13049). In paper I and II, we show 
insights on the function of the long variant of TRIM32 and its role in selective autophagy. 
TRIM32 requires auto-ubiquitylation and oligomerization to become catalytically active (Overå 
et al. 2019). However, how this auto-ubiquitylation takes places is not fully understood yet. In 
order to try to answer this question, we perfomed a Mass spectrometry analysis (MS) of 
TRIM32WT, TRIM32D487N, TRIM32P130S to identify which lysine residues in TRIM32 are 
targeted for auto-ubiquitylation. By the comparison of both TRIM32WT and TRIM32P130S, 
which are both catalytically active, to the catalytically inactive TRIM32D487N, we obtained 
several hints. One on side, TRIM32D487N did not display any ubiquitylated lysine, which was 
expected from results shown in our previous study (Overå et al. 2019). On the other side, 
TRIM32WT and TRIM32P130S shown two ubiquitylated peptides in K50 and K401. Additionally, 
peptides with acetylation on lysine K247 were identified in the TRIM32 disease mutants’ 
precipitates. From these results, we decided to produce plasmids containing mutations of the 
identified lysines to arginine and analyze their behavior. Peculiarly, the double mutation EGFP-
TRIM32K247R/K401R resulted in a partially cleaved protein (mix of cleaved and non-cleaved 
protein), while the triple mutation EGFP-TRIM32K50R/K247R/K401R leaded to a complete cleavage 
of TRIM32. The size of this protein was around 20 kDa (excluding the tag), which resembles 
to the short variant of TRIM32. Intriguingly, this cleaved protein is more prompt to form 
aggregates near the Golgi, while the full-length TRIM32 isoform is located throughout the 
cytoplasm as previously described in other studies (Kawaguchi et al. 2017). The short TRIM32 
variant should be transcribed with a 3’ UTR, which is not recognized so far. Therefore, this 
short isoform might be the results of post-translational modifications on the long-length 
TRIM32 variant, which is something that occurs in other proteins (Jianhui Wang et al. 2012). 
In an attempt to complete this puzzle, and since the use of the deubiquitinase USP2 did not 
produced any cleavage in TRIM32, we wondered if acetylation on position K247 could be the 
trigger for this short form of TRIM32. The replacement of the described lysines to glumatine 
(Q) in order to mimic acetylation, acetylation mimicking in position K247 completely inhibited 
the cleavage. This restored long-length TRIM32 by K247 acetylation displayed a similar 
localization as the previously analyzed TRIM32WT. To check if autophagy degradation of 
TRIM32 was affected by these PTM on the lysine residues K50, K247 and K401, we performed 
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a double-tag assay on the various TRIM32 lysine mutation constructs. This assay showed that 
the cleaved protein and TRIM32K50R/K247Q/K401R were not able to form any RedOnly dots. The 
mCherry-EYFP-TRIM32K247R/K401R and mCherry-EYFP-TRIM32K247Q constructs formed 
RedOnly dots, but to a lesser extent than mCherry-EYFP-TRIM32WT. This suggests that 
PTMs on the lysine residues K50, K247 and K401 regulate autophagic degradation of TRIM32, 
and all of them are needed for normal degradation of TRIM32 by autophagy. Thus, the 
acetylation of TRIM32 on its position K247 seems to be play a pivotal role on its stability. Then 
we wondered if TRIM32 encodes specific sequences that are exposed to proteolytic cleavage, 
such as PEST sequences. By the use of the PEST perdiction tool from EMBOSS, we obtained 
a putative PEST sequence located between amino acid 248 and 270 of TRIM32. Intriguingly, 
this sequence is located accurately adjacent to lysine K247. A partial ablation of this PEST 
sequence in TRIM32K50R/K247R/K401R lead to an inhibition of the cleavage, while not 
compromising the stability of TRIM32 in TRIM32WT. The TRIM32K50R/K247R/K401R, which is 
cleaved, and TRIM32K50R/K247Q/K401R, which is full-length, do not display auto-ubiquitylation 
activity. While, TRIM32WT with a partial deleted PEST sequence and the TRIM32K247Q are 
both able to auto-ubiquitylate. As we demonstrated in paper II, TRIM32 degradation is 
mediated by both proteasomal and lysosomal pathways. We did try to pinpoint the pathway 
implicated in PEST-mediated cleavage of TRIM32, however, we did not find it. Taken together, 
this shows the importance of lysines K50, K247 and K401 on TRIM32 activity, since the lack 
of them leads to a catalytic inactive form of TRIM32. It also highlights the critical role that 
acetylation plays as a post-transcriptional modification, since in the case of TRIM32 we suspect 
that acetylation prevents the exposure of the PEST sequence to proteolytic enzymes. It would 
be interesting to investigate how this cleavage of TRIM32 to produce a short isoform occurs, 
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Methodological considerations 
In order to assess of the role of TRIM32 and TRIM27 in selective autophagy we have performed 
several molecular biology methods, which can be found in the materials and methods section 
of each paper. Here I discuss the limitations of some of these techniques, as well as the strategies 
we have used to trouble-shoot and minimize the impact of the flaws of each method.  
 
Double tag assay 
A double-tag assay is characterized by tagging a desired protein with fluorescence tags, such 
as EGFP and mCherry, in order to be able to follow up its presence in the different 
compartments of the cell, particularly discriminating between the lysosomes and the cytosol. 
The GFP tag is acid- sensitive while the mCherry tag is acid-insensitive. The GFP tag becomes 
unstable and degraded in the lysosomes, leading to RedOnly dots (Hundeshagen et al. 2011). 
In our study, we used this assay to investigate if TRIM32 and TRIM27 were substrates for 
autophagic degradation. We also used this method to monitor the degradation dynamics of p62 
in TRIM32 KO cells, as a way to monitor autophagic flux. This assay is a very useful tool to 
investigate if the tagged proteins are localized in the lysosome, since the presence of these 
proteins in the lytic compartment suggests that they may be degraded by the autophagy 
pathway. However, this tool has main setbacks. One is that it require over-expression of the 
protein under study, another is that  the tag might affect the tagged proteins functionality or 
their ability to undergo autophagic degradation. Therefore, the observed puncta structures might 
not mimic endogenous protein. Hence, double-tag assays were only used as an initial screening 
method in our system, and the interesting findings investigated further by other methods.  
 
In vitro GST pull down essay 
GST-pulldown assay was used as a screening tool for identifying the interaction between 
TRIM27 and TRIM32 with members of the ATG8 proteins, as well as the autophagic receptors 
p62 and NDP52. This in vitro method is a suitable for examining direct interaction and estimate 
the extent of the affinity between the studied proteins. However, the accuracy of the results 
obtained in this assay are questionable. The fact that it is performed in vitro leads to an artificial 
environment far from the one found in cells. Both false positive and false negatives can be 
generated, leading to physiologically irrelevant data. In cells, proteins are folded and undergo 
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post-translational modification that produce a functional protein as a final product. In vitro 
translation can produce incorrect folding due to the lack of machinery necessary for this 
purpose. This might lead to incorrectly folded proteins, which leads to a false positive or 
negative that is physiologically irrelevant. In addition, proteins showing interaction in vitro may 
never encounter each other inside the cell due to their localization, which can also lead to a false 
positive. On the contrary, the proteins that require a post-translational modification to interact 
with others might show a negative result, leading to a false negative. In this study, in vitro GST 
pulldown was used in combination with methods performed in cells, such as 
immunoprecipitation and immunostaining, proving the interaction at a cellular level. 
 
CRISPR/Cas9 technology 
The CRISPR/Cas9 techonology was used in this study to generate TRIM27 and TRIM32 KO 
cell lines. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats and 
are part of the microbial adaptive immune system (Ran et al. 2013). First, we produced specific 
guide RNA sequences targeting the gene of interest early in exon 1 by using bioinformatics 
tools from Feng Zhang group (Ran et al. 2013), and cloned them into a plasmid expressing 
Cas9. The enzyme Cas9 cuts double-stranded DNA after recognition of the protospacer 
adjacent motif (PAM) sequence and binding of guide RNA with its specific target gene 
sequence (in our case TRIM27 and TRIM32 respectively). Then mammalian DNA repair 
system non-homologous end joining (NHEJ) or homology directed repair (HDR) repair the 
DNA, likely leading to a missing of the targeted gene. The guide RNA is normally around 20 
nucleotides long. There is the possibility that the guide RNA binds non-targeted genes, leading 
to off-target effects (Y. Fu et al. 2013). Off-target mutations may cause genomic instability and 
disruption of otherwise normal genes. In order to identify if the phenotype in due to knock out 
of the gene of interest, or an off-target effect, several methods can be used: A) validation of the 
phenotype in more than one KO clone. B) re-introduction of the KO gene into the KO clone 
and verify that the phenotype is reversed to WT, C) sequence the genome of the KO cells, either 
by complete genome sequencing or sequence the regions of the genome that have closest 
similarity to the guide RNA, which are more exposed to off-target effects. In the case of 
TRIM32 KO, we verified them by A and C. However, in the case of TRIM27 KO, we only 
managed to obtain one reliable KO clone, thus only verifying by C. We did obtain an alternative 
KO that showed possible off-target effects. This KO cell seemed displayed a proteolytic activity 
leading to cut of GFP-tagged proteins, showing a diffuse GFP signal, which really compromised 
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the reliability of the results. We tried to solve this throwback by additionally using siRNA to 
prove that the observed effect was due to the KO or KD of TRIM27. The results obtained by 
either reconstituting the TRIM27 KO cells as well as the use of siRNA show similar results, 
giving us confidence that the results obtained were a product of the effect of TRIM27 and not 
off-side effects produced by the technology.   
 
 
Stable cell lines 
The FlpIn T-REX system was used to generate cell lines that stably express TRIM27 and 
TRIM32 and its mutants. The T-Rex system consists in the use of the regulatory element from 
E. Coli Tn10-encoded tetracycline (Tet) resistance operon (Hillen and Berens 1994). The 
tetracycline regulation in the T-Rex system is based on the binding of tetracycline to the Tet 
repression and de-repression of the promoter controlling expression of the gene of interest (F. 
Yao et al. 1998). Even though desired, an induced expression by this system that leads to the 
same expression levels as the endogenous protein is rare. The promoter used in the FlpIn system 
is thepowerful CMV promoter, which activity might not resemble to the endogenous promoter 
for TRIM27 and TRIM32. This is a very delicate issue in the case of the study of autophagy, 
since excessive amounts of proteins condensate in the cytoplasm can active this process in an 
unspecific manner. This was our biggest concern in the case of TRIM27, which was easily 
overexpressed when induced with tetracycline. We troubleshoot this issue by performing 
tetracyclinetitration, leading to induction with very low concentration of tetracycline. In the 
HEK293 FlpIn TRIM32 Kos cells we failed to generate reconstituted cell-lines via the FlpIn 
system.. In a second attempt to re-constitute the TRIM32 KO cells, we decided to use 
Lentivirus, which was finally successful. The expression of TRIM27 and TRIM32 was never 
exactly as the endogenous levels, however, we believe that our results are a reflection of the 
role of these two TRIM proteins in the cell.  
 
Transfections and ubiquitin assays 
Transient transfection is a powerful and fast method to analyze the localization and activity of 
proteins in the cell without the need of producing stable expressing cell lines. However, the 
temporality and abundance of the studied protein might not be mimicking the real cellular 
environment. In all papers in this study, we perform the transfection of a variety of plasmids to 
- 59 - 
 
cells mentioned in the materials and methods section of each paper. Even though being a fast 
and simple method, the big flaw is the effect of over-expression of proteins. Similar to the 
concerns of the double-tag assay, the plasmids commonly contain a tag attached to the studied 
protein that can interfere with the functionality of the protein. Moreover, overexpression of a 
protein can lead to false interactions and localizations that do not represent the endogenous 
behavior of the protein. We started performing ubiquitylation assays co-expressing tagged 
ubiquitin together with p62. However, we noticed that the use of ubiquitin alone induced 
ubiquitylation of p62. This is in line with previous studies, which showed that overexpression 
of ubiquitin activated autophagy in a p62-dependent fashion (Peng et al. 2017). Moreover, in 
the case of the overexpression of p62, high amounts of this protein has shown to form 
aggregates (Pankiv et al. 2007), an effect that can be incorrectly attributed to the knock-out of 
the TRIM proteins, when in reality is an off-side effect due to p62 nature.  
 
Western Blotting as a quantitative method 
In our study, the detection and measurement of protein variations in the cell was measured 
mainly through Western blot. This well-described method has been used for many years in the 
biology and biochemistry fields (Mahmood and Yang 2012). Even though this method shows 
a very high sensitivity and it is able to measure very low protein concentrations, using it as a 
quantitative method has its risks for several reasons. Western blotting is a multi-step method 
were all steps are crucial for proper results. This means that many mistakes can happen along 
the process. The loading of an equal protein concentration is considered a key factor to ensure 
reliability. Transfer can be done unequally along the membrane, so a good loading shown in a 
housekeeping gene does not ensure reliability. This is why in our study we have always used 
Ponceau to check the quality of the transfer of proteins from the gel to the membrane. In 
addition, housekeeping genes such as PCNA, Actin or GAPDH have been used as loading 
controls. The  high concentrations of these housekeeping genes in comparison to the proteins 
we want to analyzed is also worth raising doubts. The detection of some proteins, for example 
TRIM27 and TRIM32, require a high protein loading to ensure being visible when developing 
the membrane. However, the amount of housekeeping proteins in those samples are in general 
high, which could potentially lead to misleading loading appreciation due to overexposure. 
Therefore, in our experiments we have always tried to keep the loading to the minimum in order 
to minimize this effect. 
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Use of antibodies in immunoblotting, immunoprecipitation and confocal microscopy 
Throughout this study, we have made an extensive use of antibodies for the experiments 
involving immunoblotting, immunoprecipitation and immunostaining. Antibodies are an 
essential tool in biomedical research, which in most cases with high specificity towards their 
targets. Broadly used antibodies, such as the one for p62, show a high degree of specificity and 
are reliable sources for analyzing the dynamics of the targeted proteins. However, some 
antibodies might bind to other proteins, leading to unspecific signal. This has been a challenge 
for us, since the TRIM27 antibody, even though showing specificity towards TRIM27, also 
bind an unidentified protein present in the serum of the cellular growing media. We made this 
early discovery when we saw a higher and thick band only in full medium treated cells 
compared to the ones treated with HBSS. Moreover, TRIM27 antibody did not work properly 
on immunostaining. We solved this problem using stable cell lines. 
In addition, we used immunoprecipitation for analyzing the association of TRIM27 and 
TRIM32 with other proteins. Mass spectrometry is a powerful tool to identify possible 
interaction partners, however, the immoprecipitation procedure might not reflect the real 
situation inside the cell. The preparation of the samples involve the lysis of the cells prior to 
incubating them with the GFP/MYC-trap. This leads to an artificial environment where cells 
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Cells use autophagy, an evolutionary conserved catabolic process, to maintain proper 
homeostasis. Defects in autophagy have been associated with cancer, where it modulates cell 
resistance or sensitivity to therapy, in addition to affecting the migration and invasion 
capabilities of tumor cells. The tripartite motif-containing 27 (TRIM27) protein is highly 
expressed in various cancers including breast cancer, shown to be involved in a multitude of 
processes such as cell proliferation, transcriptional repression, apoptosis, STAT3 activation, 
inhibition of NF-kB activation, and innate immune response. Here we identify TRIM27 as an 
autophagic substrate, depending on ATG7 and the sequestosome-like receptors for its 
lysosomal degradation. We mapped a LIR motif within its coiled-coil regions, with highest 
specificity towards LC3C. TRIM27 forms small cytoplasmic bodies that colocalizes with early 
autophagy proteins, and with the autophagy receptors p62/SQSTM1 and NBR1. Ablation of 
TRIM27 in HEK293 FlpIn cells reduced the starvation induced autophagy response, and 
resulted in increased levels of the lysosomal protein LAMP2. The increased LAMP2 expression 
resulted in enhanced formation of large, perinuclear lysosomes. TRIM27 is recognized as an 
oncogene, and mRNA expression profiling confirmed that TRIM27 is significantly upregulated 
in breast cancer tissue compared to normal tissue. Importantly, TRIM27 expression levels 
seemed to be inversely correlated with LAMP2 and LC3B expression levels in various breast 
cancer cell lines. These results point to TRIM27 as a regulator of autophagy in cancer cells, 













Synthesis and clearance of functional proteins regulate their availability within the cell, 
adapting the protein pool to the cellular needs. Thus, protein degradation is a crucial element in 
the maintenance of cellular homeostasis. Such an important process is tightly regulated in a 
spatially and timely manner through two main systems: the ubiquitin-proteasome system (UPS) 
and the lysosomal-mediated proteolysis (hereafter autophagy) (Dikic 2017).  
The main tag for degradation is a globular protein of 76 amino acids called ubiquitin. 
Targeted proteins are conjugated to ubiquitin by the mediation of three sequential reactions. 
The first reaction is the activation of ubiquitin by E1 enzymes. The second reaction consists in 
the conjugation of ubiquitin to E2 enzymes for its delivery to the next step. The third and last 
reaction is mediated by E3 ligases that make possible the binding of the activated ubiquitin with 
the target molecule. While E1 and E2 are highly conserved and do not present much specificity, 
E3 ligases are in charge of recognizing the substrate, which makes them the main regulator of 
the pattern of ubiquitylation (Kleiger and Mayor 2014). Ubiquitin is a common denominator 
for both UPS and autophagy that work coordinately to create an efficient proteolytic network 
(Ji and Kwon 2017). In the beginning, ubiquitin was identified as a simple tag for protein 
degradation. However, in the last decades, evidences have shown the important role of 
ubiquitylation as a posttranslational modification in many cellular processes such as DNA 
repair response, cell cycle regulation, autophagy, cellular differentiation and cell-mediated 
immunity (Swatek and Komander 2016; Kwon and Ciechanover 2017; Yu and Matouschek 
2017). 
Tripartite motif family proteins (TRIMs) are a wide family of proteins involved in the 
control of several cellular processes such as intracellular signaling, innate immunity, 
transcription, autophagy and carcinogenesis. To date, there are more than 80 distinct protein 
members in the TRIM family (Watanabe and Hatakeyama 2017). The vast majority of those 
TRIMs present E3 ligase activity since they contain a RING finger-domain. Those TRIMs 
defined as E3 ligases are characterized by the presence of tripartite motif RBCC domain. The 
RBCC domain contains in the N-terminal a RING-finger domain, one or two B-boxes (B1/B2) 
and a coiled-coil (CC) domain. In addition, most TRIMs also present domains at the C-
terminus, which gives them specificity for their target proteins (Esposito, Koliopoulos, and 
Rittinger 2017). TRIM proteins play several roles in autophagy, both as regulators and effectors. 
Some TRIMs, such as TRIM5α, 6, 16, 17, 20, 22, 49 and 55, act as a platform through the 
assembling of ULK1 and Beclin1. This regulatory complex has been name TRIMosome, which 
 
 
regulates selective autophagy (M A Mandell et al. 2014). Other TRIMs, such as TRIM5α can 
also act as autophagy receptors of specific targets (Michael A Mandell et al. 2015). Moreover, 
some TRIMs regulate autophagy through their interaction with p62/SQSTM1 (hereafter 
p62/SQSTM1). This interaction often take place under certain cellular conditions, such as 
TRIM13 during ER stress. This shows the high specificity of this family of E3 ligases. No 
TRIM homologs have been identified in yeast, which is a well-studied autophagy model 
organism. Thus, TRIM proteins might add complexity to the mammalian autophagy system, 
being able to regulate more specific degradation processes.  
TRIM27 is an E3 ligase also known as Ret finger protein (RFP protein), which was 
firstly described as a fusion protein with the tyrosine kinase domain of the c-RET proto-
oncogene originated by DNA rearrangement (Cao et al. 1996). This 58-kDa protein can be 
found in both the cytoplasm and the nucleus of the cells, depending on the cell type (G. Tezel 
et al. 1999). TRIM27 is involved in the regulation of several cellular processes such as 
immunity, apoptosis, cell growth, proliferation and endosomal recycling (Nie et al. 2016; 
Zoumpoulidou et al. 2012; Liu et al. 2014; Zhuang et al. 2016). TRIM27 is reported to have 
several roles in host defense against pathogens. It acts as a host restriction factor during 
mycobacterial infection, enhancing immune-inflammatory response and cell apoptosis (Nie et 
al. 2016). In addition, TRIM27 has been identified as a degradation target of Herpes Simple 
Virus 1 ICP0 (Conwell et al. 2015), and together with USP7 negatively modulates antiviral type 
I interferon signaling (Cai et al. 2018). Moreover, TRIM27 plays a role in endosomal recycling 
when it is in complex with USP7 and MAGE-L2. This complex regulates the activity of the 
WASH/retromer-mediated endosomal recycling through its ubiquitylation status (Hao et al. 
2015). TRIM27 is identified as an oncogene, highly expressed in various cancer types such as 
breast cancer. TRIM27 promotes proliferation mainly through its nuclear function, participating 
in transcriptional regulation complexes (Horio et al. 2012; Iwakoshi et al. 2012; Tsukamoto et 
al. 2009; G. G. Tezel et al. 2009; H. X. Zhang et al. 2018; Cai et al. 2018) It is also shown to 
promote cell migration and invasion (Y. Zhang et al. 2018). However, whether TRIM27 plays 
a role in autophagy in cancer cells still need to be fully elucidated.  
Here we show that TRIM27 is a cargo for the sequestosome-like receptors 
p62/SQSTM1 and NDP52, directing it for lysosomal degradation. A LIR motif with specificity 
towards LC3C was identified in its coiled-coil region. However, TRIM27 did not seem to act 
as an autophagy receptor itself. TRIM27 is localized in specific structures in the cytoplasm, 
often together with early autophagy proteins such as ATG9, ATG13 and ULK1, and the 
 
 
autophagy receptors p62/SQSTM1 and NBR1. Knock out of TRIM27 in HEK293 FlpIn cells 
reduced the starvation induced autophagy response, and resulted in increased expression of 
LAMP2 and formation of large LAMP2 rings. Moreover, LAMP2 was identified as an 
interaction partner of TRIM27.  
In line with previous studies, our bioinformatics analysis show that TRIM27 expression 
is upregulated in breast cancer tissues. Interestingly, the expression of TRIM27 varies 
substantially in cells representing different breast cancer subtypes, and its expression level 
seemed to be inversely correlated with the expression of LAMP2 and LC3B. Altogether, these 
results suggest that TRIM27 may regulate the autophagy process in certain cancer cell lines. 
 
MATERIALS AND METHODS 
Antibodies and reagents. 
The following primary antibodies were used: rabbit polyclonal antibody for TRIM27 
(Proteintech, #122205-1-AP)(1:1000); rabbit polyclonal anti-GFP (Abcam, ab290)(1:5000); 
rabbit polyclonal anti-LC3B (Sigma, L7543)(1:1000 for WB, 1:500 for IF); LAMP2(Santa 
Cruz Sc-18822, 1:1000 for WB, 1:500 for IF), ATG13 (Cell signaling 13468S, 1:100 for IF), 
ULK1 (Cell signaling 8054, 1:100 for IF), GM130 (Abcam Ab 53649, 1:500 for IF), USP7 
(Biosite A300-033A, 1:200 for IF), NBR1 (Santa Cruz Sc-130380, 1:1000 for WB, 1:200 for 
IF), TOM20 (Santa Cruz Sc-11415, 1:500 for IF), FK2 (AH Diagnostics BML-PW8810-0100, 
1:1000 for WB, 1:500 for IF); mouse monoclonal anti-p62/SQSTM1 lck ligand (BD Biosciences, 
610833)(1:2000) and guinea pig polyclonal anti-p62/SQSTM1 (Progen, GP62/SQSTM1-
C)(1:2000); mouse monoclonal anti-PCNA (DAKO, M0879)(1:1000). The following 
secondary antibodies were used: Horseradish-peroxidase (HRP)-conjugated goat anti-rabbit 
IgG (BD Biosciences, 554021)(1:2000); HRP-conjugated goat anti-mouse Ig (BD Biosciences, 
554002)(1:2000); and HRP-conjugated anti-Biotin antibody (Cell Signalling, #7075)(1:2000). 
The following fluorescent secondary antibodies were used: Alexa Fluor® 488-conjugated goat 
anti-mouse IgG (Life Technologies, A-11029)(1:1000); Alexa Fluor® 555-conjugated goat 
anti-rabbit IgG (Life Technologies, A-11008)(1:5000); Alexa Fluor® 555-conjugated goat anti-
mouse IgG (Life Technologies, A-21424)(1:1000); Alexa Fluor® 647-conjugated goat anti-
guinea pig IgG (Life Technologies, A-21450)(1:1000). The reagents used were Bafilomycin 
A1 (Sigma, B1793); MG132 (Sigma, C2759); Tetracycline (Sigma, #87128); Hanks Balanced 




Construction of Plasmids  
All plasmids used in this study are listed in Table 1. Plasmids were made by use of the Gateway 
recombination system (ThermoFisher). Gateway LR reactions were performed as described in 
the instruction manual. Point mutations were carried out using the Site-directed-mutagenesis 
kit from STRATAGENE. Primers for establishment of LIR mutated TRIM27W184A/F186A/L189A 5’-
GAAGATTGTTGCGGAGGCTGAGCAGGCGTATCACTCCTTA-3’ were ordered from ThermoFisher. All 
plasmids were verified by restriction enzyme digestion and DNA sequencing (BigDye, Applied 
Biosystems, 4337455).  
 





pDest mCherry-EYFP TRIM27 (Overå et al. 2019) 
pDest EGFP-C1 (Lamark et al. 2003) 
pDest EGFP-TRIM27 This study 
pDest Myc-TRIM27  This study 







(Lamark et al., 2003) 
(Abudu et al., 2019) 
(Lamark et al. 2003) 
(Pankiv et al. 2007) 
(Pankiv et al. 2007) 
(Alemu et al. 2012) 
pDest GABARAP (Pankiv et al. 2007) 
pDest GABARAP L1 
pDest GABARAP L2 
(Pankiv et al. 2007) 
(Pankiv et al. 2007) 
pSPCas9(BB)-2A-GFP (PX458) (Ran et al. 2013) Addgene#48138 
pDest EGFP FlpIn FRT/TO 
pDest EGFP FlpIn TRIM27 






Cell culture and transfections  
HeLa (ATCC, CCL2), Hek293 (ATCC, CRL-1573) and Hek293 T-Rex (ThermoFisher, R714-
07) cells were cultured in Dulbecco’s modified eagle’s medium (DMEM) (Sigma, D6046) with 
 
 
10% fetal bovine serum and 1% streptomycin-penicillin (Sigma, P4333). Hek FlpIn T-Rex cells 
with integrated EGFP-TRIM27 were grown in the same medium with additional selection 
marker antibiotics, 200µg/ml Hygromycin B (Invitrogen, #10687010) and 7,5 µg/ml Blasticidin 
(Gibco, A1113903). The breast cancer cell lines HS578, MDA-MD-231, and MCF7 were 
cultured in DMEM medium. The breast cancer cell lines BT549, T47D, MDA-MD-468, 
BT474, HCC1569 and SKBR3 were cultured in RPMI-1640 medium. Sub-confluent cells were 
transfected using TransIT-LT1 (Mirus, MIR2300) or Metafectene Pro (Biontex, T040) 
following the manufacturer’s instructions. All cell lines were routinely tested for mycoplasma 
contamination. 
 
Recombinant protein production and GST pulldown analysis 
GST or GST-tagged proteins were expressed in Escherichia coli strain SoluBL21 (Genlantis, 
#C700200). Protein expression was induced by treating overnight bacterial culture with 
50µg/ml Isopropyl β-D-1-thiogalactopyranoside (IPTG). GST or GST fusion proteins were 
purified and immobilized on Glutathione-Sepharose 4 Fast Flow beads (GE Healtcare, 17-
5132-01). Myc-tagged proteins were in vitro translated using the TNT T7 reticulocyte Lysate 
system (Promega, #14610) in the presence of 35S-methionine. In vitro translated protein or total 
cell lysate was pre-incubated with 10µl glutathione sepharose beads and 100µl of NETN buffer 
(50mM Tris pH 8.0; 150mM NaCl; 1 mM EDTA; 0.5% Nonidet P-40) with cOmplete Mini 
EDTA-free protease inhibitor mixture tablets (Roche Applied Science, 11836170001) for 1hr 
at 4°C to reduce unspecific binding. Pre-incubated lysate was then incubated with the 
immobilized GST fusion protein for 2hrs at 4°C. Beads were washed five times with NETN 
buffer, boiled with 2xSDS gel loading buffer (125mM Tris pH 7.5; 4% SDS; 0.04% 
bromphenol blue; 8% sucrose; 100mM dithiolthreitol) and subjected to SDS-PAGE. Gels were 
stained with Coomassie Brilliant Blue R-250 Dye (Thermofisher scientific, #20278) to 
visualize GST fusion proteins and then vacuum-dried. Signals from 35S-labelled proteins were 
detected by a Fujifilm bioimaging analyzer BAS-5000 (Fujifilm).  
 
Peptide Array 
TRIM27 peptide arrays were synthesized on cellulose membranes using MultiPrep peptide 
synthesizer (INTAVIS Bioanalytical Instruments AG, Germany). Membranes were blocked 
with 5% non-fat dry milk in TBST and peptide interactions were tested with GST and GST-
GABARAP by overlaying the membrane with 1 g/ml of recombinant proteins and incubation 
 
 




Cells were seeded in 6 well dishes and treated as indicated. Cells were lysed in 1xSDS buffer 
(50mM Tris pH 7.4; 2% SDS; 10% Glycerol) supplemented with 200mM dithiothreitol (DTT, 
Sigma, #D0632) and heated at 100°C for 10 minutes. Protein concentration was measured using 
the Pierce BCA Protein Assay Kit (Thermofisher Scientific, #23227). Equal amounts of protein 
were resolved by SDS-PAGE and transferred to nitrocellulose membrane (Sigma, 
GE10600003). The membrane was stained with Ponceau S (Sigma, P3504), blocked with 5% 
non-fat dry milk in 1% TBS-T (0.2M Tris pH 8; 1.5M NaCl and 0.05% Tween20 (Sigma, 
P9416)) and then incubated with indicated primary antibodies for 24h. The membrane was 
washed three times for 10 minutes each with TBS-T followed by incubation with secondary 
antibody for 1h. The membrane was washed three times for 10 minutes and analyzed by 
enhanced chemiluminescence using the ImageQuant LAS 4000 (GE Lifescience).  
 
Immunostaining and Fluorescence confocal microscopy 
Subconfluent cells grown in 24-well plates on coverslips (VWR, #631-0150) coated with 
Fibronectin (Sigma, F1141) and treated as indicated. They were fixed in 4% paraformaldehyde 
for 20 min. The cells were then permeabilized with methanol at RT for 5min, blocked in 5% 
goat serum/PBS or 5%BSA/PBS and incubated at room temperature with a specific primary 
antibody followed by Alexa Fluor 488, 555 or 647 conjugated secondary antibody and DAPI. 
Confocal images were obtained using a 63x/NA1.4 oil immersion objective on an LSM780 
(Zeiss). Quantification of cells containing red only dots in the double tagged screen, or large 
LAMP2 rings, was done manually in three independent experiments. 
 
Generation of TRIM27 knock out in HEK293 FlpIn cell lines 
To generate knock out cells for TRIM27, the CRISPR/Cas9 system was exploited as described 
by (Ran et al. 2013). The Guide RNA sequence 5’-CTTTACCAGTTGGGTCACGT-3’ was ligated into 
the vector pSpCas9(BB)-2A-GFP (PX458) (Addgene, #48138) using BbsI restriction sites. 
Subconfluent Hek293 FlpIn T-Rex cells were transfected with the targeting plasmid using 
Metafectene Pro (Biontex, T020). EGFP-positive cells were sorted by FACS and plated into 
96-wells plates three days post transfection. Single colonies were expanded up to 12-well plates 
 
 
and KO validated by immunoblotting. Confirmed KO clones were further screened by genomic 
sequencing. The targeted genomic regions were amplified by PCR using the primers 5’-
CCGGAGAGAGCGCCGGAGAGTTG-3’ and 5’-CAAGGTGAGGGCGCGGATCCGGGAG-3’ and the resulting 
PCR products ligated into the pGEM-T-EASy vector (Promega, A3600). Sequencing were 
conducted for at least 3 clones for each PCR product. 
 
Generation of tetracycline inducible HEK293 FlpIn cell lines 
Stable cell lines were generated using the FlpIn T-Rex system (Thermofisher, R71407). 
TRIM27 cDNA was transferred to the inducible FlpIn expression vector pDest-EGFP-Flp-In 
by GATEWAY cloning. FlpIn T-Rex cells were then cotransfected with the TRIM27 FlpIn 
expression vector and the FlpIn recombinase vector pOG44 in the ratio of 1:3. Cells were 
selected by treatment with 200µg/ml Hygromycin B (Invitrogen, #10687010) and 7,5 µg ml-1 
Blasticidin (Gibco, A1113903), and protein expression verified by induction with Tetracycline 
(Sigma, #87128). 
 
Cell proliferation assay  
The cell lines HEK293 T-Rex FlpIn, HEK293 T-Rex FlpIn TRIM27 KO, HEK293 T-Rex FlpIn 
TRIM27 KO + TRIM27 WT and HEK293 T-Rex FlpIn TRIM27 KO + GFP were harvested 
with trypsin and seeded into 12-well plates at a density of 100.000 cells per well. Afterwards, 
cells were incubated in IncuCyte (Essen BioScience, Ann Arbor, MI, USA) at 10x 
magnification and images were taken in the phase and green channels every 24h. Images were 
analyzed by Incucyte S3 Live-cell analysis system. The assays were performed in triplicate. 
 
Migration assay  
The cell lines HEK293 T-Rex FlpIn, HEK293 T-Rex FlpIn TRIM27 KO, HEK293 T-Rex FlpIn 
TRIM27 KO + TRIM27 WT and HEK293 T-Rex FlpIn TRIM27 KO + GFP were harvested 
with trypsin and seeded into 96-well Image-Lock Microplate (Essen BioScience, Ann Arbor, 
MI, USA) at a density of 8.000 cells per well. Twenty-four hours after seeding, a scratch wound 
was made by using the Incucyte 96-well WoundMaker tool (Essen BioScience, Ann Arbor, MI, 
USA) according to the manufacturer’s instructions. Cells were incubated at 37 °C with CO2 in 
the Incucyte (Essen BioScience, Ann Arbor, MI, USA) at 10x magnification and pictures were 
taken in the phase and green channels every 15h (for figure presentation, quantification ever 24 
hours is shown). Images were analyzed by Incucyte S3 Live-cell analysis system. The assay 




For the analysis of TRIM27 expression in normal versus tumor, two publically available breast 
cancer datasets, PRJNA399721 and PRJNA172761, were downloaded from the Sequence Read 
Archive (SRA). PRJNA399721 consist of 22 primary invasive breast cancer carcinoma 
expressing estrogen receptors and their paired adjacent mammary healthy tissues. Libraries 
were prepared using the TruSeq® Stranded Total RNA kit and Ribo-Zero rRNA Removal kit 
(Illumina) and sequencing was performed by strand-specific RNA sequencing on a Illumina 
HiSeq. PRJNA172761 consist of 53 primary breast cancers and 6 normal breast samples from 
mammoplasty patients. Single-end Illumina-based RNA-sequencing was performed, using both 
29 bp reads (on 29 tumor samples) and 100 bp reads (on 24 tumor samples and 6 normals).  
The CLC Genomic workbench (v8.5.1) was used for analyzing the RNA-Seq data. Raw reads 
were trimmed for quality (Quality limit = 0.05) and adaptor (Illumina TruSeq LT and HT 
adaptor or Illumina 1.5 Small RNA). Trimmed reads were mapped to GRCh38 with Ensembl 
annotation v84, using either strand specific mapping (PRJNA399721) or non-strand specific 
mapping (PRJNA172761), (Mismatch cost = 2, Insertion cost = 3, Deletion cost = 3, Length 
fraction = 0.9, Similarity fraction = 0.8). Only uniquely mapped reads were included in gene 
quantification. Reads per million (RPM) normalization was utilized, and gene counts were log2 
transformed. Graphpad prism was used for making illustrations and statistical analysis. A paired 
t-test was used for the comparison of paired tumor versus normal samples, while a non-paired 
t-test was used for the calculation of normal versus tumor samples.  
Statistics 
All experiments were repeated at least three times, unless otherwise specified. Error bars 
represent the s.d. or s.e.m. as indicated in Figure legends. Replicates were not pooled for 










Autophagic degradation of TRIM27 is dependent on ATG7 and the Sequestosome-Like 
receptors. 
In a qualitative screen in HeLa cells using the double tag mCherry-EYFP fused to 22 various 
members of the TRIM family of ubiquitin E3 ligases, we identified TRIM27 as a potential target 
for autophagic degradation (Figure 1A) (Overå et al. 2019). Both under normal and starved 
conditions, RedOnly puncta could be observed in the mCherry-EYFP-TRIM27 expressing cells 
(Figure 1A), with a slightly increased induction of RedOnly puncta upon starvation (Figure 
1B). To pinpoint the autophagy pathway implicated in TRIM27 degradation, the mCherry-
EYFP-TRIM27 double tag assay was performed in ATG7 KO cell lines. We were not able to 
observe any RedOnly dots in the transfected ATG7 KO cell lines (Figure 1A,B). Previously, 
we have shown that autophagic degradation of TRIM32 is mediated by selective autophagy 
involving the Sequestosome-Like-Receptors (SLRs) (Overå et al. 2019). To investigate if also 
TRIM27 is degraded by selective autophagy mediated by the SLRs, the mCherry-EYFP-
TRIM27 double tag assay was applied on a cell line knocked out for the five SLRs 
p62/SQSTM1, NBR1, NDP52, Optineurin and Tax1BP1 (pentaKO) (Lazarou et al. 2015). No 
RedOnly dots of mCherry-EYFP-TRIM27 could be observed neither under normal nor starved 
conditions (Figure 1A,B). Together, these results indicate that autophagic degradation of 
TRIM27 is mediated by selective autophagy. 
To measure whether p62/SQSTM1 is sufficient to direct TRIM27 to autophagic 
degradation, we applied the mCherry-EYFP-TRIM27 double tag assay on the HeLa penta KO 
cell line reconstituted with EGFP-p62/SQSTM1 (Figure 1A,B) (Overå et al. 2019). 
Reintroduction of EGFP-p62/SQSTM1 facilitated formation of mCherry-EYFP-TRIM27 
RedOnly dots, but not to the same extent as the wild type cells (Figure 1A-B). Similar results 
were obtained by reintroduction of EGFP-NDP52 (Figure 1A,B). Thus, both SLRs were able 
to direct autophagic degradation of mCherry-EYFP-TRIM27. To sum up, here we suggest that 
TRIM27 is a cargo for selective autophagy, and its dependence on the SLRs for autophagic 
degradation indicates that it does not act as an autophagy receptor itself. 
In order to determine if endogenous TRIM27 is degraded by autophagy, we analyzed 
the TRIM27 protein levels in HeLa ATG9 KO cells (kindly provided by Y. Abudu, 
unpublished). ATG9 vesicles are required for nucleation of the autophagic isolation membrane, 
and hence ablation of ATG9 will block the autophagy process (Orsi et al. 2012). Notably, 
TRIM27 seems to be stabilized and modified in the ATG9 KOs cells. The slower migrating 
TRIM27 band suggests that ATG9 and inhibition of autophagy has an impact on TRIM27 
 
 
expression (Fig 1C,D). The autophagy receptors p62/SQSTM1 and NBR1 also display 
migration differences in HeLa ATG9 KO cells compared to normal HeLa cells (Fig 1C). This 
further suggests that there is a link between TRIM27 and the autophagy receptors.  
 
TRIM27 has a LIR with specificity towards LC3C. 
TRIM27 belongs to the same TRIM family subclass as TRIM5α retroviral restriction factor 
acting during the early post entry stages of the retroviral life cycle to block infection by a broad 
range of retroviruses, disrupting reverse transcription and integration  (Sawyer et al. 2005). 
Trim5α was reported to act as a selective autophagy receptor, targeting a restricted virus to the 
autophagosome for degradation (Michael A Mandell et al. 2015). It was demonstrated that 
TRIM5α interacts directly with ATG8 proteins via a LIR motif. Later, the LC3 interacting 
region in TRIM5α was proposed to be located in a helical region within the coiled-coil region, 
including the residues D192, W196 and E203 (Keown et al. 2018). The similarity of TRIM5α 
and TRIM27 prompted us to apply a peptide array to identify putative ATG8 interacting regions 
in TRIM27. In this assay, various 20 amino acid long peptides covering the complete region of 
TRIM27 were spotted on filter paper and probed against GST-GABARAP proteins expressed 
and purified from E. coli. The spot blot identified a putative LIR located within the W184-
F186-L189 region of TRIM27 (Figure 2A). To verify this putative LIR motif, we established 
the TRIM27W184A/F186A/L189A mutant and compared its ability to bind the ATG8s with the binding 
ability of wild type TRIM27 in a GST-pulldown assay using GST-ATG8 proteins expressed 
and purified from E. coli, and TRIM27 proteins produced by in vitro translation. Figure 2B 
shows that wild type TRIM27 has high affinity for  LC3C, binds with lower affinity to 
GABARAP and GABARAPL1, and very weakly or not at all to LC3A, LC3B and 
GABARAPL2. 
Introduction of the W184A/F186A/L189A mutations in TRIM27 resulted in strong 
reduction of the LC3C binding, and some reduction in the binding to GABARAP and 
GABARAPL1 (Figure 2B). This suggests that TRIM27 contains a LIR with highest specificity 
against LC3C, located close to or within its coiled-coil region. The specificity for LC3C and 
partially GABARAP was further verified by GST-pulldown assay using cell extracts from the 
HEK293 FlpIn EGFP-TRIM27 cell line (Figure 2C). To sum up, here we show that TRIM27 
contains a LIR motif with high specificity towards LC3C. The TRIM27 LIR displays strong 




TRIM27 forms cytoplasmic puncta that co-localizes with proteins implicated in the 
autophagy process 
To further address if TRIM27 may impact the autophagy process, we established a HEK293 
FlpIn TRIM27 KO cell line by CRISPR/Cas9 (Ran et al. 2013), reconstituted cell line with 
tetracycline inducible expression of EGFP-TRIM27, and a HEK293 FlpIn TRIM27 KO cell 
line with inducible expression of EGFP as control cell line (Figure S1A-C). The expression 
level of EGFP-TRIM27 in the reconstituted TRIM27 KO cell line was close to the endogenous 
level (Figure S1D), and localized to certain dots/aggregates in the cytoplasm, in addition to a 
few nuclear dots (Figure S1E). This is in line with the reported localization of endogenous 
TRIM27 (proteinatlas.org). Next, we compared the proliferation and migration potential of the 
HEK293 FlpIn TRIM27 KO cells with the reconstituted TRIM27 KO cell lines (Figure S1F). 
The HEK293 FlpIn TRIM27 KO cell line displays an enhanced proliferation rate compared to 
the HEK293 FlpIn TRIM27 KO cell line reconstituted with EGFP-TRIM27 (Figure S1F, left 
graph). This suggests that TRIM27 expression may inhibit cell proliferation in HEK293 FlpIn 
cells. Conversely, the migration rate of the TRIM27 KO cells was reduced compared to the 
HEK293 FlpIn cells, while reintroduction of EGFP-TRIM27 restored the migration rate (Figure 
S1F, right graph). Thus, in HEK293 FlpIn cells TRIM27 seems to facilitate cell migration but 
not cell proliferation. This is in line with previous studies showing that TRIM27 facilitates cell 
migration and invasion (H. X. Zhang et al. 2018), and may have a role in Epithelial to 
Mesenchymal transition in cancer cells. 
Since the expression level of induced EGFP-TRIM27 in the HEK293 FlpIn TRIM27 
KO cells is similar to the endogenous TRIM27 expression levels (Figure S1D), the 
physiological effect of the reconstituted EGFP-TRIM27 may be close to the effect of 
endogenous protein.  
Next, we analyzed whether TRIM27 is localized to autophagic structures in the cell. For 
this purpose, we performed immunostaining of autophagy related proteins in the HEK293 FlpIn 
TRIM27 KO EGFP-TRIM27 cells. EGFP-TRIM27 formed several cytoplasmic puncta in 
addition to a few nuclear puncta, and in some cells EGFP-TRIM27 formed larger structures 
(Figure 3). TRIM27 does not seem to co-localize with GM130 (Golgi marker) and calreticulin 
(ER marker), suggesting that TRIM27 is not present or migrates to the Golgi or the ER (Figure 
S2A). 
EGFP-TRIM27 co-localizes strongly with the autophagy receptors p62/SQSTM1 and 
NBR1 (Fig 3). This supports the finding that TRIM27 is a substrate for selective autophagy. 
 
 
Moreover, TRIM27 co-localizes in multiple dots with the autophagy proteins ATG9, ATG13, 
and ULK1 (Fig 3). Together these results suggest that TRIM27 is associated with autophagy 
structures, and hence is a potential regulator of the autophagy process. As controls of the EGFP-
TRIM27 localization pattern, we stained the HEK293 FlpIn TRIM27 KO EGFP-TRIM27 cells 
with antibodies against USP7 and ubiquition (FK2). TRIM27 forms a complex with USP7 that 
is in charge of the regulation of Tumor necrosis factor alpha induced apoptosis, and together 
with USP7 and MAGE2, this complex regulates the protein levels of WASH that is involved in 
vesicles trafficking (Cai et al. 2018; Zaman et al. 2013). In accordance with this, we see that 
USP7 is present in certain EGFP-TRIM27 dots (Fig 3). Also several of the EGFP-TRIM27 dots 
are recognized by the ubiquitin antibody (FK2) (Fig 3). Thus, reconstituted EGFP-TRIM27 
localization seems to represent the localization pattern of endogenous TRIM27, suggesting that 
TRIM27 associates with autophagic structures in the cytoplasm. 
 
TRIM27 is associated with several proteins involved in the autophagy process. 
To further assess the potential role of TRIM27 in autophagy, we applied mass spectrometry 
(MS) analysis to identify whether autophagy-related proteins co-precipitated with EGFP-
TRIM27 immunoprecipitated from the reconstituted HEK293 FlpIn TRIM27 KO cells. The 
HEK293 FlpIn TRIM27 KO cells reconstituted with EGFP only were used as a control to 
discard possible unspecific binding with the EGFP-tag. The MS data identified that TRIM27 
co-precipitates the autophagy receptors p62/SQSTM1, NBR1, CALCOCO2 (NDP52) and 
TAX1BP1 (Fig 4A). This supports that TRIM27 is a substrate for selective autophagy. 
Additionally, we identified the autophagy protein ATG7, the autophagy regulator TBK1, and 
the lysosomal protein LAMP2 as putative interaction partners of TRIM27, supporting our 
findings that TRIM27 co-localizes with autophagy structures in the cell (Fig 3). To verify these 
interactions further, we performed Western blotting against selected proteins from the MS 
screen, on immunoprecipitated EGFP-TRIM27 extracts from the reconstituted HEK293 FlpIn 
TRIM27 KO cells As displayed in Figure 4B, the autophagy receptors p62/SQSTM1 and NBR1 
are associated with EGFP-TRIM27, although the NBR1 interaction seems weak. To test 
whether the interaction with p62/SQSTM1 were directly, a GST-pulldown assay with GST-
p62/SQSTM1 expressed and purified from E. coli was incubated with in-vitro translated 
TRIM27 (Figure 4C). This assay was also performed with GST-NDP52, which displayed a very 
weak interaction with TRIM27 (Figure 4C). Clearly, TRIM27 seems to interact directly with 
the autophagy receptor p62/SQSTM1. To elucidate whether TRIM27 has the ability to 
 
 
ubiquitylate p62/SQSTM1, we transfected myc-p62/SQSTM1 expression plasmids into the 
HEK293 FlpIn TRIM27 KO EGFP-TRIM27 cell lines. Ubiquitylation of myc-p62/SQSTM1 
was detected by immunoprecipitation of myc-p62/SQSTM1 and Western Blotting using an 
antibody recognizing ubiquitin (Figure 4D). EGFP-TRIM27 expression leads to a slower 
migrating myc-p62/SQSTM1 band that are detected by the ubiquitin antibody, indicating that 
TRIM27 ubiquitylates p62/SQSTM1. This was further supported by Western blotting of 
endogenous p62/SQSTM1 in HEK293 FlpIn TRIM27 KO cells and the TRIM27 KO cells 
reconstituted with EGFP-TRIM27. Our results display a slower migrating band of endogenous 
p62/SQSTM1 in cells expressing EGFP-TRIM27 (Figure S2B). 
Notably, the immunoprecipitation also verified association of TRIM27 with LAMP2 
(Figure 4B). Previous reports has linked TRIM27 to subcellular membrane systems, as a 
MAGE2-USP7-TRIM27 complex regulates the retromer at sorting endosomes (Hao et al. 
2015). The interaction of TRIM27 with LAMP2 may suggest a role for TRIM27 in lysosomal 
pathways, such as autophagy. 
 
TRIM27 facilitates starvation-induced autophagy 
Next we set out to analyze whether TRIM27 may impact the autophagy process. It is well 
recognized that p62/SQSTM1 and LC3B co-localizes in certain cytoplasmic dots indicative of 
autophagosomes in HEK293 cells, and that the number of dots increases upon starvation due to 
induction of autophagy. Starvation induced autophagy is initiated by activation of ULK1, 
leading to phosphorylation of the ULK1 complex members ATG13 and FIP200 (Dossou and 
Basu 2019). Subsequently, the BECLIN1 complex including the VPS34 lipid kinase is activated 
and produces a pool of phosphatidylinositol 3-phosphate (PtdIns(3)P) at membrane sites where 
formation of the omegasome takes place. Generation of PtdIns(3)P facilitates recruitment of 
WIPI2 (WD-repeat PtdIns(3)P effector protein) which can be observed as specific starvation 
induced WIPI2 dots by immunostaining. WIPI2 recruits LC3B via the LC3 conjugation system 
to the forming omegasome (Melia, Lystad, and Simonsen 2020). Co-staining of p62/SQSTM1 
and LC3B in the TRIM27 KO cells under normal and starved conditions, indicated that 
starvation induced initiation of the autophagy process was affected by TRIM27 ablation (Figure 
5A,B). In the HEK293 FlpIn cell line, p62/SQSTM1 and LC3B co-localized in certain 
cytoplasmic dots in the cells cultured in normal medium, and the number of such dots increased 
by changing the medium with HBSS for 2 hours. In contrast, in HEK293 FlpIn TRIM27 KO 
cells, the number of p62/SQSTM1 dots did not show an increase upon starvation. Moreover, 
 
 
the number of LC3B dots decreased upon starvation in the HEK293 FlpIn TRIM27 KO cells. 
In line with this, the number of WIPI2 dots in the HEK293 FlpIn cells increased upon starvation, 
while this increase could not be observed in the HEK293 FlpIn TRIM27 KO cells (Figure5C,D). 
Thus, the starvation induced initiation of autophagy seems to be impaired in the TRIM27 KO 
cells, suggesting that TRIM27 facilitates the induction of autophagy upon starvation.  
 
Depletion of TRIM27 leads to increased LAMP2 levels and formation of large LAMP2 
rings in HEK293 FlpIn cells.  
TRIM proteins interacting with the core autophagy machinery have been already  identified (T 
Kimura et al. 2015; T Kimura, Mandell, and Deretic 2016; Tomonori Kimura et al. 2017; M A 
Mandell et al. 2014), and recently we showed that TRIM32 binds to p62/SQSTM1 and the 
ATG8s in vitro, and co-localizes with p62/SQSTM1 and LC3B in specific puncta in cell 
cytoplasm (Overå et al. 2019). TRIM27 is an ubiquitin E3 ligase that can direct other proteins 
for degradation. In order to assess whether TRIM27 and its interaction with autophagy-
associated proteins lead to their degradation, we analyzed the protein levels of p62/SQSTM1, 
NBR1, LC3B, ATG9, LAMIN-B1 (used as nuclear control) and LAMP2 (used as a cytoplasmic 
control) in the cytoplasmic and nuclear fractions of HEK293 FlpIn, TRIM27 KO and TRIM27 
reconstituted with EGFP-TRIM27 (Figure 6A). Surprisingly, the level of LAMP2 seems to 
increase strongly in the HEK293 TRIM27 KO cell line compared to the HEK293 FlpIn cells, 
while the levels of the other autophagy proteins remain the same in all cells (Figure 6A).  
Normal LAMP2 expression was fully recovered in the reconstituted HEK293 FlpIn EGFP-
TRIM27 cells (Figure 6A,B). Similar increase in LAMP2 level were seen in HEK293 FlpIn 
cells treated with TRIM27 siRNA (Figure 7C). To further assess this effect of TRIM27 on 
LAMP2 levels, we immunostained the HEK293 FlpIn TRIM27 KO cells, HEK293 FlpIn 
TRIM27 KO EGFP-TRIM27 and HEK293 FlpIn cells treated with TRIM27 siRNA with 
LAMP2 antibodies. Whereas HEK293 FlpIn cells and HEK293 FlpIn TRIM27 KO cells 
reconstituted with EGFP-TRIM27 cells showed similar LAMP2 staining, a large proportion of 
the HEK293 FlpIn TRIM27 KO cells and HEK293 FlpIn TRIM27 KD cells displayed large 
LAMP2 rings (Figure 6D) often localized in the perinuclear region and close to the EGFP-
TRIM27 bodies and the mitochondria (Figure 6E). Together these results indicate that TRIM27 





TRIM27 and LAMP2 expression is inversely correlated in breast cancer cell lines. 
 
Our results suggest that TRIM27 is an autophagy substrate and has a role in the regulation of 
starvation induced autophagy. TRIM27 is described as an oncogene, and high expression of 
TRIM27 is associated with increased invasion and migration of cancer cells (H. X. Zhang et al. 
2018). It is well recognized that autophagy is an important process for the survival and growth 
of cancer cells (Hatakeyama 2017; Koukourakis et al. 2015; Alessandrini, Pezzè, and Ciribilli 
2017). Upregulated TRIM27 expression has been associated with breast cancer and 
mechanistically this has been linked to its nuclear role implicated in Estrogen Receptor 
transcription complexes (G. G. Tezel et al. 2009). In order to investigate if TRIM27 expression 
is associated with autophagy activity in breast cancer, we first analysed the TRIM27 mRNA 
expression in tumor tissue and normal tissue from two different patient cohorts (Figure 7A). In 
both cohorts, TRIM27 mRNA was significantly upregulated in the cancer tissues compared to 
normal tissue. Next, the amount of TRIM27 and LC3B proteins in various breast cancer cell 
lines representing various breast cancer subtypes were analysed by Western blotting (Figure 
7B). The TRIM27 expression level varies substantially within the the various cell lines, with 
high expression in the luminal cell lines MCF7 and T47D, and in the basal-like cell ine MDA-
MD-468. Moreover, in the MDA-MD-468 cells, the TRIM27 protein migrates slower 
suggesting that it may represent a TRIM27 fusion protein, or a TRIM27 protein highly modified 
by post-translational modifications. TRIM27-RET fusions are described in several cancers, 
however has not been detected in breast cancer (Hameed et al. 2009). In contrast, in the trippel-
negative MDA-MD-231 and BT549 cell lines,  no TRIM27 expression could be detected. 
Interestingly, LC3B was highly expressed in the triple-negative breast cancer cell lines, while 
it was low in luminal and Her2 positive cell lines. Hence, the expression of TRIM27 and LC3B 
seems to be inversely correlated in the breast cancer cells. Moveover, LAMP2 expression is 
upregulated in the breast cancer cell lines displaying no or very low expression levels of 
TRIM27. This correlates well with our analyses in HEK293 cells, suggesting that loss of 
TRIM27 leads to enhanced LAMP2 expression. Collectively, these results point to TRIM27 as 
a putative regulator of autophagy, and that one of its oncogenic features is to facilitate the 
autophagy process in cancer cells. Moveover, breast cancer cell lines with various expression 
levels of TRIM27 represent promising model systems for further revealing the molecular 





This study originated from a double-tag assay of various TRIM proteins, in order to identify 
TRIMs that were localized inside the lysosomes (Overå et al. 2019). Our hypothesis was that 
TRIMs that are directed to degradation in the lysosome, may have a role in regulation of the 
autophagy process. We observed that mCherry-EYFP-TRIM27 formed several RedOnly puncta 
both in normal conditions and upon starvation. In this work, we show that degradation of 
TRIM27 can happen via autophagic pathways, and that the core autophagy protein ATG7 and 
the SLRs family of autophagy receptors are required for this degradation. This indicates that 
TRIM27 is degraded via selective autophagy.   
It is recently shown that the only transmembrane autophagy protein ATG9 plays an 
important role in the nucleation of the autophagosome (Sawa-Makarska et al. 2020). ATG9 
vesicles traffics from Golgi to endosomes in a ULK1-dependent manner under stress conditions 
(Young et al. 2006), and ULK1 phosphorylation regulates trafficking of ATG9 under 
autophagy-inducing conditions (Zhou et al. 2017). In this work, we show that depletion of 
ATG9 leads to increased levels of TRIM27. TRIM27 seems to be modified in the ATG9 KO 
cells, resulting in a slower migrating band visualized by Western blotting. Moreover, certain 
EGFP-TRIM27 bodies co-localized with ATG9 in the reconstituted HEK293 FlpIn EGFP-
TRIM27 cell line. In addition, the autophagy receptors p62/SQSTM1 and NBR1 displayed 
increased protein levels in the ATG9 KO cells, and occurred as slower migration bands on the 
Western blot gels. This clearly points to TRIM27 as an autophagy substrate similarly as NBR1 
and p62/SQSTM1. In contrast, the autophagy receptor NDP52 did not display aberrant mobility 
in the ATG9 KO cell extract, even if its protein level were slightly increased. Protein levels of 
lipidated LC3B were decreased in the ATG9 KO cells. This is in line with recent reports 
describing that ATG9 vesicles recruit the autophagy machinery and establish membrane contact 
sites with membrane donor compartments. ATG2 mediates transfer of lipids from donor 
membrane to the autophagosome formation sites, leading to PIP3 formation and ATG8 
lipidation. Hence, lipidation of LC3 is dependent on ATG9 vesicles (Sawa-Makarska et al. 
2020). Interestingly, we observed decreased levels of LC3B dots in the HEK293 FlpIn TRIM27 
KO cell lines, indicative of reduced LC3B lipidation in these cells. Moreover, in the breast 
cancer cell lines, we observed an inverse correlation between TRIM27 expression and the 
amount of lipidated LC3B. This may suggest that TRIM27 is implicated in the ATG9 regulated 
pathway for autophagosome formation. 
 
 
Mass spectrometry analyses revealed that several proteins linked to autophagy 
associates with EGFP-TRIM27 precipitated from the reconstituted HEK293 FlpIn cells, further 
suggesting a role for TRIM27 in autophagy. Among the autophagy receptors, p62/SQSTM1 
seemed to be the one that associated strongest with TRIM27. Similarly as we have previously 
shown for TRIM32 (Overå et al., 2019), co-expression of TRIM27 and p62/SQSTM1 in the 
HEK293 FlpIn TRIM27 KO cells led to ubiquitylation of p62/SQSTM1. Moreover, enhanced 
ubiquitylation of endogenous p62/SQSTM1 could be detected in HEK293 FlpIn TRIM27 KO 
cells reconstituted with EGFP-TRIM27, compared to HEK293 FlpIn TRIM27 KO cells. 
Induction of EGFP-TRIM27 expression in the HEK293 FlpIn TRIM27 KO cells also lead to 
strong accumulation of p62/SQSTM1 in the EGFP-TRIM27 cytoplasmic bodies. This may be 
due to a strong interaction between TRIM27 and p62/SQSTM1, or it may be caused by strong 
ubiquitylation of certain TRIM27 bodies as detected by immunostaining with the ubiquitin 
antibody FK2. P62/SQSTM1 binds strongly to ubiquitin (Bjørkøy et al. 2005). This aggregation 
of p62/SQSTM1 in TRIM27 bodies thus may lead to the ubiquitylation of p62/SQSTM1 
detected on Western blots.  
Surprisingly, we identified LAMP2 as a TRIM27 interaction partner. LAMP2 is a highly 
glycosylated protein decorating the luminal surface of lysosomal membranes (Eskelinen, 
Tanaka, and Saftig 2003). It is an important regulator of maturation of autophagosomes, and 
LAMP2 deficiences leads to accumulation of autophagosomes (Saftig et al., 2008). Ablation of 
TRIM27 either by genetic KO, or by TRIM27 siRNA treatments, resulted in accumulation of 
LAMP2 protein levels, and the formation of large LAMP2 rings in HEK293 FlpIn cells. The 
large LAMP2 rings were often localized in the perinuclear region, in close proximity with 
TRIM27 bodies and mitochondria. Whether LAMP2 accumulation as such leads to formation 
of large lysosomes, or whether these large LAMP2 rings indicate that TRIM27 is implicated in 
the regulation of lysosome biogenesis, is an interesting question to address in further studies. 
However, we clearly show that TRIM27 deficiency result in accumulation of LAMP2. This 
accumulation can be due to impaired degradation of LAMP2 in TRIM27 KO cells, since 
TRIM27 is an E3 ligase that directs proteins to degradation by ubiquitylation. Alternatively, it 
can also be due to increased expression of LAMP2 at the transcriptional level, since TRIM27 
also have a nuclear role.  
TRIM27 was originally identified as a gene involved in the oncogenic rearrangements 
with the RET proto-oncogene (Hasegawa et al. 1996). Later it is shown that TRIM27 is highly 
expressed in various cancers including breast, endometrial, ovarian, lung, colon and colorectal 
 
 
cancer, and colitis and colitis-associated carcinogenesis (Ma et al. 2016; Zoumpoulidou et al. 
2012). In these studies TRIM27 has been proposed as a oncogene promoting cell proliferation, 
and the mechanisms have been connected to its nuclear function participating in transcriptional 
regulation complexes (Zurek et al. 2012). The proliferation and migration studies in the 
HEK293 FlpIn TRIM27 KO cells suggest that TRIM27 facilitates cell migration,, which is in 
line with a recent study showning TRIM27 to activate epithelial-mesencymal transition in 
colorectal cancer  and to promote anchorage-independent growth  of various cell lines (Y. 
Zhang et al. 2018). 
Breast cancer is the most frequent malignancy in women and is a heterogeneous disease 
on the molecular level (Harbeck et al. 2019). In our results, TRIM27 mRNA expression in 
tumor tissue and normal tissue from two different patient cohorts was significantly upregulated 
in the cancer tissues compared to normal tissue. Moreover, the TRIM27 expression level varies 
substantially within the the various breast cancer cell lines. LAMP2 expression is upregulated 
in the breast cancer cell lines displaying  no or very low expression levels of TRIM27. This 
correlates well with our analyses in HEK293 cells, suggesting that loss of TRIM27 leads to 
enhanced LAMP2 expression. LAMP2 plays a role in the support of early cancer progression, 
helping cancer cells surviving in acidic enviroments (Mogami et al. 2013). LAMP2 is highly 
expressed in several cancers, where reduced expression of LAMP2 has been associated with a 
loss of migration and invasion capabilities (Koukourakis et al. 2015). LAMP2A isoform has 
shown increased expression in breast tumor tissue, and its inhibition reuslts in sensitation of 
tumor cells to radioation and doxorubicin therapy (Saha 2012). Autophagy helps cancer cells 
to survive under nutrient and oxygen stress (Filomeni, De Zio, and Cecconi 2015). TRIM27 
seems to facilitate starvation induced autophagy. Hence, this can be one mechanism that 
TRIM27 uses to facilitate growth of cancer cells. Collectively, these results point to TRIM27 
as a putative regulator of autophagy, and that one of its oncogenic features is to facilitate the 
autophagy process in cancer cells. Moveover, breast cancer cell lines with various expression 
levels of TRIM27 represent promising model systems for further revealing the molecular 
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Figure 1. Autophagic degradation of TRIM27 is dependent on ATG7, ATG9 and the 
Sequestosome-Like receptors. A) Normal HeLa cells and cells that were genetically knocked 
out for ATG7, the 5 autophagy receptors p62/SQSTM1, NBR1, NDP52, Optineurin and 
Tax1BP1 (pentaKO), pentaKO cells with reintroduced GFP-p62/SQSTM1 or pentaKO cells 
with reintroduced GFP-NDP52 as indicated to the right, were transfected with mCherry-EYFP-
TRIM27 expression plasmids. One-day post transfection half of the cells were treated with 
HBSS for 2 hours (SM), before all cells were fixated, stained with DAPI and imaged using a 
Zeiss780 confocal microscope. FM: Full medium, SM: HBSS 2hrs. Scale bar (10 μm). B) The 
graphs represent the amount of Yellow dots and RedOnly dots in the mCherry-EYFP-TRIM27 
transfected cells shown with representative images in (A). The graphs are representative for 3 
independent experiments. Normal (FM) and starved (HBSS 2hrs) (SM) conditions. C) Western 
blot analysis of endogenous TRIM27 in HeLa ATG9 KO cells in normal medium (FM) or 
treated with HBSS (SM) for 4 hours. D) Quantitation of Western blot analysis as displayed in  
(C). The graph represents the average of three independent experiments with standard 
deviations. *: p < 0.05 using student T-test; n.s.: p>0.05 using student T-test. 
 
Figure 2. TRIM27 interacts with ATG8s and has a LIR with specificity towards LC3C. 
A) Schematic representation of the domain architecture of TRIM27 with RING, B-box, Coiled-
Coil (CC), LIR, and PRY/SPRY domains indicated. Peptide array with 20-mers spanning the 
complete region of TRIM27 to define the peptides of TRIM27 able to interact with recombinant 
GST-GABARAP. The peptide walk was done with steps of three amino acid from one spot to 
 
 
the next. The peptide arrays were probed with 1μg/ml GST-GABARAP for 2 h, and binding to 
GST-GABARAP was detected with anti-GST antibodies. The identified putative LIR is 
highlighted by stars and shadowed background in the amino acid sequence. B) GST-pulldown 
assay using 35S-labeled Myc-TRIM27 or 35S-labeled Myc- TRIM27W184A/F186A/L189A and 
recombinant GST and GST-ATG8 proteins. The amount of Myc-TRIM27 or Myc- 
TRIM27W184A/F186A/L189A bound to the various ATG8 proteins was detected by autoradiography. 
The graph represents the average binding compared to input from three independent 
experiments. C) GST-pulldown assay using cell extracts from HEK293 FlpIn EGFP-TRIM27 
cells and GST or GST-ATG8 proteins as indicated, immobilized on Glutathione Sepharose 
beads. EGFP-TRIM27 was detected using an anti-GFP antibody. GST proteins were visualized 
by Ponceau staining. D) Sequence alignment of LIR in TRIM27 and LIR2 in TRIM5α. The 
LIRs are indicated by shadowed background, and the residues important for TRIM5α LIR2 
interaction with the ATG8s are highlighted in red. 
 
Figure 3: TRIM27 co-localizes with core autophagy proteins and SLRs. Representative 
images of HEK293 FlpIn TRIM27 KO EGFP-TRIM27 cells fixed and stained with antibodies 
for p62/SQSTM1, NBR1, ATG9A, ATG13, ULK1, USP7 and FK2 (Ubiquitin). Images were 
obtained using a ZEISS780 confocal laser scanning microscope, and the co-localization 
monitored using the ZEN software. Scale bar (10 μm), on inserts (2 μm). Arrows indicate 
colocalisation between EGFP-TRIM27 and the indicated proteins. 
 
Figure 4: TRIM27 associates withthe SLR family of autophagy receptors and core 
autophagy proteins. A) Results from Mass Spectometry (MS) from GFP trap using HEK293 
FlpIn TRIM27 KO reconstituted with EGFP and EGFP-TRIM27 cells. The list represents 
proteins that precipitated with EGFP-TRIM27 induced in the HEK293 FlpIn TRIM27 KO cells, 
and not with induced EGFP. The experiment was performed in triplicate.. B) HEK293 FlpIn 
TRIM27 KO reconstituted with EGFP and EGFP-TRIM27 cells were harvested and incubated 
overnight with GFP trap. The cell extracts were then analyzed by Western blot to detect 
p62/SQSTM1, NBR1, LAMP2, GFP and TRIM27. C) GST-pulldown assays using 35S-labeled 
Myc-TRIM27 and recombinant GST, GST-p62/SQSTM1 or GST-NDP52 immobilized on 
Glutathione Sepharose beads.  D) HEK293 FlpIn TRIM27 KO cells were transfected with 
EGFP-TRIM27 or EGFP and myc-62/SQSTM1. Then cell extracts were incubated overnight 
with Myc-trap. Input and IP were analyzed by Western blot using Myc and Ubiquitin (FK2) 




Figure 5: Depletion of TRIM27 impairs starvation induced autophagy. A) Representative 
images of HEK293 FlpIn and HEK293 FlpIn TRIM27 KO cells in full media (FM) or starved 
with HBSS (2 hrs) (SM) fixed and stained with antibodies for LC3B and p62/SQSTM1. Images 
were obtained using a ZEISS780 confocal laser scanning microscope. Scale bar (10 μm), on 
inserts (2 μm).. B) The graphs display the quantitation of p62/SQSTM1 dots (upper panel) and 
LC3B dots (lower panel) in the HEK293 FlpIn TRIM27 KO cell line and the HEK293 FlpIn 
wild type cell line under normal and starved (HBSS 2hrs) conditions using the Volocity 
software (PerkinElmer). Each graph represents the average of three independent experiments 
with standard deviations, each including around 100 cells per condition. *: p < 0.05 using 
student T-test; n.s.: p>0.05 using student T-test. 
C) Representative images of HEK293 FlpIn and HEK293 FlpIn TRIM27 KO cells in full media 
(FM) or starved with HBSS (2 hrs) (SM) fixed and stained with antibodies for WIPI2. Images 
were obtained using a ZEISS780 confocal laser scanning microscope Scale bar (10 μm), on 
inserts (2 μm). D) The graph displays the quantitation of WIPI2 dots in the HEK293 FlpIn 
TRIM27 KO cell line and the HEK293 FlpIn wild type cell line under normal and starved 
(HBSS 2hrs) conditions using the Volocity software (PerkinElmer). Each graph represents the 
average of three independent experiments with standard deviations, each including around 100 
cells per condition. *: p < 0.05 using student T-test; n.s.: p>0.05 using student T-test. 
 
 
Figure 6: TRIM27 KO and KD increase LAMP2 levels and promotes the formation of big 
LAMP2 rings in HEK293 FlpIn cells. A) Western blot analyses of the nuclear and 
cytoplasmic fractions of HEK293 FlpIn, HEK293 FlpIn TRIM27 KO and HEK293 FlpIn 
reconstituted with EGFP-TRIM27 cell lines. LAMP2 antibody and LAMIN B1 antibody were 
used as cytoplasmic and nuclear controls, respectively. The * indicates an unspecific band 
detected by the TRIM27 antibody. B) Upper panels shows Western blot analyses of extracts 
from HEK293 FlpIn, HEK293 FlpIn TRIM27 KO and HEK293 FlpIn EGFP-TRIM27 cells 
incubated in full media (FM) or starved with HBSS 4 hrs (SM). The * indicate an unspecific 
band detected by the TRIM27 antibody. The graph in the lower panel shows average band 
intensities with standard deviations quantitated using ImageJ (Fiji) from three independent 
experiments. **: p < 0.005 using student T-test;  *: p < 0.05 using student T-test; n.s.: p>0.05 
using student T-test. C) Upper panels shows Western blot analyses of extracts from HEK293 
FlpIn cells treated with Control siRNA or TRIM27 siRNA, incubated in full media (FM) or 
 
 
starved with HBSS 4 hrs (SM). The graph in the lower panel shows average band intensities 
with standard deviations quantitated using ImageJ (Fiji) from three independent experiments. 
*: p < 0.05 using student T-test; n.s.: p>0.05 using student T-test. D) Representative images of 
HEK293 FlpIn, HEK293 FlpIn TRIM27 KO, HEK293 FlpIn reconstituted with EGFP-TRIM27 
and HEK293 FlpIn transfected with TRIM27 siRNA immunostained with LAMP2 antiodies 
(red). The nucleus is visualized by DAPI (blue). Images were obtained using a ZEISS780 
confocal laser scanning microscope. Scale bar (10 μm).. The graph represents the average 
amount (%) of cells containing large LAMP2 rings for each of the cell lines represented by the 
images. The quantitations were performed manually in two independent experimens, each 
containing 50 cells per condition. E) Representative image of HEK293 FlpIn reconstituted with 
EGFP-TRIM27 immunostained with antibodies against LAMP2 and TOM20. Images were 
obtained using an AiryScan 880 microscope. Scale bar (10 μm), on insert (5 μm). 
 
Figure 7: TRIM27 is highly expressed in breast cancer tissues and inversely correlated 
with LAMP2 and LC3B expression in various breast cancer cell lines. A) Graphs 
representing the TRIM27 mRNA (log2) expression levels in breast cancer tissues compared to 
normal tissues. The left graph represents average TRIM27 mRNA expression in breast cancer 
tissue compared to normal tissue in the same patients (n=23). The right graph represents average 
TRIM27 mRNA expression in tissue from healthy individuals (n=5) compared to average 
TRIM27 mRNA expression in breast cancer tissue from patients (n=53). B) Western blot 
analysis of endogenous TRIM27, LC3B, p62/SQSTM1 and LAMP2 in cell extracts from nine 
different breast cancer cell lines representing different breast cancer subtypes. The blot is 
representative of three independent experiments.  
 
Supplementary Figure 1: TRIM27 localizes to cytoplasmic bodies and facilitates cell 
migration of HEK 293T FlpIn cells. A) DNA sequences encompassing the target sequence 
employed in the CRISPR/Cas9 mediated strategy generation TRIM27 KO cell line. The lower 
part show the DNA sequences of the PCR products obtained from the genomic loci targeted by 
CRISPR/Cas9. B) Western blot analysis of HEK293 FlpIn cells and the TRIM27 KO cells, 
showing KO of TRIM27. The * indicates an unspecific band detected by the TRIM27 antibody. 
C) Western blot analysis of HEK293 FlpIn TRIM27 KO cells reconstituted with tetracycline 
inducible expression of EGFP or EGFP-TRIM27. Expression of EGFP and EGFP was detected 
by an anti-GFP antibody. Tetracyclin (100 ng) were added where indicated above the blot. D) 
Western blot analysis comparing expression of endogenous TRIM27 in the HEK293 FlpIn cells 
 
 
and tetracycline (100 ng) induced expression of EGFP-TRIM27 in the reconstituted HEK293 
FlpIn TRIM27 KO cell lines. The proteins were detected using an anti-TRIM27 antibody. The 
* indicate an unspecific band detected by the TRIM27 antibody. E) Representative images of 
EGFP-TRIM27 expressed in the reconstituted HEK293 FlpIn TRIM27 KO cell lines, upon 
normal (FM) and starved (SM) (HBSS 2 hrs) conditions. Images were obtained using a 
ZEISS780 confocal laser scanning microscope.Scale bar (10 μm). F) Proliferation (left graph) 
and migration (right graph) curves of HEK293 FlpIn, HEK293 FlpIn TRIM27 KO, and 
HEK293 FlpIn TRIM27 KO reconstituted with EGFP-TRIM27. The graphs were obtained 
using the IncuCyte® S3 Live-Cell Analysis System (Sartorius). Error bars indicate s.d. of 
independent experiments (n=3 for Proliferation, n=2 for migration). 
 
Supplementary Figure 2: A) Representative images of HEK293 FlpIn TRIM27 KO cells 
reconstituted with EGFP-TRIM27fixed and stained with antibodies for GM130 orCalreticulin 
as indicated. Images were obtained using a ZEISS780 confocal laser scanning microscope. 
Scale bar (10 μm), on inserts (2 μm). B) Western blot analysis showing that a fraction of 
p62/SQSTM1 is ubiquitylated in HEK293 FlpIn TRIM27 KO cells that are reconstituted with 
EGFP-TRIM27 compared to HEK293 FlpIn TRIM27 KO cells both in full media (FM) or when 
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TRIM32, but not its muscular dystrophy-associated mutant,
positively regulates and is targeted to autophagic degradation
by p62/SQSTM1
Katrine Stange Overå1, Juncal Garcia-Garcia1, Zambarlal Bhujabal1, Ashish Jain1,*, Aud Øvervatn1,
Kenneth Bowitz Larsen1, Vojo Deretic2,3, Terje Johansen1, Trond Lamark1 and Eva Sjøttem1,‡
ABSTRACT
The tripartite motif (TRIM) proteins constitute a family of ubiquitin
E3 ligases involved in a multitude of cellular processes, including
protein homeostasis and autophagy. TRIM32 is characterized by
six protein–protein interaction domains termed NHL, various point
mutations in which are associated with limb-girdle-muscular
dystrophy 2H (LGMD2H). Here, we show that TRIM32 is an
autophagy substrate. Lysosomal degradation of TRIM32 was
dependent on ATG7 and blocked by knockout of the five autophagy
receptors p62 (also known as SQSTM1), NBR1, NDP52 (also known
as CALCOCO2), TAX1BP1 and OPTN, pointing towards degradation
by selective autophagy. p62 directed TRIM32 to lysosomal
degradation, while TRIM32 mono-ubiquitylated p62 on lysine
residues involved in regulation of p62 activity. Loss of TRIM32
impaired p62 sequestration, while reintroduction of TRIM32 facilitated
p62 dot formation and its autophagic degradation. A TRIM32LGMD2H
disease mutant was unable to undergo autophagic degradation and
to mono-ubiquitylate p62, and its reintroduction into the TRIM32-
knockout cells did not affect p62 dot formation. In light of the important
roles of autophagy and p62 in muscle cell proteostasis, our results
point towards impaired TRIM32-mediated regulation of p62 activity as
a pathological mechanisms in LGMD2H.
KEY WORDS: TRIM32, p62/SQSTM1, LGMD2H, Autophagy, BBS11,
Ubiquitylation
INTRODUCTION
Protein quality control is crucial for cellular health, especially in
tissues containing long-lived cells like the muscles and nervous
system. Dysfunctional quality control leads to protein aggregation
and development of diseases with increasing prevalence related to age
(Dikic and Elazar, 2018). The two most important biological
machineries controlling protein degradation are autophagy and the
ubiquitin-proteasome system (UPS), where protein ubiquitylation
mediated by E3 ubiquitin ligases provide substrate specificity. Based
on their structural properties, E3 ubiquitin ligases are classified as
RING, HECT or RBR ligases (Morreale and Walden, 2016). TRIM
family proteins belong to the RING E3s, which constitute the most-
abundant family of ubiquitin ligases (Hatakeyama, 2017). TRIMs are
characterized by the highly conserved RING finger–B-box–coiled-
coil domains at their N-termini, generally constituting their E3 ligase
and oligomerization activity. Human TRIM family proteins comprise
82members that are classified into 12 different subfamilies according
to the domain structure of their C-terminal region (Fig. 1A). They
have important functions in development, differentiation, immune
responses and carcinogenesis (reviewed in Hatakeyama, 2017).
Furthermore, certain TRIM proteins act as regulators of autophagy
activity (Pizon et al., 2013; Tomar et al., 2012) and as autophagy
receptors (Chauhan et al., 2016; Kimura et al., 2015, 2016; Mandell
et al., 2016, 2014). TRIM32 is characterized by six repeats of NHL
(NCL-1, HT2A and LIN-41) motifs in its C-terminus, which are
thought to mediate protein–protein interactions (Slack and Ruvkun,
1998). TRIM32 is expressed throughout the body, but with high
expression levels in the brain and heart (Frosk et al., 2002). The
biological roles of TRIM32 are multi-faceted, impacting muscle
physiology, cancer and immunity. This is reflected in the many
substrates reported to be targeted by its E3 ligase activity, such as the
muscular relevant proteins actin, α-actinin, desmin, tropomysin and
dysbindin, the cell cycle regulators c-Myc, MYCN and p53, and the
innate immunity adaptor STING (also known as TMEM173)
(reviewed in Lazzari and Meroni, 2016). The finding that mutations
in the NHL domains of TRIM32 can lead to the hereditary muscular
disease limb-girdle muscular dystrophy 2H (LGMD2H), identified
TRIM32 as an important player in muscular physiology (Frosk et al.,
2002).Whether the pathogenic effect of LGMD2H is due to a role for
TRIM32 in muscle atrophy (Cohen et al., 2012) or more in muscle
homeostasis and regrowth after atrophy (Kudryashova et al., 2012,
2005; Nicklas et al., 2012; Servián-Morilla et al., 2019) is not well
understood. However, it has been shown that the LGMD2Hmutations
lead to impaired self-oligomerization and auto-ubiquitylation, and
reduced TRIM32 expression level (Albor et al., 2006; Kudryashova
et al., 2011; Locke et al., 2009; Servián-Morilla et al., 2019).
Moreover, recent work analyzing muscle biopsies and primary
myoblasts from LGMD2H patients, described reduced proliferation
and differentiation capacity, diminished satellite cell pool, and
enhanced senescence and autophagy activity (Servián-Morilla et al.,
2019). In addition, another very recent publication reported that
TRIM32 is important for induction of autophagy in atrophic muscle
cells, while the LGMD2Hmutant was unable to activate autophagy in
these cells (Di Rienzo et al., 2019). All mutations associated with
LGMD2H are either deletions or point mutations located in the
NHL domains, while a point mutation in the B-box of TRIM32 is
associated with a completely unrelated disease, multisystemic disorderReceived 15 July 2019; Accepted 28 October 2019
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Bardet–Biedl syndrome 11 (BBS11) (Chiang et al., 2006). The
pathogenic mechanism for the disease is not understood.
Autophagy is a cellular renovation system that uses lysosome-
mediated pathways to degrade and recycle almost any type of cell
content (Mizushima and Komatsu, 2011). Autophagy is described to
act both as a non-selective bulk degradation pathway, and as a
selective elimination of components such as aberrant protein
aggregates, RNA bodies, lipid droplets, unwanted organelles and
invading pathogens in a process termed selective autophagy (reviewed
in Rogov et al., 2014). Selective autophagy provides quality control of
cellular components, degrading damaged and harmful material during
normal cellular conditions. When cells are stressed by hypoxia,
ischemia, starvation or infection, selective autophagy is stimulated and
specifically targets excess or toxic structures (Johansen and Lamark,
2011; Rogov et al., 2014). This allows the cell to adapt to the
unfavorable conditions. Autophagy receptors are instrumental in the
process. They bind specifically to the cargo and to ATG8 family
proteins (such as LC3B, also known as MAP1LC3B) at the forming
autophagosome, directing the cargo for degradation in the lysosome.
The first selective autophagy receptor to be identified was p62, also
known as sequestosome-1 (SQSTM1) (Bjørkøy et al., 2005).
Ubiquitin labeling is one of the signals for cargo degradation via
selective types of autophagy. Ubiquitylated protein aggregates
containing autophagy receptors are evident in a range of human
diseases. p62 contains a C-terminal ubiquitin-binding domain (UBA),
a LC3-interacting region (LIR) and an N-terminal Phox and Bem1
(PB1) domain with an oligomerization property (Pankiv et al., 2007).
The oligomerization activity of p62 is important for sequestering its
cargo and for scaffolding phagophore membrane development
(Bjørkøy et al., 2005; Itakura and Mizushima, 2011), described as a
p62-mediated phase separation process dependent on ubiquitin (Sun
et al., 2018; Zaffagnini et al., 2018). Recent studies have revealed that
the autophagy activity of p62 itself is regulated by ubiquitylation
(Heath et al., 2016; Jongsma et al., 2016; Lee et al., 2017; Pan et al.,
2016; Peng et al., 2017). The UBA domain of unmodified p62 has a
strong tendency to form an intermolecular dimer that spatially
occludes ubiquitin binding (Isogai et al., 2011; Long et al., 2010).
Ubiquitylation of several residues both inside and outside the UBA
domain is reported to enhance the ubiquitin-binding activity and
autophagy activity of p62 (Lee et al., 2017; Peng et al., 2017).
Interestingly, several studies implicate p62 as an important player of
protein homeostasis in muscle cells (Arndt et al., 2010; Lee et al.,
2018; Rodriguez-Muela et al., 2018). Furthermore, proper regulation
of autophagy is fundamental for muscle homeostasis, and
dysregulation of autophagy has a pathogenic role in several forms
of muscle diseases (Jiao and Demontis, 2017).
By employing a fluorescence-based double-tag screen of 22
TRIM proteins representing each of the TRIM subfamilies, we
identified TRIM32 as a potential autophagy cargo protein.
Interaction analysis in vitro and in cells revealed direct interaction
and colocalization of TRIM32 and p62, while autophagy assays
showed that p62 was able to mediate autophagic degradation of
TRIM32. Conversely, ubiquitylation assays and proteomic analysis
identified p62 as a TRIM32 substrate. TRIM32 mediated mono-
ubiquitylation of p62 at residues previously shown to be important
for the ubiquitin-binding activity of p62. By establishment of
TRIM32-knockout (KO) and reconstituted cells, we show that
TRIM32 facilitates p62 sequestration and autophagic degradation.
Introduction of the LGMD2H disease mutation in TRIM32 inhibited
its autophagic degradation, and also its ability to regulate p62
Fig. 1. TRIM proteins from various subclasses are degraded in the lysosome. (A) Subclasses and domain organization of the 22 TRIM proteins
analyzed in the double-tag screen. The ability of each mCherry–EYFP–TRIM protein to form RedOnly structures is indicated by ND (no RedOnly structures
detected),+(<10 RedOnly structures in cells with fluorescent puncta), ++ (many RedOnly structures in cells with fluorescent puncta). R, Ring finger B1/B2: Bbox1/
Bbox2; CC, Coiled coil. (B) Confocal images of mCherry–EYFP-tagged TRIM proteins representing each of the categories ND, + and ++. HeLa cells were
transfected with mCherry–EYFP-tagged TRIM22, TRIM31 or TRIM32 1 day before fixation and imaged using a Zeiss780 confocal microscope and the Zen
software. Blue, DAPI staining. Scale bars: 10 µm.
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activity. In contrast, introduction of the BBS11 mutation in TRIM32
strongly facilitated p62 sequestration and degradation. Our results
demonstrate a dual role for TRIM32 in autophagy, acting both as a
substrate and as a positive regulator of p62. Importantly, the
inactivity of the TRIM32 LGMD2H mutant points toward
dysfunctional TRIM32 mediated regulation of p62 as a
pathological mechanism in LGMD2H.
RESULTS
TRIM proteins from various subclasses are degraded in
the lysosome
Recent studies have shown that certainTRIMproteins are implicated in
the autophagy process, as regulators and as receptors in selective
autophagy (reviewed in Di Rienzo et al., 2019; Hatakeyama, 2017;
Kimura et al., 2017, 2016; van Gent et al., 2018). Furthermore, a few
TRIM proteins seemingly are degraded by autophagy themselves,
including TRIM50 (Fusco et al., 2012), TRIM30 (Choi et al., 2015)
and TRIM5α (Mandell et al., 2016). Here, we employed the double-
fluorescence-tag strategy (Pankiv et al., 2007) to identify TRIM
proteins that could be degraded by autophagy, and hence that are
potential as autophagy regulators and receptors. A total of 22 different
TRIM proteins, representing 11 subclasses of the TRIM family, were
fused to the double fluorescence tag mCherry–EYFP and expressed in
HeLa cells. Since EYFP is unstable in acidic milieus with a pH below
6, while mCherry is stable, double-tagged proteins will only have red
florescence when they are sequestered in the lysosome (denoted
‘RedOnly’ structures), which has a pH of ∼4.7. At 24 h after
transfection, the cells were exposed to normal medium or were starved
for 2 h in Hanks’ balanced salt solution (HBSS), before fixation and
confocal microscopy imaging. To verify that the RedOnly structures
represented lysosomal compartments, we analyzed, in parallel, cells
treated with the lysosomal inhibitor Bafilomycin A1 (BafA1) for 4 h
before fixation. BafA1 impairs the acidification of the lysosomes, and
hence the quenching of EYFP localized in the lysosome. As presented
in Fig. 1, 13 of the 22 TRIM proteins tested formed some RedOnly
structures. Nine of these have previously been linked to autophagy,
namely, TRIM20 and TRIM21 (Kimura et al., 2015), TRIM50 (Fusco
et al., 2012), TRIM23 (Sparrer et al., 2017), TRIM13 (Tomar et al.,
2012), TRIM31 (Ra et al., 2016), TRIM5α (Mandell et al., 2014),
TRIM32 (Di Rienzo et al., 2019; Yang et al., 2017) and TRIM16
(Chauhan et al., 2016;Kimura et al., 2017). Theobservation that not all
TRIM proteins form RedOnly structures may indicate that this is not a
general trait of the conserved N-terminal RING finger–B-box–coiled-
coil domains, or that degradation of certain TRIMs by autophagy is
dependent on factors not present in HeLa cells. Furthermore, RedOnly
structures were detected among TRIMs from many different
subclasses (Fig. 1A), suggesting that it is not dependent on any
specific domains in the C-terminal. However, four of the six TRIM
proteins that gave a substantial amount of RedOnly structures both in
normal medium and upon starvation conditions contain a SPRY
domain in their very C-terminal end. Three of these, TRIM5α,
TRIM16 and TRIM20, have been previously identified as autophagy
receptors (Chauhan et al., 2016; Kimura et al., 2017; Mandell et al.,
2014) and hence confirm our screening strategy. mCherry–EYFP–
TRIM32 displayed a strong and reproducible formation of RedOnly
dots in both normal and starved conditions (Fig. 1B). Interestingly,
TRIM32 is reported to interactwith the autophagy receptorTAX1BP1,
and thereby mediate autophagic degradation of the TLR3/4 adaptor
protein TRIF (Yang et al., 2017) and a recent report suggests
autophagic degradation of the TRIM32 LGMD2H disease mutants
(Servián-Morilla et al., 2019). However, whether TRIM32 is a
substrate for autophagic degradation is unresolved.
TRIM32 interacts and colocalizes with the autophagy
marker proteins LC3B and p62
The double tag assay clearly indicated lysosomal degradation of
exogenous TRIM32. In order to determine whether endogenous
TRIM32 is degraded via lysosomal pathways or via the proteasome,
the lysosomal inhibitor BafA1 and the proteasomal inhibitor MG132
were applied on HEK293 cells grown in full medium or starved in
HBSS for 4 h. The protein levels of endogenous TRIM32 during the
various conditions was analyzed by western blotting and the band
intensities quantitated and correlated to the level of PCNA (Fig. 2A).
Treatment with the lysosomal inhibitor and the proteasomal inhibitor
increased the amount of TRIM32 to a similar degree under starvation
conditions, while the proteasomal pathway seems to be most
important under normal cellular conditions. The increase of the
LC3B II band (representing lipidated LC3B) upon BafA1 treatment,
and the phosphorylation status of the mTOR-regulated translation
initiation factor 4E (p4E-BP1) verified that the cells responded as
expected to the lysosomal inhibitor and to the starvation medium.
These data suggest that TRIM32 is degraded via the proteasomal and
lysosomal pathways to a similar extent during starvation conditions,
while the proteasomal pathway is dominant under normal conditions.
Several TRIM proteins are reported to interact with core
components of the autophagy machinery, and to function as
autophagy receptors and regulators of autophagosome formation
(Kimura et al., 2015, 2016; Mandell et al., 2016, 2014). We applied
in vitroGST-pulldown assays to determine whether TRIM32 has the
ability to bind directly to the ATG8 family proteins. Fig. 2B shows
that TRIM32 binds to LC3A (MAP1LC3A), LC3C (MAP1LC3C),
GABARAP and GABARAP-L1, and weakly to LC3B and
GABARAP-L2. However, we were not able to find any candidate
LC3-interacting regions (LIRs) in TRIM32 with bioinformatic tools,
and GST-pulldown assays with the N-terminal part of TRIM32
(the RING finger–B-box–coiled-coil domains) and the C-terminal
part (NHL-domains) both displayed binding to GST–LC3B and
GST–GABARAP (Fig. S1A). Further attempts to identify LIRs in
TRIM32 did not give any consistent results (data not shown). We
next tried to identify whether the interaction between TRIM32 and
the ATG8 protein family was mediated by the newly characterized
ubiquitin-interacting motif (UIM) docking site (Marshall et al.,
2019). However, we were not able to identify a UIM motif in
TRIM32. This suggests that TRIM32 can interact directly with
ATG8 proteins in a non-LIR- and non-UIM-dependent way,
suggesting that other or more complex interfaces are involved.
To further investigate the lysosomal degradation of the TRIM32
mutants, Flp-In T-Rex 293 cell lines with tetracycline-inducible
expression of EGFP–TRIM32P130S and EGFP–TRIM32D487N were
established (Fig. S1B). In accordance with previous reports,
TRIM32 is normally a cytoplasmic protein forming distinct
perinuclear bodies or aggregates (Fig. 2C; Fig. S1B) (Locke et al.,
2009). Furthermore, western blots of the expressed EGFP fusion
proteins revealed a slower-migrating form of EGFP–TRIM32 and
the BBS11 mutant EGFP–TRIM32P130S, but not the LMGD2H
mutant EGFP–TRIM32D487N (Fig. S1B). Co-staining the FlpIn
EGFP–TRIM32 cells with antibodies against the autophagy marker
protein LC3B and the autophagy receptor protein p62 showed that
certain TRIM32 bodies colocalized with LC3B-positive p62
bodies (Fig. 2C). This indicates that a subpopulation of the
TRIM32 bodies represent autophagosomes. Such bodies were
observed both in full medium and in starvation conditions. To
further evaluate whether TRIM32 interacts with p62 in cells, the
DuoLink proximity ligation assay was employed to detect close
colocalization of EGFP–TRIM32 and endogenous p62 in the Flp-In
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EGFP–TRIM32 cell line. The DuoLink assay revealed close to 30
distinct spots per cell (Fig. 2D). Together, these data show that
TRIM32 is recruited to LC3B-positive p62 bodies, and is stabilized
by treating cells with the lysosomal inhibitor BafA1. This strongly
indicates that a subpopulation of TRIM32 proteins is degraded by
autophagy.
Seven various mutations in the NHL repeat region of TRIM32
are associated with the recessive muscular dystrophy disease
LGMD2H, with the TRIM32D487N mutation being the most
common (Fig. 2E) (Frosk et al., 2002), while a point mutation in
the B-Box2, TRIM32P130S, leads to the pleiotropic disorder
BBS11 (Fig. 2E) (Chiang et al., 2006). We applied the in vitro
Fig. 2. See next page for legend.
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GST-pulldown assay to verify the direct interaction between p62
and wild-type TRIM32 and its two disease mutants. p62 expressed
in E.coli and immobilized on glutathione beads was added to
in-vitro-translated Myc–TRIM32WT, Myc–TRIM32P130S or Myc–
TRIM32D487N. The amount of bound proteins was analyzed by
SDS-PAGE (Fig. 2E). Wild-type TRIM32 and both its disease
mutants bound weakly to p62. The interaction between TRIM32
and p62 in cells was further confirmed by GST-pulldown assays
using cell extracts from HEK293 cell lines expressing EGFP-tagged
wild-type TRIM32 and its disease mutants (Fig. 2F), and by
co-immunoprecipitation of endogenous p62 (Fig. S1D).
The PB1 domain and the UBA domain of p62 is important for p62
oligomerization and for binding to ubiquitylated proteins (Bjørkøy
et al., 2005; Lee et al., 2017). In order to identify whether the PB1
domain or the UBA domain of p62 is implicated in the interaction
with TRIM32, we performed GST-pulldown assays using p62 PB1
and UBA deletion constructs fused to GST and cell extracts from
cells expressing exogenous EGFP–TRIM32. We found that deletion
of the UBA domain or the PB1 domain did not affect the interaction
with TRIM32, indicating that the interaction is not mediated by
ubiquitin (Fig. 2G). These results show that TRIM32 binds directly
to the autophagy receptor p62, and this interaction is not impaired by
the LGMD2H and BBS11 disease mutations.
TRIM32 is targeted to autophagic degradation by p62
Next, we evaluated whether the lysosomal degradation of TRIM32
is mediated by macroautophagy. For this purpose, we applied the
mCherry–EYFP–TRIM32 double-tag assay in the autophagy-
deficient ATG7-KO cells (Mejlvang et al., 2018). ATG7 is an
ubiquitin E1-like activating enzyme that is essential for assembly
and function of the ubiquitin-like conjugation systems (Nakatogawa
et al., 2009). mCherry–EYFP–TRIM32 did not form any RedOnly
dots in the ATG7-KO cells (Fig. 3A,C). Furthermore, degradation of
endogenous TRIM32 was not stabilized by BafA1 treatment in
ATG7-KO cells (Fig. 3B). This clearly indicates that lysosomal
degradation of TRIM32 is mediated by the macroautophagy
pathway. Next question was whether TRIM32 is degraded by
selective autophagy. To this end, the degradation of TRIM32 was
assayed in a cell line lacking the five autophagy receptors p62,
NBR1, NDP52, TAX1BP1 and OPTN (denoted the ‘pentaKO’)
(Lazarou et al., 2015). Only a few cells with mCherry–EYFP–
TRIM32 RedOnly dots were observed in pentaKO cells grown
under normal and starvation conditions (Fig. 3A,C). This suggests
that TRIM32 is dependent on the autophagy receptors for efficient
degradation by autophagy, pointing towards degradation by
selective autophagy.
The interaction and colocalization of TRIM32with p62 prompted
us to analyze the degradation of TRIM32 in pentaKO cells
reconstituted with EGFP–p62. mCherry–EYFP–TRIM32 formed
several RedOnly dots both under normal and starvation conditions
in this cell line, indicating that p62 is able to mediate autophagic
degradation of TRIM32 (Fig. 3C,D). To evaluate if p62 is essential
for autophagic degradation of TRIM32, we employed the double tag
assay in a HEK293 FlpIn cell line knocked out for p62. The T-REx
HEK293 p62−/− cell line was established by CRISPR/Cas9 as
described in theMaterials andMethods section (Fig. S1C). Ablation
of p62 strongly reduced the number of RedOnly dots in the
mCherry–EYFP–TRIM32-transfected cells compared to wild-type
cells (Fig. 3C,D), but did not completely abolish lysosomal
degradation of mCherry–EYFP–TRIM32. This indicates that p62
can mediate autophagic degradation of TRIM32. However, other
autophagy receptors beside p62 may also be involved.
The LGMD2H disease mutant of TRIM32 is not degraded by
autophagy
To investigate whether the TRIM32P130S and TRIM32D487N disease
mutants were degraded by autophagy, they were fused to the
mCherry–EYFP double tag and transfected into HeLa cells.
Interestingly, we found that mCherry–EYFP–TRIM32P130S
displayed a strong ability to form RedOnly dots, especially under
starvation conditions (Fig. 4A). TRIM32D487N on the other hand,
wasmainly diffuse except from in some cells where it formed several
round dots distributed throughout the cell. However, none of these
dots were found to be RedOnly (Fig. 4A). Similar results were
obtained when we transfected the double-tag constructs into the
myoblast cell line C2C12 (Fig. S2A). Around 75% of the C2C12
cells expressingmCherry–EYFP–TRIM32WT andmCherry–EYFP–
TRIM32P130S contained RedOnly dots, compared to only 12% of the
C2C12 cells expressing mCherry–EYFP–TRIM32D487N. Moreover,
double-tag analyses in the C2C12 cells expressing the mutants
TRIM32R394H and TRIM32V591M, both of which arewithin theNHL
repeats region and are associated with LGMD2H, revealed that they
did not localize in acidic compartments (Fig. S2A). These results
clearly indicate that TRIM32 undergoes autophagic degradation in
muscle cells, and that this degradation is strongly inhibited by
mutations associated with LGMD2H.
Fig. 2. TRIM32 interacts and colocalizes with the autophagy marker
proteins LC3B and p62. (A) HEK293 FlpIn cells were treated with BafA1
(200 nM) or MG132 (10 µM) for 4 h in HBSS (starvation medium, SM) or full
medium (FM), before cell extracts were harvested in 1× SDS. 10 µg of the
various cell extracts were separated on SDS-PAGE gels and blotted against
the indicated antibodies. The bar graphs on top panel represent the mean±
s.e.m. relative band intensities estimated by ImageJ from three independent
experiments (n=3). *P<0.05, ***P<0.0005 (Student’s t-test). (B) GST-pulldown
assay using 35S-labeled Myc–TRIM32 and recombinant GST and GST–ATG8
proteins. The amount of Myc–TRIM32 bound to the various ATG8 proteins was
detected by autoradiography. The assay was repeated with similar results.
(C) HEK293 FlpIn EGFP-TRIM32 cells in full medium or starved in HBSS
(2 h) were fixed and stained with antibodies for LC3B and p62. Images were
obtained using a ZEISS780 confocal laser scanning microscope, and the
colocalization monitored using the ZEN software. Scale bars: 10 µm (main
images), 2 µm (magnifications). Intensity profiles along the indicated line are
shown to the right. (D) Representative images of the Flp-In EGFP-TRIM32
cells analyzed by the proximation ligation assay DuoLink using antibodies
against GFP and p62. The graph represents the mean±s.d. of colocalization
dots using the Volocity software, from three independent experiments. Each
experiment includes z-stack images of n=100 cells per condition. Scale bars:
10 µm. (E) The top panel shows a schematic of the TRIM32 domain
organization with the localization of the disease point mutations P130S and
D487N indicated. R, Ring finger; B2, Bbox2; CC, Coiled coil. The lower panels
show GST-pulldown assays using 35S-labeled Myc–TRIM32WT, Myc–
TRIM32P130S or Myc–TRIM32D487N and recombinant GST and GST–p62
immobilized on glutathione–Sepharose beads. Quantifications of the binding
of wild-type and mutant constructs to GST–p62 are presented as percentage
binding relative to input. The bars represent the mean±s.d. band intensities
compared to input as quantified using ImageJ of three independent
experiments. *P=0.025; n.s., not significant (Student’s t-test).
(F) GST-pulldown assay using cell extracts from FlpIn EGFP-TRIM32WT,
EGFP-TRIM32P130S or EGFP-TRIM32D487N cells and GST–p62 immobilized
on glutathione–Sepharose beads. EGFP–TRIM32 was detected using an
anti-GFP antibody. GST proteins were visualized by Ponceau staining.
Quantifications of the band intensities of the bound proteins compared to 5%
input are indicated below the blot. (G) GST-pulldown assays using cell extracts
from the FlpIn EGFP–TRIM32 cells and recombinant GST, GST-p62, or
various GST-p62 deletion constructs immobilized on glutathione–Sepharose
beads. Bound EGFP–TRIM32 was detected using anti-GFP antibody, while
the GST proteins were visualized by Ponceau staining. Quantifications of the
band intensities of the bound proteins compared to 5% input using ImageJ are
indicated below the blot.
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Fig. 3. TRIM32 is targeted to autophagic degradation by p62. (A) Normal HeLa cells and cells that were genetically knocked out for ATG7 or the five autophagy
receptors p62, NBR1, NDP52, OPTN or TAX1BP1 (pentaKO) as indicated, were transfected with mCherry–EYFP–TRIM32. At 1 day post transfection, half
of the cells were treated with HBSS for 2 h (starvation medium, SM) and half were maintained in full medium (FM), before all cells were fixed, stained with DAPI
and imaged using a Zeiss780 confocal microscope. Scale bars: 10 µm. (B)Western blot analysis of endogenous TRIM32 in wild-type HeLa cells and HeLa ATG7-
KO cells in normal medium (FM) in HBSS (SM), and treated or not with BafA1 (Baf) and MG132 (MG) for 4 h. The graph represents the mean±s.d. TRIM32 band
intensities from three independent experiments quantitated using ImageJ. P-values are obtained using Student’s t-test. n.s.=not significant (P-value>0.05).
PCNA represents the loading control, while p62 and LC3B are controls of autophagy flux. (C) The graphs represent the amount of mCherry-EYFP-TRIM32
transfected cells that contain RedOnly dots compared to the amount of cells that display mCherry-EYFP-TRIM32 dots (representative images shown in A and D)
under normal and starvation (HBSS 2 h) conditions. Each graph represents themean±s.e.m. of at least three independent experiments (n=25–50 cells). *P<0.05,
**P<0.005, ***P<0.0005, n.s., not significant (Student’s t-test). (D) PentaKO cells reconstituted with GFP–p62 (green dots) and HEK293 FlpIn cells genetically
knocked out for p62 as indicated to the right, were transfected and treated as described in A. Scale bars: 10 µm.
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Fig. 4. The LGMD2H disease mutant of TRIM32 is not degraded by autophagy. (A) HeLa cells were transfected with mCherry–EYFP–TRIM32WT,
mCherry–EYFP–TRIM32P130S or mCherry–EYFP–TRIM32D487N as indicated, kept in normal medium (full medium, FM) or starved with HBSS for 2 h (starvation
medium, SM) at 1 day post transfection and imaged bya Zeiss780 confocal microscope. The graphs to the right displaymanual quantification of RedOnly dots and
yellow dots in n=30 cells, and are representative of three independent experiments. Scale bars: 10 µm. (B) GFP fluorescence intensities (arbitrary units) of
EGFP–TRIM32WT, EGFP–TRIM32P130S and EGFP–TRIM32D487N asmeasured by flow cytometry 24 h after promoter shut off in full medium (FM) or HBSS for 6 h
(SM), supplemented with BafA1 2 µm (Baf) or MG132 20 µM (MG) as indicated. Bars show average mean±s.d. GFP intensity from three independent
experiments (n=10,000 cells). P-values are as indicated; n.s., not significant (Student’s t-test). (C) Representative images of the Flp-In EGFP-TRIM32 cells
analyzed by the proximation ligation assay DuoLink using antibodies against GFPand p62. The graph represents the mean±s.d. relative number of colocalization
dots with from three independent experiments. Each experiment includes z-stack images of n≈100 cells per condition, and was quantified using the Volocity
software. P-values are as indicated; n.s., not significant (Student’s t-test). Scale bars: 10 µm.
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Next, a flow-based reporter cell system (Larsen et al., 2010) was
applied on the HEK293 FlpIn EGFP–TRIM32 cell lines, to monitor
degradation of EGFP–TRIM32 and the two disease mutants under
normal conditions and starvation. Expression of EGFP–TRIM32 or
the disease mutants was induced by treatment with tetracycline for
24 h. Thereafter, the expression was shut off by tetracycline wash-
out. The cells were starved in HBSS for 6, 12 and 24 h, and the
degradation measured by flow cytometry using the mean GFP
intensity in the cell population as a read out. BafA1 was applied to
determine degradation by lysosomal pathways, while MG132 was
included to measure proteasomal degradation. In full medium,
EGFP–TRIM32 is stabilized to a similar extent by BafA1 and
MG132, implicating both autophagy and the proteasome system in
TRIM32 degradation under normal conditions (Fig. 4B). This is in
line with the data presented in Fig. 2A, showing that endogenous
TRIM32 is degraded both by autophagy and by the proteasome.
This shows that EGFP–TRIM32 inducibly expressed in FlpIn cell
lines is degraded similarly to the endogenous protein. Upon 6 h
starvation, EGFP–TRIM32 expression is reduced by 85% compared
to normal conditions. The degradation is inhibited both by BafA1
and MG132, pointing towards involvement of both autophagy and
the proteasomal system also under starved conditions. Similar
results were obtained when the starvation period was extended to 12
and 24 h (data not shown). However, the expression level of EGFP–
TRIM32 did not decline further, indicating that the expression of
TRIM32 is stabilized after 6 h starvation. Applying the flow reporter
assay on the BBS11 disease mutant EGFP–TRIM32P130S indicated
a higher rate of degradation compared to the wild-type protein, with
a 90% reduction in the expression after 6 h of starvation (Fig. 4B).
The LGMD2H disease mutant EGFP–TRIM32D487N, however, was
not stabilized by BafA1 treatment under either normal or starvation
conditions (Fig. 4B). The expression level of EGFP–TRIM32D487N
upon starvation is reduced by 50%, which indicates a dramatically
lower turnover than the wild-type protein and the BBS11 mutant.
Hence, as indicated by the double-tag assay in Fig. 4A, EGFP–
TRIM32D487N is not an autophagic substrate, suggesting that it
shows dependence on its oligomerization and/or auto-mono-
ubiquitylation abilities to be recognized as an autophagic
substrate. This is in contrast to a recent report showing BafA1-
mediated stabilization of a TRIM32 LGMD2H mutant in primary
myoblasts isolated from a patient (Servián-Morilla et al., 2019).
This discrepancy can be explained by a TRIM32V591M mutation in
this patient, while we have analyzed the TRIM32D487N mutation.
Since we found that TRIM32 colocalizes with p62 in punctate
structures, and that reintroduction of p62 into the pentaKO cells was
sufficient to direct TRIM32 to autophagic degradation, the next
question was whether EGFP–TRIM32D487N had lost its ability to
interact with endogenous p62. To this end, the Duolink proximation
ligation assay was performed on the FlpIn EGFP–TRIM32
wild-type and mutant cell lines (Fig. 4C). Importantly, EGFP–
TRIM32D487N colocalized with p62 to a similar extent as
EGFP–TRIM32WT. Hence, interaction with p62 is not sufficient
to target TRIM32 to autophagic degradation. Interestingly, the
BBS11 disease mutant interacted strongly with p62, forming around
twice as many dots in the Duolink assay as wild-type TRIM32
(Fig. 4C). This suggests that the P130S mutation in TRIM32 may
modulate the colocalization of TRIM32 and p62 in cells.
Wild-type TRIM32, but not the LGMD2H disease mutant,
mono-ubiquitylates p62
In order to investigate the role of TRIM32 in selective autophagy,
we established HEK293 FlpIn TRIM32-KO cell lines by CRISPR/
Cas9. Knockout of TRIM32 expression in the cell lines was verified
by western blotting (Fig. S2B) and genomic sequencing (Fig. S2C).
Measuring the proliferation curve of the TRIM32-KO cell lines
revealed that they had impaired proliferation compared to the
mother HEK293 FlpIn cell line (Fig. 2D). This is in line with the
reported roles of TRIM32 in tumorigenesis (Liu et al., 2014; Wang
et al., 2018; Yin et al., 2018; Zhao et al., 2018), and thus validates
the TRIM32-KO cell lines further.
Recent research connects the upregulation of TRIM proteins in
tumor cells to enhanced protein quality control and antioxidant
defense (Chen et al., 2017). p62 plays important roles both in
protein quality control and in antioxidant defense via NRF2 (also
known as NFE2L2) (Jain et al., 2010; Pankiv et al., 2007), and
ubiquitylation is an important signaling event in these processes.
Moreover, reports describing ubiquitin modifications of p62 as a
modulator of its activity are emerging (Heath et al., 2016; Jongsma
et al., 2016; Lee et al., 2017; Lin et al., 2017; Pan et al., 2016). This
prompted us to investigate whether TRIM32 has the ability to
ubiquitylate p62. Myc–p62 was immunoprecipitated from a
HEK293 p62-KO cell line co-expressing Myc–p62 and EGFP–
TRIM32. Western blotting revealed a slow-migrating band both for
Myc–p62 and EGFP–TRIM32 (Fig. 5A), indicative of mono-
ubiquitylation of both proteins. Whether these slower migrating
bands indeed represented ubiquitin modification was verified by
coexpressing the de-ubiquitylase USP2 (Fig. 5B). Expressing USP2
removed the slow-migrating band of both p62 and TRIM32.
Furthermore, such slower-migrating bands were not detected
when Myc–p62 was precipitated from HEK293 cells expressing
EGFP–TRIM32C44S (catalytic dead) or EGFP–TRIM32D487N (an
LGMD2H disease mutation). This indicates that TRIM32 mediates
mono-ubiquitylation of p62, and that this is impaired by mutations
in the NHL domains involved in the LGMD2H disease. Mutation in
the BBox2 (P130S, a BBS11 disease mutation), however, did not
affect mono-ubiquitylation of p62. Both K63- and K48-linked
ubiquitylation were responsible for the p62 modification to a similar
extent (Fig. 5C). Both wild-type and mutated forms of EGFP–
TRIM32 co-precipitated with Myc–p62, which is in line with the
GST-pulldown (Fig. 2) and Duolink assay (Fig. 4) results. Hence,
the disease mutations do not impair the p62–TRIM32 interaction
in cells. Similar ubiquitylation of p62 was obtained when
co-transfecting Myc–p62 and wild-type or P130S EGFP–TRIM32
constructs in the HEK293 FlpIn TRIM32-KO cells (Fig. 5C). Myc–
p62 also formed a high-molecular-mass band in the SDS gel when
co-transfected with the active forms of TRIM32 (Fig. 5D),
suggesting that TRIM32-mediated ubiquitylation of p62 leads to
the formation of stable p62 oligomers. To identify whether impaired
ubiquitylation of p62 is a general trait of LGMD2H disease
mutations, the recently described V591M mutant of TRIM32
(Di Rienzo et al., 2019) was co-transfected with Myc–p62 in the
HEK293 FlpIn TRIM32-KO cells (Fig. 5E). Introduction of the
V591M mutation strongly impaired the p62 ubiquitylation, clearly
pointing towards aberrant ubiquitylation of p62 as a general
phenotype of LGMD2H. Western blotting of the Myc–p62
precipitates using an antibody against mono-and poly-ubiquitin
(FK2) verified that p62 ubiquitylation was strongly reduced upon
introduction of the LGMD2H disease mutations D487N and
V591M (Fig. 5E).
Next, we undertook mass spectrometry (MS) analysis to identify
which lysine residues in p62 were modified by TRIM32.
MS analysis of Myc–p62 immunoprecipitated from HEK293
TRIM32-KO cells co-transfected with Myc–p62 and EGFP–
TRIM32, or the TRIM32 disease mutants EGFP–TRIM32P130S
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and EGFP–TRIM32D487N, revealed that co-expression of wild-type
TRIM32 and the BBS11 disease mutant lead to ubiquitylation of
p62 at two lysine residues, K157 and K295 (Fig. 5F,G). No lysine
residue was found to be ubiquitylated when the LGMD2H disease
mutant was co-expressed with p62. To verify ubiquitylation on
these two residues, we introduced K157R or K295R single
and double mutations into p62. However, these mutations did not
abolish TRIM32 mediated mono-ubiquitylation (Fig. S3A,B).
Mono-ubiquitylation of endogenous p62 under ubiquitin stress is
reported to occur on p62K157 and p62K295, together with p62K313 and
p62K420 (Peng et al., 2017); in that study, mono-ubiquitylation of
p62 at those residues was proposed to inhibit formation of inactive
p62 dimers with ‘closed’ UBA domains, and thereby promote p62–
polyubiquitin interactions and autophagy activity. Hence, next we
established a p62K157R/K295R/K420R triple mutant and subjected it to
TRIM32, but still TRIM32 was able to mediate ubiquitylation of
Fig. 5. TRIM32 wild-type, but not the LGMD2H disease mutant, mono-ubiquitylates p62. (A) Western blot of two independent experiments from lysates of
HEK293 p62-KO cells co-expressingMyc–p62 with EGFP–TRIM32. Myc–p62was immunoprecipitated (IP) using aMyc-trap and precipitated p62 detected using
an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP antibody. * indicates mono-ubiquitylated Myc–p62 and EGFP–TRIM32.
(B) Myc–p62 was co-expressed with EGFP–TRIM32 and HA–ubiquitin, and with mCherry–USP2, where indicated, in the HEK293 p62-KO cell line. Myc–p62 was
immunoprecipitated using a Myc-trap and precipitated p62 detected using an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP
antibody. * indicates mono-ubiquitylated Myc–p62 and EGFP–TRIM32. (C) Myc–p62 was co-transfected with HA–Ub-K48 or HA–Ub-K63 in the HEK293
EGFP–TRIM32WT, EGFP–TRIM32P130S and EGFP–TRIM32D487N cell lines and expression induced by tetracyclin (1 µM) for 24 h. Myc–p62 was
immunoprecipitated using a Myc-trap and precipitated p62 detected using an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP
antibody. * indicates mono-ubiquitylated p62 and mono-ubiquitylated EGFP–TRIM32. (D) Myc–p62 was co-transfected with EGFP–TRIM32WT, EGFP–
TRIM32P130S or EGFP–TRIM32D487N in the HEK293 TRIM32-KO (#1) cell line. Myc-p62 was immunoprecipitated using a Myc-trap and precipitated p62
detected using an anti-Myc antibody. The EGFP–TRIM proteins were detected using an anti-GFP antibody. * indicates mono-ubiquitylated p62 and a high-
molecular-mass form of p62. (E) Myc–p62 was co-transfected with EGFP–TRIM32WT, EGFP–TRIM32P130S, EGFP–TRIM32D487N, EGFP–TRIM32V591M, or
EGFP–TRIM32 and mCherry–USP2 in the HEK293 TRIM32-KO (#1) cell line. Myc–p62 was immunoprecipitated using a Myc-trap and precipitated p62
detected using an anti-Myc antibody. Ubiquitin modification of p62 was detected using an antibody recognizing mono- and poly-ubiquitin (FK2) (lower panels).
The EGFP–TRIM proteins were detected using an anti-GFP antibody. * indicates mono-ubiquitylated p62 and a high-molecular-mass p62. In all blots, EGFP
indicates a control plasmid expressing only EGFP. (F) Schematic of p62 domain organization with location of the two lysine residues mapped to be ubiquitylated
by TRIM32 indicated above. ZZ, Zinc finger; NLS, Nuclear localization signal; EIR, E2-interacting region; LIR, LC3-interacting region; KIR, Keap1-interacting
region; UBA, Ubiquitin-binding domain. (G) Sequence of the p62 peptides found to be ubiquitylated by TRIM32 by MS analyses.
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p62 (Fig. S3B). Neither did introduction of the single K165R or
K313R mutations, or the four mutations p62K157R/K295R/K313R/K420R
impair ubiquitylation (Fig. S3B). These results indicate that
TRIM32-mediated ubiquitylation of p62 may happen at several
lysine residues. Interestingly, introducing the D69A mutation in
p62, which impairs its ability to undergo oligomerization (Lamark
et al., 2003), abolished the TRIM32-mediated mono-ubiquitylation
(Fig. S3A,B). This indicates that TRIM32 recognize and ubiquitylate
oligomerized p62, but not monomeric p62 molecules.
TRIM32 enhances the formation and turnover of p62 dots
To assess the impact of TRIM32 on the early autophagy events, we
assayedWIPI-dot formation in the TRIM32-KO cell lines compared
to wild-type cells in normal and starvation conditions. The
TRIM32-KO cells did not display any strong effect on the
formation of WIPI dots upon starvation (Fig. S3C). However,
confocal analysis of p62 in the TRIM32-KO cells showed that the
ability of p62 to form dots was significantly reduced (Fig. 6A,B).
This suggests that TRIM32-mediated mono-ubiquitylation of p62
stimulates the formation of p62 dots and its autophagic activity, in
line with previous studies of the roles of p62 ubiquitylation
(Conway and Kirkin, 2017; Lee et al., 2017; Peng et al., 2017). In
order to verify this further, we reconstituted the TRIM32-KO cell
lines with stably expressing Myc–TRIM32WT, Myc–TRIM32P130S
and Myc–TRIM32D487N, and monitored the formation of p62 dots
under normal conditions and upon inhibition of autophagy activity
by BafA1 treatment (Fig. 6C–F). Conclusively, we found that
reintroduction of TRIM32 in the TRIM32-KO cell line strongly
facilitated the formation of p62 dots. The number of p62 dots
was enhanced upon BafA1 treatment, indicating that TRIM32
augments the autophagic degradation of p62. Importantly,
reconstitution with the TRIM32P130S mutant facilitated p62 dot
formation nearly as efficiently as TRIM32WT, while reconstitution
with the TRIM32D487N mutant had no effect on p62 dot formation
(Fig. 6F). This clearly indicates that the E3 ligase activity of
TRIM32 is important for its regulatory role on p62. Interestingly, in
the TRIM32-KO cells reconstituted with Myc–TRIM32, most cells
displayed a diffuse cytoplasmic localization of TRIM32 –with only
a few cells containing TRIM32 dots. This was in contrast to the
HEK293 FlpIn cells stably overexpressing EGFP–TRIM32. Here,
wild-type TRIM32 and the BBS11 disease mutant were found to
form cytoplasmic dots in most cells. The more diffuse localization
pattern in the reconstituted TRIM32-KO cells suggests that high
expression levels of TRIM32 leads to the formation of cytoplasmic
dots. However, the dot formation seems to be dependent on
TRIM32 ubiquitylation, since the catalytic dead TRIM32 and the
LGMD2H disease mutation were mainly diffuse. Importantly,
BafA1 treatment of the reconstituted TRIM32-KO cells resulted in
formation of several cytoplasmic dots in the cells expressing
wild-type Myc–TRIM32 and the BBS11 disease mutant. Myc–
TRIM32WT and Myc–TRIM32P130S colocalized with p62 and
LC3B in these dots (Fig. 6E). In addition, Myc–TRIM32D497N
formed large cytoplasmic dots in some cells. However, these did not
colocalize with p62 and LC3B (Fig. 6E). To conclude, our data
show that TRIM32 can act as a positive regulator of p62
sequestration and degradation. Concomitantly, TRIM32 itself is a
p62 cargo, and thus will be directed to degradation by an active p62.
This creates a negative-feedback loop in the TRIM32–p62
interaction pathway (Fig. 6G). Hence, TRIM32-mediated
ubiquitylation of p62 seems to regulate its autophagic activity,
and thereby cellular proteostasis. One mechanism for the
LGMD2H disease can thus be explained by diminished p62
mono-ubiquitylation and lower p62-mediated autophagy activity,
resulting in impaired proteostasis.
DISCUSSION
Owing to constant mechanical stress, striated muscle proteins are
particularly prone to wear and tear, and require several protein
quality-control mechanisms to coordinate protein turnover and
removal of damaged proteins. Among these, ubiquitin signaling
and the autophagy-lysosomal pathways are important players
(reviewed in Dong and Cui, 2018). Here, we identified the E3
ubiquitin ligase TRIM32 as a substrate for the autophagy receptor
p62, which targets TRIM32 for degradation by selective autophagy.
Interestingly, TRIM32 was identified as one of the proteins rapidly
degraded upon starvation together with the autophagy receptor
proteins and certain other proteins (Mejlvang et al., 2018). However,
the disease mutant of TRIM32 associated with LGMD2H was not
degraded by autophagy. Furthermore, we found TRIM32 to bind
directly to p62 and mediate mono-ubiquitylation on several lysine
residues, among them p62K157 and p62K295. In addition, the TRIM32
LGMD2H disease mutant D487N bound directly to p62. However,
TRIM32D487N did not mediate ubiquitylation of p62. Mono-
ubiquitylation of p62 is proposed to enhance its autophagy receptor
potential, which is critical for maintaining proteostasis during cellular
stress (Peng et al., 2017). We found the formation of p62 bodies to be
reduced in TRIM32-KO cells, while it was strongly facilitated when
TRIM32WT or TRIM32P130S was reintroduced into the knockout
cells. Importantly, the LGMD2H disease mutation was not able to
rescue p62 dot formation in the TRIM32-KO cells. Together, this
implicates TRIM32 as a positive regulator of p62-mediated selective
autophagy, and suggests that one mechanism for development of
LGMD2H in TRIM32D487N muscle cells is due to reduced p62
autophagy activity leading to dysregulated cellular proteostasis.
Several TRIM proteins have been shown to modulate the
selective autophagy process (Chauhan et al., 2016; Fusco et al.,
2018; Jena et al., 2018; Kimura et al., 2015, 2016; Mandell et al.,
2014), and during the completion of this paper Di Rienzo and
co-workers (2019) identified TRIM32 as a regulator of ULK1
activity in atrophic muscle cells. Similarly to ULK1, p62 activity
during selective autophagy is regulated by ubiquitylation. TRIM21
and NEDD4 are reported to mediate ubiquitylation of p62K7 leading
to suppressed protein sequestration and induced inclusion body
autophagy (Lin et al., 2017; Pan et al., 2016). The E3 ligase
RNF166 ubiquitylates p62 at K91 and K189, facilitating the role of
p62 in xenophagy (Heath et al., 2016), while RNF26 ubiquitylates
p62 within the UBA domain facilitating TOLLIP interaction and
vesicular cargo sorting (Jongsma et al., 2016). Keap1–Cullin3
poly-ubiquitylates p62K420 leading to diminished p62 sequestration
and degradation activity (Lee et al., 2017). The E2 conjugating
enzymes UBE2D2 and UBE2D3 are found to bind directly to p62
via the E2-interacting region (EIR) (Fig. 5E), and mediate mono-
ubiquitylation of p62 at several lysine residues, among them K157,
K295 and K420, upon ubiquitin stress signaling (Peng et al., 2017).
This mono-ubiquitylation is proposed to relieve the inhibition of the
UBA domain in the p62 UBA dimer, leading to enhanced binding
and tethering of ubiquitylated cargoes to ATG8 proteins conjugated
to the phagophore (Conway and Kirkin, 2017). Here, we mapped a
direct interaction between TRIM32 and p62 that was independent of
the PB1 domain and the UBA domain, similar to the p62 interaction
with Keap1–Cullin3. However, Keap1–Cullin3 poly-ubiquitylated
p62 at K420 in the UBA domain, while we found TRIM32
to mediate mono-ubiquitylation of p62 at K157 and K295. The
Keap1–Cullin3-mediated ubiquitylation of p62 increases p62
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inclusion body formation and subsequent degradation, which is
proposed to be a mechanism for Keap1 to release the antagonistic
role of p62 and thereby dampen the NRF2-mediated response to
oxidative stress (Lee et al., 2017). On the other hand, mono-
ubiquitylation of p62 at several residues, including K157, K295 and
K420, enhances p62 body formation and p62-mediated autophagy
activity. This is proposed to be critical for homeostasis during
various cellular stresses.
We show that introduction of the LGMD2H disease mutation in
TRIM32 makes it unable to mono-ubiquitylate p62. The D487N
Fig. 6. See next page for legend.
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mutation located in the evolutionarily conserved NHL region of
TRIM32 does not inhibit binding to p62. Previously, the LGMD2H
mutant is reported to have impaired oligomerization and E3 ligase
activity and to display a more diffuse cytoplasmic localization than
TRIM32 WT and TRIM32P130S that are enriched in puncta/
aggregates in most cells (Locke et al., 2009). Also, the LGMD2H
disease mutants seem to be less expressed in muscle tissues from
affected patients (Servián-Morilla et al., 2019). Apart from that, the
molecular mechanisms of TRIM32 mutants causing the LGMD2H
and BBS11 diseases are far from being understood. It is not known
if the self-mono-ubiquitylation is important for activation of
TRIM32. Our results suggest that this may be the case, and also
that this mono-ubiquitylation is important for degradation of
TRIM32 via selective autophagy. Several reports connect
TRIM32 ubiquitylation activity to substrates whose deregulation
might influence the onset and progression of muscular dystrophy,
including actin, tropomyosin, troponins, α-actinin, dysbindin and
c-Myc (reviewed in Tocchini and Ciosk, 2015). Interestingly, p62 is
strongly implicated in chaperone-assisted selective autophagy
(CASA), which is essential for muscle maintenance (Arndt et al.,
2010). Dysregulated CASA resulted in Z-disk disintegration and
progressive muscle weakness. Here, we found that the TRIM32
mutation implicated in muscle dystrophy is unable to ubiquitylate
p62 at lysine residues that are linked to p62-mediated substrate
sequestration and autophagy activity. Furthermore, TRIM32-KO
cells displayed a reduced capacity for p62 sequestration upon
cellular stress induced by starvation. Hence, LGMD2Hmutations in
TRIM32 lead to impaired substrate ubiquitylation and impaired
degradation via p62-mediated selective autophagy, both important
players in cellular proteostasis. These findings contribute to the
understanding of the pathological mechanisms of LMGD2H.
The TRIM32-mediated ubiquitylation site p62K157 is located in
the zinc-finger (ZZ) domain (Fig. 5E), and this lysine residue is
evolutionarily conserved from zebrafish to human. Recently the
small non-coding RNA molecule Vault RNA1-1 was found to bind
to the ZZ domain of p62 and thereby modulate its dimerization and
autophagy activity (Horos et al., 2019). Hence, post-translational
modifications in the ZZ domain could impact such interactions and
thereby p62-mediated autophagy activity. The p62K295 site lies at
the border of the EIR and of a previously predicted PEST sequence.
Thus, it can be speculated that this modification can regulate
interactions with ubiquitin E2 enzymes, but also have an impact on
p62 stability. The latter can thereby explain the reduced expression
level of p62 detected in muscle tissue isolated from LGMD2H
patients (Servián-Morilla et al., 2019).
In addition to being a positive regulator of p62 activity, this study
revealed that TRIM32 is a p62 substrate in selective autophagy
(Fig. 6G). TRIM32 first facilitates p62-mediated autophagy activity.
This, after a certain period, leads to a reduced TRIM32 expression
caused by p62-mediated degradation. Diminished TRIM32
expression will in turn lead to declined p62 activity, creating a
negative-feedback loop. This negative-feedback mechanismmay be
a potential target for therapeutic intervention.
MATERIALS AND METHODS
Antibodies and reagents
The following primary antibodies were used: rabbit polyclonal antibody
for TRIM32 (Proteintech, 10326-1-AP; 1:2000); rabbit polyclonal anti-GFP
(Abcam, ab290; 1:5000); mouse monoclonal Myc-Tag (9B11) [Cell
Signaling Technologies, #2276; 1:2000 for western blotting (WB), 1:200
for immunofluorescence (IF)]; rabbit polyclonal anti-LC3B (Sigma, L7543;
1:1000 for WB, 1:500 for IF); rabbit polyclonal antibody for phospho-
4E-BP1 (Cell Signaling Technologies, #9451; 1:1000); rabbit polyclonal
anti-actin (Sigma, A2066; 1:1000); mouse monoclonal anti-p62 lck ligand
(BD Biosciences, 610833; 1:2000); guinea pig polyclonal anti-p62 (Progen,
GP62-C; 1:2000); mouse monoclonal anti-ubiquitin (FK2) (BIOMOL,
PW8810, 1:1000) and mouse monoclonal anti-PCNA (DAKO, M0879;
1:1000). The following secondary antibodies were used: horseradish-
peroxidase (HRP)-conjugated goat anti-rabbit-IgG (BD Biosciences,
554021; 1:2000); HRP-conjugated goat anti-mouse-Ig (BD Biosciences,
554002; 1:2000); and HRP-conjugated anti-biotin antibody (Cell Signaling
Technologies, #7075; 1:2000). The following fluorescent secondary
antibodies were used: Alexa Fluor® 488-conjugated goat anti-mouse-IgG
(Life Technologies, A-11029; 1:1000); Alexa Fluor® 488-conjugated goat
anti-rabbit-IgG (Life Technologies, A-11008; 1:1000); Alexa Fluor® 555-
conjugated goat anti-rabbit-IgG (Life Technologies, A-11008; 1:5000);
Alexa Fluor® 555-conjugated goat anti-guinea-pig-IgG (Life Technologies,
A-21435; 1:1000); Alexa Fluor® 555-conjugated goat anti-mouse-IgG (Life
Technologies, A-21424; 1:1000); Alexa Fluor® 647-conjugated goat anti-
guinea pig IgG (Life Technologies, A-21450; 1:1000). The reagents used
were: BafA1 (Sigma, B1793); MG132 (Sigma, C2759); tetracycline
(Sigma, #87128); doxycycline (Sigma, D9891); and Hanks balanced salt
solution (Sigma, H8264).
Cell culture and transfections
HeLa (ATCC, CCL2), HEK293 (ATCC, CRL-1573) and Hek293 T-Rex
(Thermo Fisher Scientific, R714-07) cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma, D6046) with 10% fetal bovine
serum and 1% streptomycin-penicillin (Sigma, P4333). Hek FlpIn T-Rex
cells with integrated TRIM32, TRIM32 C44S, TRIM32 P130S or TRIM32
D487N were grown in the same medium with additional selection
marker antibiotics, 200 µg/ml hygromycin B (Invitrogen, #10687010) and
7.5 µg/ml blasticidin (Gibco, A1113903). Sub-confluent cells were
transfected using TransIT-LT1 (Mirus, MIR2300) or Metafectene Pro
(Biontex, T040) following the manufacturer’s instructions. All cell lines
were routinely tested for mycoplasma contamination.
Fig. 6. TRIM32 enhances the formation and turnover of p62 dots.
(A) Immunostaining of endogenous p62 in HEK293 FlpIn cells and the two
TRIM32 KO clones under normal (FM) and starvation (SM) conditions
(HBSS 2 h). Scale bars: 10 µm. (B) Quantification of p62 dots in the two
TRIM32 KO clones and the HEK293 FlpIn wild type cell line under normal (FM)
and starvation (SM) (HBSS 2 h) conditions using the Volocity software
(PerkinElmer). Each graph represents the mean±s.d. of the relative number of
p62 dots per cell (normalized to the value for FM in wild-type cells). The results
are from three independent experiments each including ∼100 cells per
condition. P-values were obtained using Student’s t-test. (C) Immunostaining
of endogenous p62 in the TRIM32 KO (#1) cell line and TRIM32 KO (#1) cells
reconstituted with stable expression of Myc–TRIM32WT, Myc–TRIM32P130S or
Myc–TRIM32D487N as indicated. The cells are grown in FM with BafA1 (2 µM,
7 h). Scale bars: 10 µm. (D) Western blot showing the expression of
Myc–TRIM32, Myc–TRIM32P130S and Myc–TRIM32D487N in the reconstituted
HEK293 TRIM32-KO cell lines, grown in FM. * indicates mono-ubiquitylated
TRIM32. (E) Upper panels show immunostaining of Myc–TRIM32WT, p62 and
LC3B in the reconstituted HEK293 TRIM32-KO cells grown in normal medium
supplemented with BafA1 (2 µM) for 7 h. The circles exemplify colocalization of
all three proteins in BafA1 dots. The lower panels show merged images of
similar immunostainings in the TRIM32-KO cell line reconstituted with Myc–
TRIM32P130S or Myc–TRIM32D487N. Images were obtained using a ZEISS780
confocal laser scanning microscope, and the colocalization line plots to the
right obtained using the ZEN software. Scale bars: 10 µm. (F) Quantification of
p62 dots in the cell lines represented in C, under normal (FM) and normal plus
BafA1 (7 h) conditions, and starvation (SM) (HBSS 4 h) and starvation plus
BafA1 conditions. The graphs represent the mean±s.d. of the relative number
of p62 dots per cell (normalized to the value for FM in TRIM32-KO cells)
quantified using Volocity software (PerkinElmer). The results are from three
independent experiments each including n>100 cells per condition. *P<0.05,
**P<0.005, ***P<0.0005; n.s., not significant (Student’s t-test). (G) A model
depicting the roles of TRIM32 both as a p62 activator and a p62 substrate
in selective autophagy. ZZ, zinc finger; UBA, ubiquitin-binding domain;
Ub, Ubiquitin.
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All plasmids used in this study are listed in Table S1. Plasmids were made by
conventional restriction enzyme-based cloning or by use of the Gateway
recombination system (Thermo Fisher Scientific). Gateway LR reactions
were performed as described in the instruction manual. Point mutation was
carried out using the site-directed-mutagenesis kit from Stratagene. PCR
and sequencing oligonucleotides (Table S2) were ordered from Thermo
Fisher Scientific. All plasmids were verified by restriction enzyme digestion
and DNA sequencing (BigDye, Applied Biosystems, 4337455). All TRIM
proteins were cloned into the pDest mCherry-EYFP (Bhujabal et al., 2017)
double tag vector.
Recombinant protein production and GST-pulldown analysis
GST or GST-tagged proteins were expressed in Escherichia coli strain
SoluBL21 (Genlantis, #C700200). Protein expression was induced by
treating overnight bacterial culture with 50 µg/ml isopropyl β-D-1-
thiogalactopyranoside (IPTG). GST or GST fusion proteins were purified
and immobilized on glutathione–Sepharose 4 Fast Flow beads (GE Healtcare,
17-5132-01). Myc-tagged proteins were in vitro translated using the TNT T7
reticulocyte Lysate system (Promega, #14610) in the presence of
[35S]methionine. In vitro translated protein or total cell lysate was pre-
incubatedwith 10 µl glutathione–Sepharose beads and 100 µl ofNETNbuffer
(50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 0.5% Nonidet
P-40) with cOmplete Mini EDTA-free protease inhibitor mixture tablets
(Roche Applied Science, 11836170001) for 1 h at 4°C to reduce unspecific
binding. Pre-incubated lysate was then incubated with the immobilized GST
fusion protein for 2 h at 4°C. Beads were washed five times with NETN
buffer, boiled with 2× SDS gel loading buffer (125 mMTris-HCl pH 7.5, 4%
SDS, 0.04%Bromophenol Blue, 8% sucrose and 100 mMdithiolthreitol) and
subjected to SDS-PAGE. Gels were stained with Coomassie Brilliant Blue
R-250 Dye (Thermo Fisher Scientific, #20278) to visualize GST fusion
proteins and then vacuum dried. Signals from 35S-labeled proteins were
detected with a Fujifilm bioimaging analyzer BAS-5000 (Fujifilm).
Immunoblotting and immunoprecipitation
Cells were seeded in 6-cm plates and treated as indicated. Cells were lysed in
1× SDS buffer (50 mM Tris-HCl pH 7.4, 2% SDS and 10% glycerol)
supplementedwith 200 mMdithiothreitol (DTT, Sigma, #D0632) and heated
at 100°C for 10 min. Protein concentration was measured using the Pierce
BCA protein assay kit (Thermo Fisher Scientific, #23227). Equal amounts of
protein were resolved by SDS-PAGE and transferred to nitrocellulose
membrane (Sigma, GE10600003). The membrane was stained with Ponceau
S (Sigma, P3504), blocked with 5% non-fat dry milk in 1% TBS-T [0.2 M
Tris-HCl pH 8, 1.5 M NaCl and 0.05% Tween 20 (Sigma, P9416)] and then
incubated with indicated primary antibodies for 24 h. The membrane was
washed three times for 10 min each with TBS-T followed by incubation with
secondary antibody for 1 h. The membrane was washed three times for
10 min and analyzed by enhanced chemiluminescence using the ImageQuant
LAS 4000 (GE Lifescience). For immunoprecipitation, cells were lysed in
modified radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris
pH 7.5; 150 mM NaCl; 1 mM EDTA; 1% NP40; 0.25% Triton-X-100)
supplemented with cOmplete Mini EDTA-free protease inhibitor cocktail
tablets (Roche, #11836170001) and phosphatase inhibitor cocktail (Merck
Millipore, #524625) by shaking at 4°C for 30 min. The cell lysate was
centrifuged at 10,000 g for 10 min. The resulting supernatant was incubated
with antibody to endogenous protein for endogenous immunoprecipitation or
with Myc-TRAP (Chromotek, yta-20) for cells stably expressing, or
transiently transfected, with Myc-tagged proteins. They were washed five
times in RIPA buffer before boiling in 2× SDS gel loading buffer. This was
followed by protein identification by immunoblotting as previously
described but on Immobilon-FL PVDF membrane (Millipore, IPFL00010),
blocked with Odyssey® blocking buffer (PBS) (LI-COR Biosciences,
#927-40000) and scanned on Odyssey CLx Imager (LI-COR).
Mass spectrometry
Cells were directly lysed in lysis buffer (Myc-TRAP®_A; Chromotek)
supplemented with cOmplete Mini EDTA-free protease inhibitor (Roche),
5 mM NAM (N-Arachidonylmaleimide; Sigma) and 10 mM NEM
(N-ethylmaleimide; Sigma). Immunoprecipitation of Myc-tagged proteins
was performed according to the supplier’s protocol (Chromotek). The
samples were fractionated by SDS-PAGE followed by SimplyBlue™
SafeStain (Thermo Fisher Scientific) staining. The lanes representing
proteins of molecular masses within 55–80 kDawere cut from the gel. In-gel
trypsin digestion was performed before analysis by high-performance liquid
chromatography–tandem mass spectrometry (HPLC-MS/MS). Gel pieces
were subjected to in-gel reduction, alkylation and tryptic digestion using
6 ng μl−1 trypsin (V511A; Promega). OMIX C18 tips (Varian) were used
for sample cleanup and concentration. Peptide mixtures containing 0.1%
formic acid were loaded onto a Thermo Fisher Scientific EASY-nLC1200
system. Samples were injected to a trap column (Acclaim PepMap
75 μm×2 cm, C18, 3 μm, 100 Å; Thermo Fisher Scientific) for desalting
before elution to the separation column (EASY-Spray column, C18, 2 μm,
100 Å, 50 μm, 50 cm; Thermo Fisher Scientific). Peptides were fractionated
using a 4–40% gradient of increasing amounts of 80% acetonitrile in water
over 60 min at a flow rate of 300 nl/min. The mobile phases contained 0.1%
formic acid. Separated peptides were analyzed using an Orbitrap Fusion
Lumos mass spectrometer. The mass spectrometer was operated in a data-
dependent mode with the precursor scan in the orbitrap over the range m/z
350–1500. The most-intense ions were selected for electron-transfer
dissociation (ETD) or collision-induced dissociation (CID) fragmentation
using 3 s between each master scan. Dynamic exclusion was set to 30 s. The
Orbitrap AGC target was set to 4E5, and the MS2 scans in the Ion Trap were
set to 1E4 with maximum injection times 50 and 100 ms, respectively.
Precursor ions with charge 3+ in them/z range 350–650 and 4+ or 5+ ions in
the m/z range 350–900 were fragmented with ETD. All ions with 6+ or
higher were also fragmented using ETD. The rest of the precursor ions were
fragmented using CID. Protein identification and post-translational
modification mapping was performed using the Proteome Discoverer 2.2
software (Thermo Fisher Scientific).
Immunostaining and fluorescence confocal microscopy
Subconfluent cells grown in 24-well plates on coverslips (VWR, #631-
0150) coated with fibronectin (Sigma, F1141) and treated as indicated. They
were fixed in 4% paraformaldehyde for 20 min to allow visualization of
acidic structures after the staining procedure. The cells were then
permeabilized with methanol at room temperature for 5 min, blocked in
5% goat serum in PBS or 5% BSA in PBS and incubated at room
temperature with a specific primary antibody followed by Alexa Fluor 488-,
555- or 647-conjugated secondary antibody and DAPI. Confocal images
were obtained using a 63× NA 1.4 oil immersion objective on an LSM780/
LSM800 system. Quantification of p62 dots were performed using the
Volocity software (Perkin Elmer) on 10 images per condition, in three
independent experiments. Each image contained 10–20 cells, and was
generated using the z-stack function in the ZEN software (Zeiss). The line-
profile tool in the ZEN software was exploited to plot colocalization of
EGFP–TRIM32 and immunostained p62 and LC3B. Quantification of cells
containing red only dots in the double-tagged screen was done manually by
two independent researchers in three independent experiments.
Generation of TRIM32- and p62-KO HEK293 FlpIn cell lines
To generate a knockout cell line for TRIM32, the CRISPR/Cas9 system was
exploited. The knockout was generated as described by Ran et al. (2013).
Guide RNAs (gRNA) as described in Table S2were annealed and ligated into
the vector pSpCas9(BB)-2A-GFP (PX458) (Addgene, #48138) using BbsI
restriction sites. Subconfluent Hek293 FlpIn T-Rex cells were transfected
with the targeting plasmids using Metafectene Pro (Biontex, T020). EGFP-
positive cells were sorted by FACS and plated into 96-well plates at 3 days
post transfection. Single colonies were expanded up to 12-well plates and
knockout validated by immunoblotting. Confirmed knockout clones were
further screened by genomic sequencing. The targeted genomic regions were
amplified by PCR using the primers TRIM32PCRfwand TRIM32PCRrv, or
p62 PCRfwand p62PCRrv (Table S2) and the resulting PCR products ligated
into the pGEM-T-EASy vector (Promega, A3600). Sequencing were
conducted for at least three clones for each PCR product.
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Reconstitution of TRIM32-KO cell lines
The TRIM32-KO cell lines were transduced using the lentiviral-based
GATEWAY destination vector pCDH-EF1a-Myc-IRES conferring
puromycine resistance. This vector enables constitutive expression of
Myc–TRIM32WT, Myc–TRIM320P130S or Myc–TRIM32D487N under
control of an EF1α promoter.
Generation of stable cell lines
Stable cell lines were generated using the FlpIn T-Rex system (Thermo
Fisher Scientific, R71407). cDNAs were PCR amplified and ligated into the
inducible FlpIn expression vector, pDest-EGFP-Flp-In (Alemu et al., 2012).
FlpIn T-Rex cells were then co-transfected with the cDNA-containing FlpIn
expression vector and the FlpIn recombinase vector pOG44 in the ratio of
1:3. Cells were selected by treatment with 200 µg/ml hygromycin B
(Invitrogen, #10687010) and 7.5 µg ml−1 blasticidin (Gibco, A1113903),
and protein expression verified by induction with tetracycline (Sigma,
#87128) or doxycycline (Sigma, D9891).
Flow cytometry
Hek293 FlpIn TRIM32WT, P130S and D487N cells in 12-well plates were
trypsinized (Sigma, T4049) and passed through cell strainer caps (BD
Biosciences, 352235) to obtain single-cell suspensions. Cells were analyzed
on a FACSAria cell sorter running FACSDiva software version 5.0 (BD
Biosciences) using the blue laser for excitation of GFP. GFP fluorescence
was collected through a 530/30 nm bandpass filter in the E detector. Data
was collected from a minimum of 10,000 singlet events per tube, and the
median GFP-A value was used for quantification. All bar graphs show the
mean±s.d. of the GFP-A median values from three independent
experiments.
Proximity ligation assay
Subconfluent HEK293 FlpIn EGFP-TRIM32 cells were fixed with 4%
paraformaldehyde. Colocalization of EGFP–TRIM32 and endogenous p62
was detected by performing a Duolink® PLA (Sigma; DUO92101)
according to the manufacturer’s protocol. The primary antibodies rabbit
polyclonal anti-GFP (1:2000, Abcam, ab290) and mouse monoclonal anti-
p62 lck ligand (1:200, BD Biosciences, 610833) were incubated at 4°C
overnight. The signals were detected using a 63× NA 1.4 oil immersion
objective on an LSM780 system. Quantification of dots was performed
using the Volocity software (Perkin Elmer) on 10 images per condition, in
three independent experiments. Each image contained 10–20 cells, and was
generated using the z-stack function in the ZEN software (Zeiss).
Cell proliferation assay
Hek FlpIn TRIM32 KO Clone #1, KO Clone #2 and FlpIn T-Rex control
cells were seeded with four different concentrations (2000, 4000, 6000 and
8000 cells) in 100 μl DMEM (Sigma, D6046) on E-Plate L16 PET readers
(ACEA Biosciences Inc, #2801185). xCELLigence® Real-Time Cell
Analysis (RTCA) (ACEA Biosciences) were used to measure the cell
proliferation over a time of 96 h with recording at 1 h intervals.
Statistics
All experiments were repeated at least three times, unless otherwise
specified. Error bars represent the s.d. or s.e.m. as indicated in figure
legends, and two-sided unpaired, homoscedastic Student’s t-tests were
performed to assess significant differences between populations. Replicates
were not pooled for statistical analyses. *P<0.05, **P<0.005 and
***P<0.0005; n.s. denotes not signififcant (P>0.05). Sample sizes are
denoted in the figure legends.
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Several members of the tripartite motif (TRIM) family proteins are identified as regulators of 
autophagy. They associate with autophagy factors and serve as platforms for recruitment of 
activated ULK1 and BECLIN1, promoting phagophore formation and expansion. TRIM32 acts 
both as regulator and cargo of the autophagy receptor p62/SQSTM1, and is identified as an 
activator of ULK1 in atrophic muscle cells. Mutations in the C-terminal NHL domains of 
TRIM32 is linked to Limb-Girdle-Muscular-Dystrophy 2H, while a mutation in its BBox causes 
Bardet-Biedl-syndrome type 11. The autophagy receptor NDP52 is important for recruiting 
ULK1 and the autophagic machinery to damaged mitochondria. Here we show that TRIM32 is 
a potential cargo and a regulator of NDP52. TRIM32 mediates ubiquitylation of NDP52. 
Reintroduction of TRIM32 in TRIM32 KO cells leads to ULK1 stabilisation and increased 
TBK1 autophosphorylation. Conversely, the LGMD2H mutated version of TRIM32 does not 
affect NDP52 and ULK1 expression, or facilitate TBK1 autophosphorylation.  Moreover, our 
data show that mitophagy is impaired in TRIM32 KO cells compared to normal cells and 
TRIM32 KO cells reconstituted with TRIM32. Collectively, this study identify TRIM32 as a 
potential regulator of NDP52, ULK1 and TBK1, facilitating selective degradation of 
















Selective autophagy is a catabolic process that plays an important role in the maintenance of 
cellular homeostasis. It identifies and recycles unwanted or dysfunctional components, such as 
protein aggregates, damaged mitochondria, ferritin and intracellular pathogens (Rogov et al., 
2014). In this way, selective autophagy protects from diseases such as cancer, 
neurodegeneration, and uncontrolled infections (Levine and Kroemer, 2019). Recent studies 
have revealed that selective autophagy is induced by cargo receptors that bind to their substrates 
and orchestrate the autophagy machinery to initiate phagophore assembly (Vargas et al., 2019, 
Turco et al., 2019, Agudo-Canalejo et al., 2020, Fujioka et al., 2020). The most extensive 
studied cargo receptors are the family of sequestosome-like-receptors (SLRs); sequestosome-1 
(p62/SQSTM1), nuclear dot protein 52 kDa (NDP52); neighbor of BRCA1 gene 1 (NBR1); 
Optineurin and Tax1-binding protein 1 (Tax1BP1) (Johansen and Lamark, 2011, Rogov et al., 
2014). The SLRs seem to have at least partly overlapping functions, in which they recognize 
ubiquitylated cargo via their ubiquitin binding domains, oligomerize and interacts directly with 
the autophagy machinery via FIP200 and the ATG8s (Khaminets et al., 2016, Turco et al., 
2019).  
One of the main cargo receptors of damaged mitochondria is NDP52, which is recruited 
to depolarized mitochondria by the ubiquitin ligase PINK1 (Lazarou et al., 2015). Tethering of 
NDP52 to the mitochondria leads to positioning of the autophagy initiation complex including 
FIP200 and ULK1 on the mitochondria (Vargas et al., 2019).  The process is facilitated by 
TBK1, and leads to activation of ULK1 and induction of mitophagy. A similar scenario takes 
place upon cellular infection of cytosol-invading bacteria (Ravenhill et al., 2019). Here, NDP52 
recognizes Galectin-8 on the damaged bacterial-containing vacuole. This leads to recruitment 
of ULK1 and TBK1 via the ULK1 complex subunit FIP200 and the TBK1 adaptor SINTBAD, 
which promotes phagophore formation and xenophagy 
Several members of the tripartite motif (TRIM) protein family of E3 ligases function as 
autophagy receptors, acting in precision autophagy (Kimura et al., 2015). They recruit the 
autophagy initiation complexes ULK1 and PI3Kc1 to their substrates to facilitate autophagic 
degradation (Mandell et al., 2014). TRIM proteins are characterized  by a RING-domain which 
constitutes the E3 ligase activity, one or two BBox domains, a coiled-coil domain and a variable 
C-terminal region (Reymond et al., 2001). The C-terminal domain of TRIM32 encompasses six 
NHL-repeats which are involved in dimerization and cargo recognition (Koliopoulos et al., 
2016). Genetic mutations in the NHL domains cause the muscle disorder Limb Girdle Muscular 
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Dystrophy 2H (LGMD2H), and is associated with impaired auto-oligomerization and self-
ubiquitylation, and reduced TRIM32 expression level (Zhao et al., 2019, Locke et al., 2009). A 
missense-mutation in the BBox domain results in the disease Bardet-Biedl syndrome 11 
(BBS11) which has a pleiotropic phenotype (Chiang et al., 2006). A recent study demonstrates 
that TRIM32 activates ULK1 and thereby facilitates autophagy in muscle cells upon atrophy 
induction (Di Rienzo et al., 2019). TRIM32 was linked to ULK1 via the autophagy cofactor 
AMBRA1. Importantly, the LGMD2H disease mutant of TRIM32 was unable to associate with 
ULK1 and induce autophagy. In another study, we show that TRIM32 mediates ubiquitylation 
of p62/SQSTM1, leading to enhanced p62/SQSTM1 sequestration and degradation (Overa et 
al., 2019). 
Here we show that TRIM32 downregulates the protein levels of all SLR proteins, 
without affecting their expression at the RNA level. Conversely, autophagic degradation of 
TRIM32 is dependent on the SLRs, and beside p62/SQSTM1 both NDP52 and NBR1 are able 
to direct TRIM32 to degradation in the lysosome. We reveal that TRIM32 interacts directly 
with and ubiquitylates NDP52. Furthermore, mitophagy induced by co-overexpression of 
FKBP8 and LC3A is significantly reduced in TRIM32 KO cells compared to normal HEK293 
cells. Reintroduction of myc-TRIM32 into the KO cells restored the mitophagy activity.  In line 
with this, TRIM32 enhances ULK1 stability and TBK1 autophosphorylation, both shown to 
facilitate NDP52 mediated mitophagy. 
 
MATERIALS AND METHODS 
Antibodies and reagents 
The following primary antibodies were used: rabbit polyclonal antibody for TRIM32 
(Proteintech, 10326-1-AP); rabbit polyclonal anti-GFP (Abcam, ab290); mouse monoclonal 
Myc-Tag (9B11) (Cell Signalling, #2276); rabbit polyclonal anti-LC3B (Sigma, L7543); rabbit 
polyclonal anti-Actin (Sigma, A2066); mouse monoclonal anti-p62 lck ligand (BD Biosciences, 
610833); rabbit polyclonal anti-CALCOCO2/NDP52 (Sigma, HPA023195); rabbit polyclonal 
anti-TAX1BP1 (Sigma, HPA024432); mouse monoclonal mono- and polyubiquitinylated 
conjugates FK2 (Enzo, BML-PW8810); rabbit monoclonal anti-ULK1 (D8H5) (Cell 
Signalling, #8054);  rabbit polyclonal anti-GABARAP (MBL, PM037); rabbit monoclonal anti-
TBK1 (Millipore, 108A429); rabbit monoclonal anti-Phsopho-TBK1/NAK (Cell Signalling, 
#5483); mouse monoclonal anti-NBR1 (Santa Cruz, sc-130380). The following secondary 
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antibodies were used: Horseradish-peroxidase (HRP)-conjugated goat anti-rabbit IgG (BD 
Biosciences, 554021); HRP-conjugated goat anti-mouse Ig (BD Biosciences, 554002); HRP-
conjugated anti-Biotin antibody (Cell Signalling, #7075); IRDye 800CW Goat anti-Rabbit IgG 
(Li-Cor, 925-32211); IRDye 680RD Goat anti-Mouse IgG (Li-Cor, 925-68070). The following 
fluorescent secondary antibodies were used: Alexa Fluor® 488-conjugated goat anti-mouse IgG 
(Life Technologies, A-11029); Alexa Fluor® 555-conjugated goat anti-rabbit IgG (Life 
Technologies, A-11008). The reagents used were Hanks Balanced salt solution (Sigma, 
H8264).  
Plasmids 
Plasmids used in this study are listed in Table 1.  
Table 1: Plasmids used in this study 
pDest Myc (Lamark et al., 2003) 
pDest Myc TRIM32 (Overå et al., 2019) 
pDest Myc TRIM32 D487N (Overå et al., 2019) 
pDest Myc TRIM32 P130S (Overå et al., 2019) 
pDest Myc NDP52 (Abudu et al., 2019) 
pDest mCherry-EYFP TRIM32 (Overå et al., 2019) 
pDest EGFP-C1 (Lamark et al., 2003) 
pDest EGFP TRIM32 (Overå et al., 2019) 
pDest EGFP TRIM32 D487N (Overå et al., 2019) 
pDest EGFP TRIM32 P130S (Overå et al., 2019) 
pDest EGFP ULK1 
pDest Myc FKBP8 
mCherry-EGFP-OMP25-TM 
pDest-3XFlag-LC3A 
(Alemu et al., 2012) 
(Bhujabal et al., 2017) 
(Wang et al., 2015) 
(Bhujabal et al., 2017) 
 
Cell culture and transfections 
HeLa (ATCC, CCL2), HEK293 (ATCC, CRL-1573), HEK293 FlpIn T-Rex (ThermoFisher, 
R714-07), HEK293 FlpIn TRIM32 KO (Overå et al., 2019); HEK293 FlpIn TRIM32 KO myc-
TRIM32WT (Overå et al., 2019) , HEK293 FlpIn TRIM32 KO myc-TRIM32P130S (Overå et al., 
2019), HEK293 FlpIn TRIM32 KO myc-TRIM32D487N (Overå et al., 2019), HeLa Penta KO 
(Lazarou et al., 2015), HeLa Penta KO EGFP-NDP52 and HeLa Penta KO EGFP-NBR1 cells 
were cultured in Dulbecco’s modified eagle’s medium (DMEM) (Sigma, D6046) with 10% 
fetal bovine serum and 1% streptomycin-penicillin (Sigma, P4333). Sub-confluent cells were 
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transfected using TransIT-LT1 (Mirus, MIR2300) or Metafectene Pro (Biontex, T040) 
following the manufacturer’s instructions.  
Recombinant protein production and GST pulldown analysis 
GST or GST-tagged proteins were expressed in Escherichia coli strain SoluBL21 (Genlantis, 
#C700200). Protein expression was induced by treating overnight bacterial culture with 
50µg/ml Isopropyl β-D-1-thiogalactopyranoside (IPTG). GST or GST fusion proteins were 
purified and immobilized on Glutathione-Sepharose 4 Fast Flow beads (GE Healtcare, 17-
5132-01). Myc-tagged proteins were in vitro translated using the TNT T7 reticulocyte Lysate 
system (Promega, #14610) in the presence of 35S-methionine. In vitro translated protein or total 
cell lysate was pre-incubated with 10µl glutathione sepharose beads and 100µl of NETN buffer 
(50mM Tris pH 8.0; 150mM NaCl; 1 mM EDTA; 0.5% Nonidet P-40) with cOmplete Mini 
EDTA-free protease inhibitor mixture tablets (1 tablet/10ml) (Roche Applied Science, 
11836170001) for 1hr at 4°C to reduce unspecific binding. Pre-incubated lysate was then 
incubated with the immobilized GST fusion protein for 2hrs at 4°C. Beads were washed five 
times with NETN buffer, boiled with 2xSDS gel loading buffer (125mM Tris pH 7.5; 4% SDS; 
0.04% bromphenol blue; 8% sucrose; 100mM dithiolthreitol) and subjected to SDS-PAGE. 
Gels were stained with Coomassie Brilliant Blue R-250 Dye (Thermofisher scientific, #20278) 
to visualize GST fusion proteins and then vacuum-dried. Signals from 35S-labelled proteins 
were detected by a Fujifilm bioimaging analyzer BAS-5000 (Fujifilm).  
Western Blotting 
Cells were seeded in 6 well dishes and treated as indicated. Cells were lysed in 1xSDS buffer 
(50mM Tris pH 7.4; 2% SDS; 10% Glycerol) supplemented with 200mM dithiothreitol (DTT, 
Sigma, #D0632) and heated at 100°C for 10 minutes. Protein concentration was measured using 
the Pierce BCA Protein Assay Kit (Thermofisher Scientific, #23227). Equal amounts of protein 
were resolved by SDS-PAGE and transferred to nitrocellulose membrane (Sigma, 
GE10600003). The membrane was stained with Ponceau S (Sigma, P3504), blocked with 5% 
non-fat dry milk in 1% TBS-T (0.2M Tris pH 8; 1.5M NaCl and 0.05% Tween20 (Sigma, 
P9416)) and then incubated with indicated primary antibodies for 24h. The membrane was 
washed three times for 10 minutes each with TBS-T followed by incubation with secondary 
antibody for 1h. The membrane was washed three times for 10 minutes and analyzed by 





Subconfluent HEK293 FlpIn TRIM32 KO cells seeded in 6-well dishes were transiently co-
transfected with pDEST myc-NDP52 (500 ng) and pDEST EGFP-TRIM32WT (500 ng), pDEST 
EGFP-TRIM32P130S(500 ng), or pDEST EGFP-TRIM32D487N(500 ng) using Metafecten Pro 
(Biontex, T040). Subconfluent TRIM32 KO cells and reconstituted TRIM32 KO with Myc-
TRIM32 WT, Myc-TRIM32 P130S or Myc-TRIM32 D487N cells were transfected with 
pDEST EGFP-ULK1 (500 ng) using Metafectene Pro. One day post transfection, the cells were 
lysed in modified Radioimmunoprecipitation assay (RIPA) buffer (50mM Tris pH 7.5; 150mM 
NaCl; 1mM EDTA; 1% NP40; 0.25% Triton-X-100) supplemented with cOmplete Mini 
EDTA-free protease inhibitor cocktail tablets (Roche, #11836170001) and phosphatase 
inhibitor cocktail (Merck Millipore, #524625) by shaking at 4°C for 30 min. The cell lysate was 
centrifuged at 10.000 x g for 10 min. The resulting supernatant was incubated with Myc-TRAP 
(Chromotek, yta-20) or GFP-TRAP (Chromotek, gta-20). They were washed five times in RIPA 
buffer before boiling in 2X SDS gel loading buffer. This was followed by protein identification 
by immunoblotting as previously described but on Immobilon-FL PVDF membrane (Millipore, 
IPFL00010), blocked with Odyssey® blocking buffer (PBS) (LI-COR Biosciences, #927-
40000) and scanned on Odyssey CLx Imager (LI-COR).   
Immunostaining and Fluorescence confocal microscopy 
Subconfluent cells were grown on coverslips (VWR, #631-0150) coated with Fibronectin 
(Sigma, F1141) and treated as indicated. They were fixed in 4% formaldehyde for 20min at 
R.T., permeabilized with methanol at RT for 5min, blocked in 5% goat serum/PBS or 
5%BSA/PBS and incubated at room temperature with a specific primary antibody followed by 
Alexa Fluor 488 or 555 conjugated secondary antibody and DAPI. Confocal images were 
obtained using a 63x/NA1.4 oil immersion objective on an LSM780 system or LSM800 system 
and the ZEN software (Zeiss). Quantification of cells containing red only dots in the mCherry-
EYFP-double tag assay was done manually in three independent experiments. 
RT-PCR/QPCR 
Total RNA was extracted from HEK 293T FlpIn cells TRIM32 KO cells reconstituted with 
TRIM32 WT, TRIM32 P130S mutant and TRIM32 D487N mutant using the Gene Elute 
Mammalian Total RNA Miniprep kit (Sigma). The RNA quality was checked by 260/280 nm 
absorption using a NanoDrop 2000 spectrophotometer (Thermo Fisher scientific). First-strand 
cDNA was prepared using the High Capacity RNA-to-cDNA Kit according to the 
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manufacturer’s instruction. Amplification was performed with SYBR green kit FastStart 
Essential DNA Green Master (Roche) in a 20 μl reaction. Reactions were run with the following 
cycling parameters temperatures (58 degrees aneling temperature for Actin, GAPDH, NDP52 
and Optineurin and 60 for p62 and NBR1) and 45 cycles by Lightcycler 96 (Roche). All 
reactions were performed in triplicate. Relative expression levels were calculated after 
correction for the expression of Actin and GAPDH as an endogenous reference. The primer 
sequences used for p62 fw and reverse were 5’-ggagaagagcagctcacagcca-3’ and 5’-
ccttcagccctgtgggtccct-3’, NBR1 forward and reverse 5’-ggaagcagaagaagacctgagtg-3' and 5’-
ccagagtctgtgaggtcgtgag-3’, and NDP52 fw and reverse 5’-accatggaggagaccatcaa-3’ and  5’-
ttctggacggaattggaaag-3’, and standards (Actin and GAPDH) fw and reverse Actin 5’-
tgacggtcaggtcatcactatcggcaatga-3’ and 5’-ttgatcttcatggtgataggagcgagggca-3’, gapdh 5’-
ggcactgtcaaggctgaaaacg-3’ and 5’-ggagatgagatgataccacgcttag-3’. 
Mitophagy assay 
HEK293 FlpIn T-Rex cells, TRIM32 KO cells and TRIM32 KO cells reconstituted with Myc-
TRIM32 were seeded on fibronectin-coated coverslips two days before transient co-transfection 
with the plasmids mCherry-EGFP-OMP25-TM (100 ng), pDEST-3xFlag-LC3A (100 ng) and 
pDEST-myc-FKBP8 (100 ng) using the Trans-IT (Mirus) transfection reagent. One day post 
transfection, the cells were fixated in 4% Formaldehyde, 15 minutes at R.T., stained with DAPI 
(5 min). The cells were imaged using a Zeiss800 confocal microscope, and z-stack images of 
at least 100 cells per condition per experiment were manually quantitated for RedOnly stuctures 
using the ZEN software (Zeiss).   
Statistics 
All experiments were repeated at least three times, unless otherwise specified. Error bars 
represent the standard deviation, or standard error of the mean as indicated in the Figure 
legends. Two-sided unpaired, homoscedastic Student T-Tests, were performed to assess 
significant differences between populations. Replicates were not pooled for statistical analyses.  
 
RESULTS AND DISCUSSION 
Recently we showed that TRIM32 is an autophagy substrate (Overa et al., 2019). Its lysosomal 
degradation was mediated by selective autophagy, dependent on ATG7 and the sequestosome-
like receptors (SLRs). Reintroduction of p62/SQSTM1 in a cell line lacking the SLRs was 
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sufficient to direct autophagic degradation of TRIM32. However, knock out of p62/SQSTM1 
did not abolish lysosomal degradation of TRIM32, suggesting that other SLRs may direct 
TRIM32 to autophagic degradation. Furthermore, we identified TRIM32 as an activator of 
p62/SQSTM1, facilitation p62/SQSTM1 sequestration and degradation.  Here we set out to 
identify the effect of TRIM32 expression on the protein levels of other SLRs than 
p62/SQSTM1. Cell extracts from two different TRIM32 knock-out clones, KO#1 and KO#2 
(Overa et al., 2019), reconstituted with myc-TRIM32 wild type or the disease mutants 
TRIM32D487N and TRIM32P130S, were exposed to antibodies against the SLRs p62/SQSTM1, 
NBR1, NDP52 and TAX1BP1 (Fig. 1A).  Consistently, reintroduction of myc-TRIM32WT or 
myc-TRIM32P130S reduced the protein levels of the SLRs, suggesting that TRIM32 enhances 
SLR mediated selective autophagy (Fig. 1A, B). In contrast, reintroduction of the LGMD2H 
disease mutant form of TRIM32, TRIM32D487N, did not affect the protein levels of the SLRs. 
As shown previously (Frosk et al., 2002, Overa et al., 2019), TRIM32WT and TRIM32P130S 
contain ubiquitylation activity and are themselves degraded by autophagy. TRIM32D487N is not 
found to ubiquitylate itself or any target proteins, suggesting that mutations in the NHL-repeat 
region abolish its enzymatic activity and its ability to be degraded by autophagy. Western blot 
analyses of LC3B and Gabarap in the same cell extracts did not display a reproducible change 
of their protein level or lipidation (Fig. 1A). Moreover, exposure of the TRIM32 KO and the 
TRIM32 KO myc-TRIM32WT cell lines to starvation conditions, followed by additions of  the 
lysosome and proteasome inhibitors Bafilomycin A1 and MG132, respectively, showed that the 
autophagy flux is not  severe inhibited in the TRIM32 KO cells (Fig. S1). This is in line with 
previous data showing that TRIM32 does not display any prominent effect on global autophagy, 
but instead on SLR mediated selective autophagy (Overa et al., 2019). In order to investigate 
whether the TRIM32 induced reduction of SLR expression was due to reduced transcription of 
the SLR genes, we analysed RNA expression by QPCR of representative SLRs in the same cell 
lines (Fig. 1C). Comparing SLR RNA levels in the reconstituted cell lines with the SLR RNA 
levels in the TRIM32 KO#1 cell line revealed no significant change in RNA expression. 
Together, our results show that expression of catalytic active TRIM32 reduces the protein levels 
of the SLRs. For p62/SQSTM1 we have shown that this is due to TRIM32 mediated 
ubiquitylation of p62/SQSTM1 leading to enhanced p62/SQSTM1 autophagic activity. An 
interesting question to address is whether this is a general mechanism for all SLRs, pointing 
towards an important regulatory role of TRIM32 in selective autophagy. 
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 We have previously shown that autophagic degradation of TRIM32 is strongly inhibited 
in a HeLa pentaKO cell line (Lazarou et al., 2015) lacking expression of the five SLRs (Overa 
et al., 2019). To identify if any of the SLRs beside p62/SQSTM1 were able to direct autophagic 
degradation of TRIM32, we established pentaKO cell lines stably expressing each of the SLRs. 
Transfection of mCherry-EYFP-tagged TRIM32 into these cell lines revealed that 
reintroduction of NDP52 or NBR1 facilitated autophagic degradation of TRIM32 (Fig. 2). This 
suggests that each of the SLRs mediates autophagic degradation of TRIM32, and that they are 
independent of each other for facilitating this process. 
 The very consistent downregulation of NDP52 protein levels in the TRIM32 KO cells 
reconstituted with catalytic active TRIM32 (Fig. 1A), prompted us to investigate whether there 
is a direct interaction between TRIM32 and NDP52. GST-pulldown assays using immobilised 
GST-NDP52 or GST-p62/SQSTM1 expressed and purified from E. coli together with in vitro 
translated EGFP-TRIM32WT or the disease mutants EGFP-TRIM32P130S and EGFP-
TRIM32D487N, showed that there is a direct interaction between NDP52 and TRIM32 in vitro 
(Fig. 3A). The interaction is weak, but stronger than the previously reported interaction between 
TRIM32 and p62/SQSTM1 (Overa et al., 2019). Both TRIM32WT and the two disease mutants 
bound to NDP52, suggesting that the in vitro interaction is independent on the E3 ligase activity 
of TRIM32. Next, we applied immunofluorescence assays to determine if TRIM32 colocalizes 
with endogenous NDP52 in cells. TRIM32 KO cells, and TRIM32 KO cells reconstituted with 
myc-TRIM32WT or the disease mutants myc-TRIM32P130S and myc-TRIM32D487N, were grown 
in normal medium or normal medium supplemented with Bafilomycin A1, fixated and exposed 
to an NDP52 antibody (Fig. 3B). TRIM32WT and both disease mutants colocalised with NDP52 
in certain dots under normal conditions (Fig. 3B). Inhibition of the lysosome resulted in 
accumulation of larger NDP52 dots that colocalised with TRIM32WT and TRIM32P130S. 
However, the LGMD2H disease mutant TRIM32D487N, which displays augmented E3 ligase 
activity and is not a substrate for autophagic degradation, did not accumulate in larger NDP52 
dots upon BafA1 treatment. These results indicate that TRIM32, both WT and disease mutants, 
are enriched in certain NDP52 dots in cells under normal conditions. However, accumulation 
of TRIM32WT and TRIM32P130S but not TRIM32D487N in NDP52 dots upon lysosomal 
inhibition, suggest that NDP52 mediated lysosomal degradation of TRIM32 is dependent on 
the E3 ligase activity of TRIM32. We therefore went on to test if NDP52 is a TRIM32 substrate. 
Immunoprecipitation of myc-NDP52 co-expressed with EGFP-TRIM32 WT and disease 
mutants in TRIM32 KO cells, revealed several slow-migrating myc-NDP52 forms in the cells 
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expressing TRIM32WT or TRIM32P130S. In the precipitate from the TRIM32D487N expressing 
cells, no such slow migrating NDP52 forms was observed (Fig. 3C). To identify if these slow-
migrating NDP52 could represent mono and poly-ubiquitylation NDP52, the 
immonoprecipitates were blotted against an antibody recognising mono- and poly-ubiquitin 
(Fig. 3C, lower panels). Clearly, NDP52 immunoprecipitated from cells expressing the E3 
ligase active forms of TRIM32, TRIM32WT and TRIM32P130S, is modified by ubiquitin. On the 
other hand, NDP52 precipitated from the cells expressing the E3 ligase inhibited form of 
TRIM32, TRIM32D487N, is not recognised by the ubiquitin antibody. The upper panel in Figure 
3C show that TRIM32WT and TRIM32P130S co-precipitate very well NDP52, while the 
association between TRIM32D487N and NDP52 is weaker. Together, these data show that 
NDP52 interacts with TRIM32 in vitro and in cells, and that they colocalise in certain dots in 
cells. Furthermore, TRIM32 mediates ubiquitylation of NDP52, and this ubiquitylation seems 
to be important for regulation of NDP52 protein levels.  
 Recent reports have demonstrated that NDP52 plays an important role in selective 
degradation of depolarized mitochondria (mitophagy) (Lazarou et al., 2015, Vargas et al., 2019, 
Heo et al., 2015). Tethering of NDP52 to the mitochondria recruited the ULK1 complex via 
FIP200 interactions, and the authors suggested that this recruitment initiated autophagosome 
biogenesis directly on the mitochondria (Vargas et al., 2019). TRIM proteins are reported to 
control autophagy by modulating the activity of BECLIN1 and ULK1 (Mandell et al., 2014). 
Moreover, in atrophic muscle cells TRIM32 mediates induction of autophagy via ULK1 
activation. This activation of ULK1 requires TRIM32 E3 ligase activity, and is impaired in 
atrophic muscle cells expressing the LGMD2H disease mutant TRIM32D487N (Di Rienzo et al., 
2019). These reports prompted us to investigate whether ULK1 and TBK1 were aberrantly 
expressed in the HEK293 FlpIn TRIM32 KO and reconstituted cell lines.  Western Blot 
analyses of ULK1 expression levels in the TRIM32 KO cells, and TRIM32 KO cells 
reconstituted with myc-TRIM32WT, myc-TRIM32P130S or myc-TRIM32D487N, revealed that 
ULK1 is strongly stabilised in the cells expressing myc-TRIM32WT and myc-TRIM32P130S (Fig. 
4 A, B). In contrast, reintroduction of the LGMD2H disease mutant TRIM32D487N, did not affect 
ULK1 protein levels (Fig. 4 A, B).  K63-linked ubiquitylation of ULK1 stimulates its kinase 
activity (Nazio et al., 2013). To assess if TRIM32 mediated stabilization of ULK1 is due to 
ubiquitylation of ULK1, ULK1 was immunoprecipitated from HEK293 cells co-expressing 
TRIM32 and EGFP-ULK1. However, no increased ubiquitylation of ULK1 could be detected 
(Fig. 4C). This is in line with the work of Di Rienzo et al. (Di Rienzo et al., 2019), where they 
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found that ULK1 is not a direct substrate of TRIM32 in their system. Instead, they showed that 
ULK1 associated with unanchored K63-linked polyubiquitin chains synthesized by TRIM32 in 
an AMBRA1 dependent manner, and this binding to polyubiquitin chains stimulated ULK1 
activity, monitored as increased phosphorylation of VPS34(S249) and  BECLIN1 (S15). TBK1 
facilitates the association of NDP52 with the ULK1 complex on mitochondria leading to 
mitophagy, while a kinase-dead TBK1 does not (Vargas et al., 2019). Recruiting TBK1 to the 
mitochondria induced TBK1 S172 autophosphorylation. Furthermore, selective autophagy of 
cytosol-invading bacteria involves NDP52 meditated recruitment of the TBK1-SINTBAD and 
ULK1-FIP200 complexes to the bacteria containing vacuole, promoting phagophore formation 
(Ravenhill et al., 2019). Assessing the TBK1 S172 phosphorylation in the TRIM32 KO and 
reconstituted cell lines, revealed that the amount of S172 phosphorylated TBK1 is highly 
upregulated in the cells reconstituted with TRIM32 compared to the TRIM32 KO cells (Fig. 4 
D, E). Since TBK1 undergoes autophosphorylation at S172 when TBK1 is enriched at 
subcellular structures, this suggests that TRIM32 facilitates TBK1 recruitment and activation 
which is important for efficient mitophagy and xenophagy. 
Next question was if TRIM32 could facilitate mitophagy. For this purpose, we induced 
mitophagy in HEK293 FlpIn cells, and the TRIM32 KO and reconstituted cell line. Mitophagy 
induction was obtained by overexpression of FKBP8 and LC3A, and autophagic degradation 
of mitochondria measured using the double-tag mCherry-EGFP-OMP25TM (Bhujabal et al., 
2017) (Fig. 4F). In the HEK293 FlpIn cells, co-overexpression of FKBP8 and LC3A induced 
mitophagy in 10-12% of the cells (Fig. 4G). However, in the HEK293 FlpIn TRIM32 KO cells, 
the amount of cells undergoing mitophagy by FKBP8 and LC3A overexpression was reduced 
to 5%. Importantly, reintroduction of myc-TRIM32 in the TRIM32 KO cells restored the 
mitophagy activity (Fig. 4G). 
 To sum up, here we show that TRIM32 affect the protein expression levels of the SLRs. 
Focusing on autophagy receptor NDP52, we reveal that TRIM32 interacts with NDP52 and 
subjects it for ubiquitylation. NDP52 is an important receptor for mitophagy, and in congruence 
with this we find that mitophagy is downregulated in TRIM32 KO cells compared to normal 
HEK293 FlpIn cells and TRIM32 KO cells reconstituted with myc-TRIM32. Furthermore, 
ULK1 is stabilised and TBK1 autophosphorylation upregulated in cells expressing active 
TRIM32, but not in cells expressing the LGMD2H disease version of TRIM32 shown to have 
impaired E3 ligase activity (Fig. 4H).  An important question to address in future study is 
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whether the TRIM32 mediated ubiquitylation of NDP52 directly facilitates its role as a 
mitophagy and xenophagy receptor. 
 
FIGURE LEGENDS 
Figure 1: E3 ligase active TRIM32 downregulates the protein levels of the sequestosome-
like cargo receptors. A) Western blots showing the protein levels of the autophagy cargo 
receptors p62/SQSTM1, NBR1, NDP52 and TAX1BP1, and the autophagy marker proteins 
LC3B and GABARAP, in TRIM32 KO cells, and TRIM32 KO cells reconstituted with stable 
expression of myc-TRIM32WT, myc-TRIM32P130S, and myc-TRIM32D487N. Actin serves as 
loading control, and the blot against TRIM32 shows the expression levels of the various 
TRIM32 proteins in the reconstituted cells. A biotinylated molecular weight marker is shown 
to the left. B) Quantitation of the band intensities from three independent experiments as 
represented in A. The bar graphs represent the average band intensities normalized to the 
corresponding actin band from three independent experiments with s.e.m. The band intensities 
were quantitated by the use of ImageJ. *: p<0.05; ***: p<0.0005; n.s.: p>0.05;  C) RNA levels 
of the SLRs p62/SQSTM1, NBR1 and NDP52 in the reconstituted TRIM32WT, TRIM32P130S 
and TRIM32D487N expressing cell lines relative to the RNA levels in the TRIM32 KO cell line. 
The graphs represent the average relative RNA levels with s.e.m. obtained by QPCR in three 
independent experiments, each performed in triplicate. 
 
Figure 2: The cargco receptors NDP52 and NBR1 direct TRIM32 to autophagic 
degradation. A) Normal HeLa cells and cells that were genetically knocked out for the 5 SLRs 
(pentaKO), or pentaKO cells reconstituted with stable expression of EGFP-NDP52 or EGFP-
NBR1 as indicated to the right, were transfected with mCherry-EYFP-TRIM32 expression 
plasmids. One day post transfection the cells were fixated, stained with DAPI and imaged using 
a Zeiss780 confocal microscope. Scale bar (10 m). B) Quantitation of the number of yellow 
dots and red-only dots in the cells transfected as described in A. The graphs display the average 
number of yellow and RedOnly dots with S.D. in cells with mCherry-EYFP-TRIM32 dots, 




Figure 3: TRIM32 associates with and ubiquitylates NDP52. A) GST-pulldown assays using 
35S-labeled Myc-TRIM32, Myc-TRIM32P130S, or Myc-TRIM32D487N and recombinant GST, 
GST-p62 and GST-NDP52 immobilized on Glutathione Sepharose beads. Quantifications of 
the binding of wild type and mutant constructs to the GST proteins are presented as percentage 
binding relative to the 5% input. The bars represent the average band intensities with s.d. 
quantitated using ImageJ, of three independent experiments. B) Representative images of 
HEK293 FlpIn TRIM32 KO cells, and the TRIM32 KO cells reconstituted with myc-
TRIM32WT, myc-TRIM32P130S or myc-TRIM32D487N cells in full media (FM) or full media 
added the lysosomal inhibitor Bafilomycin A1 (BafA1)  (4 hrs) fixed and stained with 
antibodies for NDP52. Images were obtained using a ZEISS780 confocal laser scanning 
microscope, and monitored using the ZEN software. Scale bar (10 m). C) Myc-NDP52 
expression plasmid was cotransfected with EGFP-TRIM32, EGFP-TRIM32P130S or EGFP-
TRIM32D487N expression constructs in the HEK293 FlpIn TRIM32 KO cell line. Myc-NDP52 
was immunoprecipitated using a myc-trap and precipitated NDP52 detected using an anti-myc 
antibody. The EGFP-TRIM proteins were detected using an anti-GFP antibody, and ubiquitin 
by using an FK2 antibody recognizing both mono-and poly-ubiquitin chains. * indicates 
ubiquitylated NDP52. 
 
Figure 4: TRIM32 stabilizes ULK1 and facilitates TBK1 phosphorylation and mitophagy. 
A) Western blots showing the protein levels of ULK1 in HEK293 FlpIn TRIM32 KO cells, and 
HEK293 FlpIn TRIM32 KO cells reconstituted with stable expression of myc-TRIM32WT, 
myc-TRIM32P130S, and myc-TRIM32D487N. Actin serves as loading control, and the blot against 
TRIM32 shows the expression levels of the various TRIM32 proteins in the reconstituted cells. 
A biotinylated molecular weight marker is shown to the left. B) Quantitation of the band 
intensities from three independent Western blots as represented in C. The bar graphs represent 
the average band intensities normalized to the corresponding actin band from three independent 
experiments with s.e.m. The band intensities were quantitated by the use of ImageJ. **: 
p<0.005; *: p<0.05; n.s.: p>0.05. C) EGFP-ULK1 expression plasmid was transfected into 
TRIM32KO cell lines reconstituted with myc-TRIM32, myc-TRIM32P130S or myc-
TRIM32D487N. EGFP-ULK1 was immunoprecipitated using a GFP-trap and precipitated EGFP-
ULK1 detected using an anti-GFP antibody. The myc-TRIM proteins were detected using an 
anti-myc antibody, and ubiquitin by using an FK2 antibody recognizing both mono-and poly-
ubiquitin chains. D) Western blots showing the protein levels of phosphorylated TBK1 and 
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TBK1 as indicated to the right, in TRIM32 KO cells, and TRIM32 KO cells reconstituted with 
stable expression of myc-TRIM32WT, myc-TRIM32P130S, and myc-TRIM32D487N. The extracts 
are from cells exposed to normal medium and cells starved in HBSS for two hours, as indicated 
above. Tubulin serves as loading control. E) Quantitation of the band intensities from three 
independent Western blots as represented in D. The bar graphs represent the average band 
intensities normalized to the corresponding tubulin band from three independent experiments 
with s.e.m. The band intensities were quantitated by the use of ImageJ. *: p<0.05; n.s.: p>0.05.   
F) HEK293 FlpIn cells, HEK293 TRIM32 KO cells, or HEK293 TRIM32 KO cells 
reconstituted with myc-TRIM32 were transiently transfected with expression plasmids for the 
mitochondria marker mCherry-EGFP-OMP25TM, 3xFlag LC3A and mitophagy receptor myc-
FKBP8. The appearance of RedOnly structures indicates acidified mitochondria. G) 
Quantitation of the cells represented in A displaying RedOnly dots indicative of mitophagy 
activity. The bars represent the average with s.e.m. of three independent experiments, each 
including > 100 cells per condition. *: p<0.05; n.s.: p>0.05. H) TRIM32 induces ubiquitylation 
of NDP52, enhances TBK1 phosphorylation and ULK1 expression that are important for 
phagophore formation on the mitochondria, and facilitates mitophagy. 
 
Supplementary Figure S1: Loss of TRIM32 does not impair autophagic degradation of 
the SLRs. A) Western blots showing the protein levels of the autophagy cargo receptors NBR1, 
TAX1BP1, p62/SQSTM1 and NDP52, and the autophagy marker protein LC3B, in TRIM32 
KO cells, and TRIM32 KO cells reconstituted with stable expression of myc-TRIM32WT. The 
cells were exposed to full medium (FM) or starvation medium (SM, HBSS 2 hrs), and treated 
with lysosomal inhibitor (Baf, 4 hrs) or proteasomal inhibitor (MG, 4 hrs) where indicated 
above. Actin serves as loading control, and the blot against TRIM32 shows the expression levels 
of the TRIM32 in the reconstituted cells. A biotinylated molecular weight marker is shown to 
the left. * indicate an unspecific band recognized by the TRIM32 antibody. 
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TRIM32 is an E3 ligase implicated in diverse biological pathways and pathologies such as muscular 
dystrophy and cancer. TRIM32 are expressed both as full-length proteins, and as a truncated protein. 
The mechanisms for regulating these isoforms are poorly understood.  Here we identify a PEST 
sequence in TRIM32 located in the unstructured region between the RING-BBox-CoiledCoil domains 
and the NHL repeats.  The PEST sequence directs cleavage of TRIM32, generating a truncated protein 
similarly to the short isoform. We map three lysine residues that regulate PEST mediated cleavage and 
auto-ubiquitylation activity of TRIM32. Mimicking acetylation of lysine K247 completely inhibits 
TRIM32 cleavage, while the lysines K50 and K401 are implicated in auto-ubiquitylation activity. We 
show that the short isoform of TRIM32 is catalytic inactive, suggesting a dominant negative role. These 
findings uncover that TRIM32 is regulated by post-translational modifications of three lysine residues, 
















Tripartite motif (TRIM) proteins have emerged as a large family of ubiquitin E3 ligases that are involved 
in a wide range of cellular processes such as development, differentiation, immunity and carcinogenesis 
[1]. As a member of the TRIM family, TRIM32 shows the common RBCC domain organization in its 
N-terminal, consisting of a “Really interesting New gene” (RING) domain, followed by one B-box 
domain, and a Coiled Coil (CC) region [2]. TRIM32 is characterized by six NHL repeats in its C-
terminus. The RING domain is essential for the E3 ligase activity, while the BBOX domain is necessary 
to modulate chain assembly rate of ubiquitin units. The CC domain assumes an α-helix structure that 
allows the formation of anti-parallel dimers [3]. To date, the NHL repeats are found to be involved in 
dimerization and cargo recognition [4]. TRIM32 oligomerization is a pre-requisite for its catalytic 
activity.  
TRIM32 has multiple target proteins involved in innate immunity, carcinogenesis and muscle 
physiology [5]. TRIM32 is linked to two different genetic diseases [4]. Mutations in the NHL domains 
result in the muscle disorders Limb Girdle Muscular Dystrophy 2H (LGMD2H) and Sarcotubular 
myopathy (STM). These mutants display impaired oligomerization and auto-ubiquitylation activity, as 
well as reduced overall TRIM32 expression. A missense mutation in the BBOX domain causes Bardet-
Biedl Syndrome 11 (BBS11), which has a pleiotropic phenotype [6].  TRIM32 can be degraded both by 
the proteasome and by selective autophagy, and auto-ubiquitylation activity is required for its autophagic 
degradation [7]. The autophagy receptor p62/SQSTM1 can direct ubiquitylated TRIM32 to autophagic 
degradation, but is at the same time a TRIM32 substrate, uncovering a role for TRIM32 in the regulation 
of selective autophagy.  
Post-translational modifications (PTMs) such as phosphorylation, acetylation, ubiquitylation 
and SUMOylation are essential for the function and fate of most proteins. The attachment of these small 
molecules can modulate greatly the properties of a protein, affecting its stability, function, intracellular 
distribution and interaction with other proteins [8]. Acetylation is the most common PTM, playing 
important roles in cell signaling, and in the regulation of protein localization, stability and functionality. 
The addition of the acetyl group from an Acetyl coenzyme A (Ac-CoA) can occur in two different 
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positions, in their Nα-termini of the amino acid or in the ε-amino group of a lysine amino acid. Lysine 
acetylation is a reversible modification that is tightly controlled by multiple acetyltransferases and 
deacetylases [9]. This repertoire of addition and removal of molecules allow the cell to control fast and 
efficiently the different changes in the environment. 
Ubiquitylation of proteins are implicated as a regulatory mechanism of many cellular processes. 
The addition of ubiquitin moieties is a reversible process that occur on lysine residues. Ubiquitin itself 
contains seven lysine residues that can be ubiquitylated, forming ubiquitin chains. This allows multiple 
combinations, which adds a high degree of complexity to this cellular regulation mechanism [10]. As 
acetylation, ubiquitylation processes are controlled by a balance between ubiquitin E3 ligases and de-
ubiquitin enzymes. 
A PEST sequence is a region rich in proline (P), glutamic acid (E), serine (S) and threonine (T). 
This sequence of amino acids acts as a proteolytic signal to control the rapid turnover of the protein [11]. 
Originally PEST sequences were attributed to short-lived proteins, but later PEST sequences are also 
identified in some long-lived proteins. Moreover, alternative functions have been linked to PEST 
domains, hence their function is not limited to proteolytic signaling [12]. PEST regions are generally 
unstructured and flexible, and the 26S Proteasome and other proteases such as calpains are in charge of 
the degradation of PEST containing proteins. PEST sequences can lead to constitutive degradation of 
the protein, but they can also behave as conditional degradation signals depending on the cellular needs 
[13].  
In this work we identify a PEST sequence in the unstructured region between the RBCC region 
and the NHL domains of the ubiquitin E3 ligase TRIM32. The PEST sequence directs cleavage of 
TRIM32, leading to a truncated TRIM32 protein lacking the C-terminal NHL-repeat, resembling 
isoform 3 of TRIM32. The existence of TRIM32 isoform 3 is experimental evidenced at protein level, 
but a corresponding transcript is not verified.  We uncover that PEST mediated cleavage of TRIM32 is 
regulated by post-translational modifications of three lysine residues, K50, K247 and K401. Mimicking 
acetylation on K247 completely protects TRIM32 from PEST mediated cleavage. K50 and K401 were 
found to be important for TRIM32 auto-ubiquitylation activity, which is reported to be necessary for its 
tetramerization and cytoplasmic body formation. This is the first time that a PEST sequence has been 
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described in a TRIM protein, as well as the regulation of a PEST sequence by acetylation of an adjacent 
lysine residue.  
 
Results 
PTMs of the lysine residues K50, K247 and K401 regulate TRIM32 
cleavage  
It is well recognized that TRIM32 has auto-ubiquitylation activity in addition to conventional ubiquitin-
protein ligase activity [14, 15]. Auto-ubiquitylation seems to regulate its expression level, E3 ligase 
activity and ability to form cytoplasmic bodies [7, 16-18].  We and others have shown that the missense 
mutation TRIM32D487N causing LGMD2H does not undergo auto-ubiquitylation [7, 18]. Auto-
ubiquitylated TRIM32 can be detected as a slower-migrating band on Western Blots, as indicated in Fig 
1A where the slower migrating band is detected approximately 10 kDa above the band of the catalytic 
active EGFP-TRIM32WT and EGFP-TRIM32P130S [7]. The EGFP-TRIM32D487N mutant which do not 
contain auto-ubiquitylation activity[7], does not display this slow migrating band.  Auto-ubiquitylation  
seems to be a prerequisite for the catalytic activity of TRIM32, as the LGMD2H mutant is unable to 
ubiquitylate the substrate protein p62/SQSTM1 [7]. Moreover, PKA mediated phosphorylation of 
TRIM32S651, which impairs its ability to undergo auto-ubiquitylation, leads to repression of its E3 ligase 
activity. The PKA phosphorylation was shown to be regulated by 14-3-3 protein binding to soluble 
TRIM32, trapping it in a soluble and functionally latent complex [17]. In an attempt to better understand 
the regulation of TRIM32, we started out to identify which lysine residues in TRIM32 are targeted by 
its auto-ubiquitylation activity. For this purpose we applied Mass Spectroscopy (MS) analyses of the 
catalytic inactive disease mutant myc-TRIM32D487N, and compared it to immunoprecipitated catalytic 
active myc-TRIM32WT and myc-TRIM32P130S. All proteins were stably expressed in the HEK293 FlpIn 
TRIM32 knock out cells described previously [7]. No lysine residues of the catalytic inactive 
TRIM32LGMD2H disease mutant were detected as ubiquitylated, while peptides with K50 and K401 
ubiquitylation were found in precipitates of the catalytic active enzymes myc-TRIM32WT and myc-
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TRIM32P130S (Figs 1B and 1C). However, peptides with acetylation of lysine K247 were identified in 
precipitates of the myc-TRIM32 disease mutants, but not in the TRIM32WT precipitates (Figs 1B and 
1C). In order to determine if these lysine residues are targets for TRIM32 auto-ubiquitylation activity, 
the constructs EGFP-TRIM32K50R, EGFP-TRIM32K247R, and EGFP-TRIM32K401R were established by 
site-directed mutagenesis and transiently transfected into a HEK293 FlpIn TRIM32 KO cells [7]. 
Western Blot analysis of the transfected proteins revealed that none of these single lysine to arginine 
mutations impaired auto-ubiquitylation activity of TRIM32 (S1 Fig 1A). Next, we introduced double 
and triple K to R mutations in EGFP-TRIM32, generating EGFP-TRIM32K247R/K401R, EGFP-
TRIM32K50R/K247R, EGFP-TRIM32K50R/K401R and EGFP-TRIM32K50R/K247R/K401R, respectively. These 
mutants along with EGFP-TRIM32WT, were transiently transfected into the TRIM32 KO cells and their 
auto-ubiquitylation activity investigated by Western blotting (Fig 1 D). Surprisingly, introduction of the 
double mutation EGFP-TRIM32K247R/K401R resulted in a partially cleaved protein (Fig 1D and Fig 1E, 
lane 3), while the triple EGFP-TRIM32K50R/K247R/K401R mutation resulted in a completely cleaved protein 
(Fig 1D and Fig 1E, lane 6). Co-transfection of the broad specificity de-ubiquitinase USP2 verified that 
the slower-migrating band on the Western blots are due to ubiquitylated TRIM32 (Fig 1D, Fig 1E and 
S1 Fig 1B). Since mutations in TRIM32 is associated with muscular dystrophy, similar experiment was 
performed in the myoblast C2C12 cell line. Introduction of the K247R/K401R and K50/K247R/K401R 
mutations were exposed to cleavage also in this cell line (Fig 1E). Moreover, the polyclonal TRIM32 
antibody displayed the same protein pattern on the Western blot as the GFP antibody, indicating that 
cleavage of EGFP-TRIM32K50R/K247R/K401R generates a stable N-terminal cleavage product of around 55 
kDa. In contrast, any C-terminal cleavage products can not be detected in the gel, suggesting that this 
part of TRIM32 is exposed to further degradation.   
  
Fig 1. PTMs of TRIM32K50, TRIM32K247 and TRIM32K401 regulate its cleavage. (A) Western blot 
analysis of cell extracts from HEK293 FlpIn cells with tetracycline inducible expression of EGFP-
TRIM32WT, the BBS11 associated mutant EGFP-TRIM32P130S, or the LGMD2H causing mutant EGFP-
TRIM32D487N shows auto-ubiquitylation activity of TRIM32WT and TRIM32P130S, but not the LGMD2H 
mutant. (B) Sequence of the TRIM32 peptides identified by MS to display PTMs on lysine residues that 
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differed between the TRIM32 proteins with auto-ubiquitylation activity (TRIM32WT and TRIM32P130S) 
and the LGMD2H disease variant lacking auto-ubiquitylation activity (TRIM32D487N). (C) Schematic of 
TRIM32 domain organization. The D487N mutation in the NHL repeats that is associated with 
LGMD2H and the P130S mutation in the BBox causing BBS11 are indicated above. The three lysine 
residues that are focused in this paper are indicated in red, while the PTMs of these residues identified 
by MS are indicated above. Ub: Ubiquitylation. Ac: acetylation (D) Western Blot analysis of HEK293 
FlpIn TRIM32 KO cells transiently transfected with expression plasmids for EGFP-TRIM32WT, the 
double mutants EGFP-TRIM32K247R/K401R, EGFP-TRIM32K50R/K247R, or EGFP-TRIM32K247R/K401R, or the 
triple mutant   EGFP-TRIM32K50R/K247R/K401R. The last lane represents cotransfection of EGFP-
TRIM32WT and mCherry-USP2 expression vectors. The bands representing EGFP-TRIM32, auto-
ubiquitylated EGFP-TRIM32, and cleaved EGFP-TRIM32 are indicated to the right. PCNA represents 
the loading control. (E) Western blot analysis of a similar experiment as in (D), except that the myoblast 
C2C12 cell line is used instead of the HEK293 FlpIn TRIM32 KO cell line, and the antibody used is an 
anti-TRIM32 antibody instead of an anti-GFP antibody. 
 
Acetylation of K247 is sufficient to inhibit cleavage of TRIM32  
According to ENSEMBL genome browser (ensemble.org) and UniProt protein database (uniprot.org) 
there are two variants of the TRIM32 protein in humans. The main variant (Uniprot.org Q13049) is a 
653 amino acid protein of 72 kDa. Additional, there is clear experimental evidence for the existence of 
a short 172 amino acid long variant of TRIM32 (Uniprot.org Q5JVY0) (Fig 2A). However, the existence 
of a transcript encoding the short protein variant is not validated, since a transcript with a 3’UTR is 
unrecognized so far (ensemble.org). The short isoform contains the N-terminal RBCC domains, but lack 
the NHL-repeats and the unstructured region between RBCC and the NHL-domain. The short isoform 
is around 20 kDa, and hence has a size very similar to the 55 kDa TRIM32 N-terminal cleavage product 
that we observed above (20 kDa plus the EGFP-tag of 32.7 kDa). This prompted us to ask whether the 
short TRIM32 protein may be generated by proteolytic cleavage of the long form, and if this cleavage 
could be regulated by post-translational modifications of the lysine residues identified above (K50, 
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K247, K401)(Fig 1C). De-ubiquitylation of TRIM32 by USP2 over-expression did not result in TRIM32 
cleavage (Fig 1D and Fig 1E). Therefore, we asked whether acetylation of the lysine residues K50, K247 
and K401 would affect TRIM32 cleavage. Each of these lysine residues were replaced by the acetylation 
mimicking amino acid glutamine (Q) in the EGFP-TRIM32K50R/K247R/K401R construct. The constructs were 
transfected into the HEK293 FlpIn TRIM32 KO cell line, and their expression monitored by Western 
blotting (Fig 2B). Clearly, introduction of the acetylation mimicking mutant at position K247 completely 
inhibited cleavage of TRIM32 (Fig 2B, lane 5), while the K50Q and K401Q mutations did not (Fig 2B, 
lanes 4 and 6). This suggests that acetylation of K247 in TRIM32 is implicated in regulation of TRIM32 
cleavage. The subcellular localization of the TRIM32 lysine mimicking mutants were examined by 
transient transfection of wild type EGFP-TRIM32 and the mutant constructs into HEK293 FlpIn 
TRIM32 KO cells. In line with previous reports, EGFP-TRIM32WT is enriched in small round 
cytoplasmic bodies in addition to diffuse cytoplasmic localization. Co-staining with the Golgi marker 
GM130 showed that many of the TRIM32 bodies localize close to the Golgi apparatus (Fig 2C). The 
EGFP-TRIM32 mutants that generate the cleaved TRIM32 product (TRIM32K50Q/k247R/K401R and 
TRIM32K50R/K247R/K401Q) formed mainly a few large bodies or aggregates localized in or close to the Golgi 
region. In contrast, the TRIM32K50R/K247Q/K401R mutant that inhibits TRIM32 cleavage, displays a 
subcellular localization very similar to the wild type protein (Fig 2C). Hence, the short TRIM32 protein 
seem to have a strong tendency to form large aggregates compared to full-length TRIM32 isoform. 
 
Fig 2. K247 acetylation inhibits TRIM32 cleavage and facilitates its subcellular distribution. (A) 
Western Blot analysis of HEK293 FlpIn TRIM32 KO cells transiently transfected with expression 
plasmids for EGFP-TRIM32WT, EGFP-TRIM32K50R/K247R/K401R, EGFP-TRIM32K50Q/K247R/K401R, 
TRIM32K50R/K247Q/K401R or EGFP-TRIM32K50R/K247R/K401Q. The bands representing EGFP-TRIM32 and 
cleaved EGFP-TRIM32 are indicated to the right. Ponceau staining of the membrane represents the 
loading control. (B) Confocal images of HEK293 FlpIn TRIM32 KO cells transiently transfected with 
expression plasmids for EGFP-TRIM32WT, EGFP-TRIM32K50R/K247R/K401R, EGFP-
TRIM32K50Q/K247R/K401R, TRIM32K50R/K247Q/K401R or EGFP-TRIM32K50R/K247R/K401Q, and immunostained 
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with anti-GM130 antibodies, a Golgi marker. The cell nuclei is visualized by DAPI staining. Scale bars: 
10 M. 
 
Autophagic degradation of TRIM32 is dependent on K50, K247 
and K401 modifications 
We have recently shown that TRIM32 is a substrate for selective autophagy [7]. Our next question was 
whether the short TRIM32 isoform is a target for selective autophagy. For this purpose, the double 
fluorescent tag mCherry-EYFP was cloned in front of the TRIM32 constructs TRIM32WT, 
TRIM32K247R/K401R, TRIM32K247Q, TRIM32K50R/K247Q/K401R, and TRIM32K50R/K247R/K401R and transiently 
transfected into the HEK293 FlpIn TRIM32 KO cells. Since EYFP is unstable in acidic environments 
while mCherry is stable, double-tagged TRIM32 constructs targeted to the lysosome will be visualized 
as RedOnly dots in the fluorescence microscope, while TRIM32 bodies in the cytoplasm will occur as 
yellow. The mCherry-EYFP-TRIM32K247R/K401R and mCherry-EYFP-TRIM32K247Q constructs formed 
RedOnly dots, but to a lesser extent than mCherry-EYFP-TRIM32WT (Fig 3). However, when all three 
lysine residues were substituted with Arginine, giving rise to the cleaved TRIM32 product, or when K50 
and K401 were substituted with arginine and K247 with glutamine, giving rise to a full length TRIM32 
product, no red only dots was observed in the transfected cells (Fig 3). This suggests that PTMs on the 
lysine residues K50, K247 and K401 regulate autophagic degradation of TRIM32.  
 
Fig 3. PTMs on TRIM32K50, TRIM32K247, TRIM32K401 regulate autophagic degradation of 
TRIM32. (A) Confocal images of mCherry-EYFP-TRIM32WT, mCherry-EYFP-TRIM32K247R/K401R, 
mCherry-EYFP-TRIM32K247Q, mCherry-EYFP-TRIM32K50R/K247Q/K401R or mCherry-EYFP-
TRIM32K50R/K247R/K401R transiently expressed in HEK293 FlpIn TRIM32 KO cells and exposed to normal 
or starved conditions.  Scale bars: 10 M. (B) The graphs represent the number of cells with RedOnly 
dots in the mCherry-EYFP-TRIM32 transfected cells shown with representative images in A. The 
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graphs represent the average of three independent experiments with s.d. (n>20 cells). **P< 0.005; 
***P<0.0005 (Student’s t-test). 
 
TRIM32 cleavage is directed by a PEST sequence  
The complete cleavage of the EGFP-TRIM32K50R/K247R/K401R construct prompted us to investigate 
whether TRIM32 encodes specific sequences that are exposed for proteolytic cleavage. Sequence 
analysis using the PEST prediction tool EMBOSS:epestfind (https://emboss.bioinformatics.nl/cgi-
bin/emboss/epestfind), identified a putative PEST sequence with PEST score 7.4 located from amino 
acid 248 to 270 (Fig 4A). The predicted PEST sequence is 100% conserved in mammals, and 
interestingly it is located adjacent to lysine K247 which acetylation inhibits TRIM32 cleavage. To 
examine if the predicted PEST sequence directs TRIM32 cleavage, specific glutamate and threonine 
residues within the PEST sequence were mutated to valine or isoleucine, respectively, in the EGFP-
TRIM32WT construct. Additionally, a partial deletion of the PEST sequence was introduced in EGFP-
TRIM32WT and EGFP-TRIM32K50R/K247R/K401R (Fig 4A). The PEST mutation and deletion constructs 
were transiently transfected into the HEK293 FlpIn TRIM32 KO cell line, and their expression 
monitored by Western blotting (Fig 4B). Clearly, partial deletion of the PEST sequence in the EGFP-
TRIM32K50R/K247R/K401R constructs completely inhibits TRIM32 cleavage (Fig 4B, lane 6). Partial 
deletion or mutation of the PEST sequence in wild type TRIM32 did not compromise TRIM32 
expression (Fig 4B, lanes 3 and 4). This identifies the 248-270 region of TRIM32 to be a PEST sequence 
that directs cleavage of TRIM32 that is unable to be modified on K50, K247 and K401. Clearly, 
mimicking of acetylation on lysine K247, which is localized adjacent to the PEST sequence, completely 
protects TRIM32 from the PEST directed cleavage (Fig 4B, last lane).  
 The cleaved TRIM32 protein contains the RBCC domains, and hence may have the ability to 
undergo auto-ubiquitylation and thereby gain catalytic activity. To examine this, the auto-ubiquitylation 
activity of the triple mutant TRIM32K50R/K247R/K401R was compared to the auto-ubiquitylation activity of 
TRIM32WT and TRIM32D487N, which is known to be catalytic inactive. Clearly, no auto-ubiquitylation 
activity was detected for the cleaved TRIM32 product (Fig 4C, lane 5). Auto-ubiquitylation activity of 
11 
 
TRIM32K50R/K247R/K401R with a partial deleted PEST sequence, and the acetylation mimicking mutant 
TRIM32K50R/K247Q/K401R were analyzed in parallel. Both these mutations inhibit cleavage of TRIM32 (Fig 
4C, lanes 6,7). Notably, none of these mutant forms of TRIM32 displayed auto-ubiquitylation activity. 
In contrast, TRIM32WT with a partial deleted PEST sequence (Fig 4C, lane 4) and the TRIM32K247Q 
construct (Fig 4B, last lane) both display auto-ubiquitylation activity.  
Together, these results show that the short isoform of TRIM32 can be generated by proteolytic 
cleavage directed by a PEST sequence located between the RBCC region and the NHL domains. 
Acetylation of K247 located adjacent to the PEST sequence, completely protects TRIM32 from PEST 
mediated cleavage. The short TRIM32 isoform and TRIM32 proteins containing K50, K247 and K401 
mutations are catalytic inactive, showing the importance of these lysines for TRIM32 activity.  
 
Fig 4. Acetylation of K247 protects TRIM32 from cleavage directed by the adjacent PEST 
sequence. (A) Schematic of TRIM32 domain organization with the three regulatory Lysine residues 
identified in this work indicated above, and the sequence of the mapped PEST sequ.ence indicated 
below. MutPEST and PEST display the modifications introduced to the predicted PEST sequence. (B) 
Western Blot analysis of cell extracts from HEK293 FlpIn TRIM32 KO cells transiently transfected 
with expression plasmids for EGFP-TRIM32WT, EGFP-TRIM32mutPEST, EGFP-TRIM32PEST, EGFP-
TRIM32K50R/K247R/K401R (3KR), TRIM32K50R/K247R/K401R/PEST (3KR PEST) or EGFP-TRIM32K247Q. The 
bands representing EGFP-TRIM32 are indicated to the right. The band representing cleaved EGFP-
TRIM32 is indicated to the right. Tubulin represents the loading control. (C) Western Blot analysis of 
cell extracts from HEK293 FlpIn TRIM32 KO cells transiently transfected with expression plasmids for 
EGFP-TRIM32WT, EGFP-TRIM32WT and mCherry-USP2, EGFP-TRIM32PEST, EGFP-
TRIM32K50R/K247R/K401R (3KR), TRIM32K50R/K247R/K401R/PEST (3KR PEST) or EGFP-
TRIM32K50R/247Q/K401R or EGFP-TRIM32D487N. The bands representing ubiquitylated EGFP-TRIM32, 






In this study we aimed at gaining insight in how TRIM32 auto-ubiquitylation regulates its activity and 
stability. TRIM32 is implicated in diverse biological and physiological processes such as muscle 
physiology, neuronal differentiation, immunity and cancer [5]. TRIM32 is reported to act both as an 
oncogene and as tumor suppressor, depending on the specific organ and cellular context [5]. TRIM32 
overexpression promotes cell proliferation, transforming activity, cell motility and prevents apoptosis 
[15, 19], but it is also shown to promote asymmetric cell division of neuroblastoma cells and to enhance 
TNF-induced apoptosis [20, 21]. Abnormal expression of TRIM32 has been demonstrated in various 
human cancer cells [22-26], and in the occipital lobe of Alzheimer’s disease patients [27]. Reduced 
TRIM32 expression in lung epithelial and tracheal cells increases their susceptibility to infection of 
influenza A virus [28]. Thus, regulating TRIM32 activity is of critical importance for healthy cell 
physiology.  
Our data reveal that TRIM32 contains a conserved PEST sequence located in the unstructured 
region between the N-terminal RBCC domains and the C-terminal NHL-domains. This is the first time 
a PEST sequence is identified in a TRIM protein. Inhibition of PTMs of the K50, K247 and K401 
residues by substitution of these lysine residues with arginine, resulted in exposure of the PEST to 
proteolytic enzymes, leading to TRIM32 cleavage. However, mimicking acetylation of K247 by 
glutamine substitution but keeping the K50R and K401R mutations, completely protected TRIM32 from 
proteolytic degradation. The acetylation also facilitated distribution of TRIM32 bodies throughout the 
cytoplasm, and protected it from autophagic degradation. Importantly, K247 is located immediately 
upstream of the PEST region. Thus, our data indicate that reversible acetylation of K247 regulates PEST 
mediated cleavage of TRIM32.  
 Research over the past decades have revealed that lysine  acetylation is a common mechanism 
for regulation of protein stability, and can regulate both proteasome-dependent and lysosome-dependent 
protein degradation (recently reviewed [29]). Acetylation mediated stabilization of proteins can be due 
to direct competition between acetylation and ubiquitylation of the same lysine residue, such as 
described for SMAD7 [30] and TRIM50 [31]. However, acetylation is also reported to promote protein 
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degradation by enhancing ubiquitylation leading to degradation in the proteasome [32, 33] or the 
lysosome [34, 35]. However, lysine acetylation regulating PEST mediated cleavage is to our knowledge 
not previously described, and hence presents a new mechanism for lysine acetylation mediating protein 
expression. Originally, PEST domains were identified in short living proteins [36], and later they are 
shown to function as an anchor site of E3 ubiquitin ligases required for ubiquitin dependent protein 
degradation [37, 38]. TRIM32 degradation can be mediated both via proteasomal and lysosomal 
pathways [7]. Here we applied inhibitors of the proteasome, the lysosome and the calpain proteases (data 
not shown), but we were not able to pinpoint which pathway is implicated in the PEST mediated 
cleavage of TRIM32. We may speculate that the K247 acetylation inhibits binding of proteolytic 
enzymes, since acetylation of proteins is a well known mechanism for inhibiting (or promoting) protein-
protein interactions [29]. 
TRIM32 activity is regulated by tetramerization via its coiled-coil domain [39]. Tetramerization 
leads to formation of RING domain dimers on each side of the two antiparallel TRIM32 dimers. RING 
domain dimerization is a common pre-requisite for E3 ligase activity of TRIM proteins [40, 41]. 
TRIM32 tetramerization induces auto-ubiquitylation, which seems to be necessary for its conventional 
ubiquitin ligase activity and formation of cytoplasmic bodies. The scaffold 14-3-3 protein binds TRIM32 
proteins phosphorylated at S651 in its very C-terminal end, and thereby inhibits TRIM32 tetramerization 
and cytoplasmic body formation [17]. HSP70, on the other hand, is reported to bind TRIM32 and 
promote formation of cytoplasmic bodies in an ATP-consuming process [42]. Apart from that, very little 
is known on how TRIM32 tetramerization and catalytic activity is regulated. The TRIM32LGMD2H disease 
mutants lack ubiquitylation activity and display a diffuse cytoplasmic localization [7, 18]. This is in line 
with the MS analysis of PTMs on the TRIM32LGMD2H mutant in this study, where no lysine residues 
were found to be ubiquitylated. However, lysine K247 in the mutant protein was found to be acetylated, 
indicating that TRIM32 acetylation is not dependent on tetramerization. Mutation of the lysine residues 
K50, K247 and K401 to arginine, lead to cleavage of TRIM32 generating an around 20 kDa protein 
containing the N-terminal RBCC domains. This cleavage product resemble the short TRIM32 isoform, 
suggesting that isoform 3 of TRIM32 are generated by proteolytic cleavage. This finding is supported 
by the lack of a transcript that corresponds to isoform 3 (ensembl.org). Mimicking acetylation of lysine 
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K247, but keeping the K50R and K401R mutations, protected TRIM32 from cleavage but did not restore 
its auto-ubiquitylation activity. This was in line with our MS results showing that the catalytic inactive 
TRIM32LGMD2H mutant can undergo K247 acetylation.  Mimicking acetylation of K50 or K401 did not 
protect TRIM32 from PEST mediated cleavage and our MS data indicated that these residues are targets 
for ubiquitylation and not acetylation. Our results indicate that these two lysine residues are important 
for auto-ubiquitylation activity, and hence the E3 ligase activity of TRIM32.  
Our study uncover that TRIM32 isoform 3 may be generated by PEST mediated cleavage of 
full-length TRIM32 isoform1/2, and that acetylation of lysine K247 localized adjacent to the PEST 
sequence protects TRIM32 isoform 1/2 from cleavage. We show that the short TRIM32 isoform is 
catalytic inactive, and hence may function as a dominant negative mutant regulating TRIM32 E3 ligase 
activity. Moreover, we find that auto-ubiquitylation activity of full-length TRIM32 is dependent on the 
lysine residues K50 and K401. K50 is located in the RING domain, and hence may directly affect the 
formation of a functional catalytic unit. K401 is located in the NHL repeats. Various mutations in the 
NHL repeats cause LGMD2H, and we have previously shown that TRIM32LGMD2H mutants are catalytic 
inactive [7].  
Identification of a functional PEST sequence in a TRIM family protein is a novel finding, and 
also that acetylation of a lysine residue adjacent to the PEST region regulates the exposure of the PEST. 
These findings may contribute to the understanding of cellular mechanisms leading to dysregulated 
TRIM32 expression observed in pathological conditions. 
 
Materials and Methods 
Antibodies  
The following primary antibodies were used: rabbit polyclonal antibody for TRIM32 (Proteintech, 
10326-1-AP); rabbit polyclonal anti-GFP (Abcam, ab290); rabbit polyclonal anti-Actin (Sigma, 
A2066); mouse monoclonal anti-PCNA (DAKO, M0879); rabbit monoclonal anti-GM130 (Abcam, 
#52649). The following secondary antibodies were used: Horseradish-peroxidase (HRP)-conjugated 
goat anti-rabbit IgG (BD 5 Biosciences, 554021); HRP-conjugated goat anti-mouse Ig (BD Biosciences, 
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554002); HRPconjugated anti-Biotin antibody (Cell Signalling, #7075), and Alexa FluorR 555-
conjugated goat anti-rabbit IgG (Life Technologies, A-11008).  
 
Cell culture and transfections 
HEK293 FlpIn T-Rex (ThermoFisher, R714-07), HEK293 FlpIn T-Rex TRIM32 KO [7], C2C12 
(ATCC® CRL-1772™) were cultured in Dulbecco’s modified eagle’s medium (DMEM) (Sigma, D6046) 
with 10% fetal bovine serum and 1% streptomycin-penicillin (Sigma, P4333). Sub-confluent cells in 6-




Subconfluent cells were grown on coverslips (VWR, #631-0150) coated with Fibronectin (Sigma, 
F1141). They were fixed in 4% formaldehyde for 20min at R.T., permeabilized with methanol at RT for 
5min, blocked in 5% goat serum/PBS or 5%BSA/PBS and incubated at room temperature with a specific 
primary antibody followed by Alexa Fluor 555 conjugated secondary antibody and DAPI. Confocal 
images were obtained using a 63x/NA1.4 oil immersion objective on an LSM780 system and the ZEN 
software (Zeiss). Quantification of cells containing red only dots in the mCherry- EYFP-double tag 
assay was done manually in three independent experiments, each including at least 30 cells.  
 
Plasmids 
All plasmids used in this study are listed in Table 1. Plasmids were made by conventional restriction 
enzyme based cloning or by use of the Gateway recombination system (ThermoFisher). Gateway LR 
reactions were performed as described in the instruction manual. Point mutations and deletion were 
carried out using the Site-directed-mutagenesis kit from STRATAGENE, using the primers described 
in Table 2. The oligonucleotides were ordered from ThermoFisher. All plasmids were verified by DNA 
sequencing (BigDye, Applied Biosystems, 4337455).  
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Table 1: Plasmids used in this study 
pDest EGFP TRIM32  [7] 
pDest EGFP TRIM32 D487N  [7] 
pDest EGFP TRIM32 P130S  [7] 
pDest EGFP TRIM32 K50R  This study 
pDest EGFP TRIM32 K247R  This study 
pDest EGFP TRIM32 K401R  This study 
pDest EGFP TRIM32 K247R/K401R  This study 
pDest EGFP TRIM32 K50R/K247R  This study 
pDest EGFP TRIM32 K50Q/K401R  This study 
pDest EGFP TRIM32 K50R/K247R/K401R  This study 
pDest EGFP TRIM32 K50Q/K247R/K401R  This study 
pDest EGFP TRIM32 K50R/K247Q/K401R  This study 
pDest EGFP TRIM32 K50R/K247R/K401Q  This study 
pDest EGFP TRIM32 ΔPEST  This study 
pDest EGFP TRIM32  K50R/K247R/K401R ΔPEST  This study 
pDest EGFP TRIM32 mutPEST  This study 
pDest EGFP TRIM32 K247Q  This study 
pDest mCherry USP2   This study 
pDest mCherry-EYFP-TRIM32  [7] 
pDest mCherry-EYFP-TRIM32 K247R/K401R  This study 
pDest mCherry-EYFP-TRIM32 K247Q  This study 




pDest EGFP-C1  [43] 
pDest mCherry-EYFP  [44] 
 
 
Table 2: Oligonucleotides used in this study 
TRIM32K50R 5’-TGCCGCCAGTGCCTGGAGCGCCTATTGGCCAGTAGCATC- 3’ 
TRIM32K247R 5’-TACTTCCTGGCCAAGATCCGCCAGGCAGATGTAGCACTA- 3’ 
TRIM32K401R 5’-ATACAAGTCTTTACCCGCCGCGGCTTTTTGAAGGAAATC- 3’ 
TRIM32K50Q 5’-TGCCGCCAGTGCCTGGAGCAGCTATTGGCCAGTAGCATC- 3’ 
TRIM32K247Q 5’-TACTTCCTGGCCAAGATCCAGCAGGCAGATGTAGCACTA- 3’ 
TRIM32K401Q 5’-ATACAAGTCTTTACCCGCCAAGGCTTTTTGAAGGAAATC- 3’ 
TRIM32ΔPEST 5’-AGGCAGATGTAGCACTACTGCTCACTGCCAGCTTGCCTCG -3’ 
TRIM32mutPEST 5’- CACTACTGGTGGTGATAGCTGATGTGGTGGTGCCAGAGCT- 3’ 
 
Western Blotting 
Cells were seeded in 6-well dishes and treated as indicated. Cells were lysed in 1xSDS buffer (50mM 
Tris pH 7.4; 2% SDS; 10% Glycerol) supplemented with 200mM dithiothreitol (Sigma, #D0632) and 
heated at 100°C for 10 minutes. The lysates were resolved by SDS-PAGE and transferred to 
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nitrocellulose membrane (Sigma, GE10600003). The membrane was stained with Ponceau S (Sigma, 
P3504), blocked with 5% non-fat dry milk in 1% TBS-T (0.2M Tris pH 8; 1.5M NaCl and 0.05% 
Tween20 (Sigma, P9416)) and then incubated with indicated primary antibodies for 24h. The membrane 
was washed three times for 10 minutes each with PBS-T followed by incubation with secondary 
antibody for 1h. The membrane was washed three times for 10 minutes and analyzed by enhanced 
chemiluminescence using the ImageQuant LAS 4000 (GE Lifescience). 
 
Statistics 
All experiments were repeated at least three times, unless otherwise specified. Error bars represent the 
standard deviation. Two-sided unpaired, homoscedastic Student T-Tests, were performed to assess 
significant differences between populations. Replicates were not pooled for statistical analyses. 
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S1 Fig 1. Inhibition of proteolytic enzymes does not stabilize the TRIM32K50R/K247R/K401R mutant or 
the TRIM32K247R/K401R mutant.  A. Western Blot analysis of HEK293 FlpIn TRIM32 KO cells 
transiently transfected with expression plasmids for TRIM32K50R/K247R/K401R, EGFP-TRIM32WT, or 
TRIM32K247R/K401R. The bands representing EGFP-TRIM32 are indicated to the right. The arrow 
indicates the band representing cleaved/partial degraded EGFP-TRIM32. The cells are treated with 
lysosomal inhibitor BafA1 (0.5 M), proteasomal inhibitor MG132 (5M), and calpain inhibitor E64D 
(5 g/ml) for 18 hours where indicated. Actin represents the loading control. B. Western Blot analysis 
of cell extracts from HEK293 FlpIn TRIM32 KO cells transiently co-transfected with expression 
plasmids for EGFP-TRIM32WT and mCherry-USP2, or EGFP-TRIM32WT and myc-HDAC6, or EGFP-
TRIM32WT and mCherry-USP2 and myc-HDAC6, as indicated above. The CBP/p300 inhibitor C646 
was added where indicated. The intensities of the TRIM32 bands relative to the intensities of the actin 
bands are indicated by the numbers below the blot. Actin represents the loading control. EV: Co-
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